Original Article
Helicobacter pylori Infection and the Development of Gastric Cancer
N Engl J Med 2001; 345:784-789September 13, 2001
- Abstract
Background
Although many studies have found an association between Helicobacter pylori infection and the development of gastric cancer, many aspects of this relation remain uncertain.
Methods
We prospectively studied 1526 Japanese patients who had duodenal ulcers, gastric ulcers, gastric hyperplasia, or nonulcer dyspepsia at the time of enrollment; 1246 had H. pylori infection and 280 did not. The mean follow-up was 7.8 years (range, 1.0 to 10.6). Patients underwent endoscopy with biopsy at enrollment and then between one and three years after enrollment. H. pylori infection was assessed by histologic examination, serologic testing, and rapid urease tests and was defined by a positive result on any of these tests.
Results
Gastric cancers developed in 36 (2.9 percent) of the infected and none of the uninfected patients. There were 23 intestinal-type and 13 diffuse-type cancers. Among the patients with H. pylori infection, those with severe gastric atrophy, corpus-predominant gastritis, and intestinal metaplasia were at significantly higher risk for gastric cancer. We detected gastric cancers in 21 (4.7 percent) of the 445 patients with nonulcer dyspepsia, 10 (3.4 percent) of the 297 with gastric ulcers, 5 (2.2 percent) of the 229 with gastric hyperplastic polyps, and none of the 275 with duodenal ulcers.
Conclusions
Gastric cancer develops in persons infected with H. pylori but not in uninfected persons. Those with histologic findings of severe gastric atrophy, corpus-predominant gastritis, or intestinal metaplasia are at increased risk. Persons with H. pylori infection and nonulcer dyspepsia, gastric ulcers, or gastric hyperplastic polyps are also at risk, but those with duodenal ulcers are not.
Media in This Article
Figure 1
Kaplan–Meier Analysis of the Proportion of H. pylori–Positive and H. pylori–Negative Patients Who Remained Free of Gastric Cancer.Figure 2
Kaplan–Meier Analysis of the Proportion of Patients Who Had Nonulcer Dyspepsia, Duodenal Ulcers, Gastric Ulcers, and Hyperplastic Gastric Polyps at the Time of Enrollment Who Remained Free of Gastric Cancer.Article Activity
- Article
Since the discovery of Helicobacter pylori in 1983,1 the diagnosis and treatment of upper gastrointestinal disease have changed greatly. A higher risk of the development of gastric cancer has been reported in subjects with positive serologic tests for H. pylori.2-4 The World Health Organization and International Agency for Research on Cancer consensus group5 stated in 1994 that there was sufficient epidemiologic and histologic6,7 evidence to classify H. pylori as a definite carcinogen. Most but not all recent studies8,9 have found H. pylori to be associated with gastric cancer. The rates of infection in patients with gastric cancer vary greatly among studies. These variations may be attributable to differences in the methods of detecting H. pylori or in the patient groups. Most prospective studies8,9 have used control groups “nested” within cohorts of study patients from whom blood samples were taken years before the onset of clinical gastric cancer. Various diagnostic tests for H. pylori 10,11 may have false negative results, and the use of multiple tests may help to provide a more accurate diagnosis of H. pylori infection.12 In Japan, where the incidence of gastric cancer is high, endoscopy is performed frequently for the early detection of gastric cancer, even as part of the examination of patients without symptoms of the disease. As a result, early-stage cancers are often discovered by endoscopy.
We conducted a prospective, long-term study of a large group of patients who were assessed for H. pylori infection by endoscopy and biopsy, followed by histologic examination, a rapid urease test, and serologic testing, to determine the relation between H. pylori infection and the development of gastric cancer.
Methods
Patients
Between April 1990 and March 1993, we enrolled 1603 consecutive patients with active duodenal ulcers, active gastric ulcers, gastric hyperplastic polyps, or nonulcer dyspepsia. They were assessed for H. pylori infection and underwent endoscopic follow-up for the early detection of gastric cancer. We had previously excluded patients with severe underlying disease, including gastric cancer and adenoma, those who had undergone gastric resection, and those taking nonsteroidal antiinflammatory drugs. We then excluded 77 patients who declined a second endoscopic examination. The remaining 1526 patients (869 men and 657 women; mean age, 52 years; range, 20 to 76) were studied. Endoscopy with biopsy was performed in all patients at enrollment and between one and three years after enrollment. Follow-up data were censored because of deaths from other causes and the use of antibiotic treatment for the eradication of H. pylori. The mean duration of follow-up was 7.8 years (range, 1.0 to 10.6). All patients gave written informed consent. The study protocol was approved by the ethics committees of Kure Kyosai Hospital and was reviewed annually.
Endoscopy and Histologic Examination
All endoscopic examinations were performed with only local anesthesia (lidocaine). An Olympus videoscope (model GIF-230, Olympus, Tokyo, Japan) was used. Four biopsy specimens were taken, two from the greater curvature of the antrum and two from the upper body of the stomach (when lesions suspected to be cancerous were noted, additional biopsies were performed). Of these four specimens, two were fixed in formalin and assessed for H. pylori (by Giemsa staining) and the degree of neutrophil infiltration and intestinal metaplasia (by staining with hematoxylin and eosin). The remaining two were used for a rapid urease test (CLO, Delta West, Bentley, Australia). The degree of neutrophil infiltration was classified according to four grades (0 denoting no infiltration, 1 mild, 2 moderate, and 3 marked) and expressed as a score by two pathologists according to the updated Sydney system.13 Consensus was reached through joint review of all the slides. Active gastritis was classified into four categories (no gastritis, antrum-predominant gastritis, pangastritis, and corpus-predominant gastritis). Intestinal metaplasia was classified in two grades (absent or present), because the multifocal distribution of metaplasia may lead to misclassification when only two biopsy specimens are obtained. Gastric mucosal atrophy was evaluated according to the endoscopic-atrophic-border scale described by Kimura and Takemoto,14 which correlates with the results of histologic evaluation.15,16 There were three classifications (1 denoting mild atrophy or none, 2 moderate, and 3 severe). The pathologists were not aware of the clinical or endoscopic data. The results were scored blindly with the use of patient codes.
The rapid urease test was monitored for up to 24 hours. Gastric cancer was defined as evident invasion of neoplastic epithelium into the lamina propria of the mucosa or beyond (i.e., category 5.1 or 5.2 according to the Vienna classification17) and was classified according to Laurén18 as intestinal or diffuse type.
Serologic Evaluation
Blood was sampled immediately before endoscopy; serum was immediately separated and cryopreserved at –20°C until it was assayed for antibodies against H. pylori (HM-CAP, Enteric Products, Westbury, N.Y.). A positive serologic test for H. pylori was defined as one with a titer of 1.8 or more.
Detection of H. pylori Infection
H. pylori infection was identified by histologic examination, the rapid urease test, and serologic evaluation. Patients in whom any of these assays were positive were classified as H. pylori–positive. Those in whom all three were negative were considered H. pylori–negative.
Statistical Analysis
All statistical analyses were performed with SAS software (SAS Institute, Cary, N.C.).19 The demographic and clinical characteristics of the patients were compared by Student's t-test (for age, duration of follow-up, and number of endoscopic procedures) or the chi-square test (for sex, diagnosis, grade of gastric mucosal atrophy, distribution of gastritis, and presence or absence of intestinal metaplasia). We calculated relative risks for gastric findings — such as the degree of atrophy, the pattern of distribution of gastritis, and the presence of intestinal metaplasia — using Cox proportional-hazards models. Since gastric cancer has not been demonstrated to develop in patients with duodenal ulcers or in those who are H. pylori–negative (with or without eradication therapy), we could not calculate the difference in the incidence of gastric cancer using the Cox proportional-hazards model. For this reason, Kaplan–Meier analysis and the chi-square test or Fisher's exact test were used to assess the difference in proportions. All P values are two-sided; significance was indicated by a P value of less than 0.05.
Results
Of the 1526 patients, 1246 were H. pylori–positive and 280 H. pylori–negative. The base-line characteristics of both groups are shown in Table 1Table 1
Base-Line Characteristics of the 1526 Patients.. There were no significant differences between the two groups in age, sex, or the mean number of endoscopic procedures. The H. pylori–positive patients included 445 with nonulcer dyspepsia (206 men and 239 women; mean age, 54 years; range, 22 to 76), 275 with duodenal ulcers (198 men and 77 women; mean age, 48 years; range, 20 to 76), 297 with gastric ulcers (226 men and 71 women; mean age, 52 years; range, 22 to 75), and 229 with gastric polyps (84 men and 145 women; mean age, 56 years; range, 26 to 76). The H. pylori–negative patients all had nonulcer dyspepsia. Atrophy and intestinal metaplasia of any grade were found in 4 percent and 2 percent of H. pylori–negative patients, respectively. Of the H. pylori–negative group, only 2 percent had gastritis, all antrum predominant. In the H. pylori–positive group, 53 percent had moderate atrophy and 17 percent had severe atrophy. Antrum-predominant gastritis was found in 56 percent, pangastritis in 27 percent, and corpus-predominant gastritis in 17 percent of H. pylori–positive patients. Thirty-seven percent had intestinal metaplasia. There were significant differences in these variables between the groups (P<0.001 by the chi-square test). The duration of follow-up in the H. pylori–positive group was significantly shorter than in the uninfected group (P<0.001), because 253 of 1246 infected patients received eradication therapy at an early stage of follow-up.Development of Gastric Cancer
During follow-up, gastric cancer developed in 36 of 1246 H. pylori–infected patients (2.9 percent) but in none of the 280 uninfected patients (P<0.001). All cancers were visible on endoscopy and were identified histologically on biopsy. In Figure 1Figure 1
Kaplan–Meier Analysis of the Proportion of H. pylori–Positive and H. pylori–Negative Patients Who Remained Free of Gastric Cancer., the risk of gastric cancer is shown to be 5 percent at 10 years by Kaplan–Meier analysis. There were 23 men and 13 women with gastric cancer (at base line: mean age, 60 years; range, 41 to 76; at the time of detection of gastric cancer: mean age, 65; range, 47 to 83). Sixteen men and seven women had intestinal-type cancers (at base line: mean age, 64 years; range, 44 to 76; at the time of detection of gastric cancer: mean age, 70; range, 53 to 83), and six men and seven women had diffuse-type cancers (at base line: mean age, 52 years; range, 41 to 68; at the time of detection of gastric cancer: mean age, 58; range, 47 to 75). The mean age at enrollment and at the time of detection of gastric cancer was significantly lower in the patients with diffuse-type cancer than in those with intestinal-type cancer (P<0.001 for both comparisons).Table 2Table 2
The Development of Gastric Cancer in H. pylori–Positive Patients According to Abnormalities at Base Line. shows the abnormalities of the gastric mucosa at base line in all the H. pylori–infected patients and in the 36 patients with gastric cancer, as well as the relative risks of cancer according to the base-line abnormalities. The frequency of severe atrophy, corpus-predominant gastritis, and intestinal metaplasia was significantly higher in patients with intestinal-type gastric cancer than in those with diffuse-type cancer (P=0.002, P<0.001, and P=0.008, respectively). Nine of the patients with diffuse-type gastric cancer had moderate atrophy, and 10 had pangastritis.During follow-up, gastric cancer was detected in 21 of the 445 patients with nonulcer dyspepsia (4.7 percent), in 10 of the 297 with gastric ulcers (3.4 percent), and in 5 of the 229 with gastric polyps (2.2 percent) at base line (Figure 2Figure 2
Kaplan–Meier Analysis of the Proportion of Patients Who Had Nonulcer Dyspepsia, Duodenal Ulcers, Gastric Ulcers, and Hyperplastic Gastric Polyps at the Time of Enrollment Who Remained Free of Gastric Cancer.). No gastric cancer was detected in patients with duodenal ulcers. The frequency of gastric cancer in patients with nonulcer dyspepsia, gastric ulcers, and gastric polyps was significantly higher than in those with duodenal ulcers (Table 3Table 3
The Development of Gastric Cancer in H. pylori–Positive Patients According to Endoscopic Findings.). The frequency of diffuse-type cancer in patients with gastric ulcers was significantly higher than in patients with nonulcer dyspepsia and gastric polyps (P=0.03 by the chi-square test). The mean age at the time of diagnosis of gastric cancer in patients with gastric ulcers (53 years) was significantly lower than in those with nonulcer dyspepsia (63 years) (P=0.009 by Student's t-test). Gastric cancer did not develop in any of the 253 patients with H. pylori infection who received eradication therapy. The mean (±SD) duration of follow-up after eradication (4.8±1.2 years) was shorter than the mean duration for patients who were not treated (8.5±1.7 years; P<0.001 by Student's t-test).Discussion
We found that gastric cancer developed in patients with H. pylori infection but not in uninfected patients. Our findings are consistent with those of a recent meta-analysis.8 In Japan, it has been reported that each year, gastric cancer develops in 300,000 (0.5 percent) of the 60 million people who are H. pylori–positive,20 which means that gastric cancer develops in 5 percent of H. pylori–positive persons over 10 years. Our results support this estimate.
In previous epidemiologic studies showing a close relation between H. pylori infection and gastric cancer, a large number of patients with negative serologic results were found to have cancer.8,9 Recent studies10-12 have shown that false negative results occur with the serum antibody assay, so it is possible that the rate of H. pylori infection has been underestimated in patients with gastric cancer. Tabata et al.12 concluded from their study of this issue that a biopsy specimen should be taken from the greater curvature of the upper gastric body because this procedure results in fewer false negatives. Enomoto et al.21 performed an immunohistologic study of biopsy specimens from the greater curvature of the upper gastric body and antibodies against H. pylori; they found that 98 percent of patients with gastric cancer were H. pylori–positive. Their results and our findings suggest that there are very few patients with gastric cancer who are not infected with H. pylori. It has previously been shown that in H. pylori–negative patients, histologic evidence of gastritis, especially neutrophil infiltration, is rare, and little gastric mucosal atrophy occurs.22,23 This is what we found as well. Thus, the onset of gastric cancer may be related to histologic evidence of gastritis or atrophic gastritis associated with H. pylori infection.
Our findings suggest that patients with H. pylori infection and severe atrophic gastritis, corpus-predominant gastritis, or both, along with intestinal metaplasia are at high risk for intestinal-type gastric cancer. It has been shown that intestinal-type gastric cancer develops in patients who have severe atrophic gastritis in association with intestinal metaplasia.24 Progression of atrophic gastritis can be caused by H. pylori infection.25 Our results confirm the hypothesis of Correa24 that severe atrophic gastritis accompanying intestinal metaplasia caused by persistent H. pylori infection is closely related to the development of intestinal-type gastric cancer.
Since atrophic changes are not severe in diffuse-type gastric cancer,25,26 it was previously considered to have little relation to H. pylori infection. However, epidemiologic and histopathological studies27,28 have shown that the development of diffuse-type cancer is also closely related to H. pylori infection. In our study, many of the patients with diffuse-type gastric cancer had moderate atrophic changes and pangastritis. Our results support the hypothesis of Sipponen et al.25 and Solcia et al.26 that diffuse-type gastric cancer develops during the progression of atrophic gastritis in patients with H. pylori infection and is associated particularly with active gastritis.
In our study, gastric cancer developed in patients with nonulcer dyspepsia, active gastric ulcers, and hyperplastic gastric polyps, but no gastric cancers developed during follow-up in patients with active duodenal ulcers. Hansson et al.29 have shown that gastric ulcer is associated with a high risk of gastric cancer, whereas duodenal ulcer is associated with a low risk. Patients with gastric ulcers typically have atrophic gastritis and corpus-predominant gastritis. Patients with duodenal ulcers have few atrophic changes and have antrum-predominant gastritis.30-32 Thus, there should be a higher rate of gastric cancer in patients with gastric ulcers than in those with duodenal ulcers. Diffuse-type gastric cancer is predominant in patients with gastric ulcers, many of whom are relatively young. In young patients with gastric ulcers, it is therefore necessary to perform careful follow-up to detect diffuse-type gastric cancer even after ulcers have healed. No gastric cancer developed after eradication of H. pylori in 253 infected patients in our study, although the duration of follow-up was relatively short. We have previously shown that in patients with early gastric cancer that is treated by endoscopic mucosal resection, eradication of H. pylori prevents the development of new cancer or the continued growth of occult cancer (i.e., cancer undetectable by endoscopy at the time of initial treatment).33
In conclusion, we found that H. pylori infection is associated with the development of both intestinal-type and diffuse-type gastric cancer. Among infected patients, those with severe atrophy accompanying intestinal metaplasia, corpus-predominant gastritis, or both are at particularly high risk.
Presented in part at the annual meeting of the American Gastroenterology Association, San Diego, Calif., May 20, 2000.
Supported in part by a grant-in-aid for cancer research (8-14) from the Ministry of Health and Welfare of Japan.
We are indebted to Professor Anthony Axon (of the Center for Digestive Disease at the General Infirmary at Leeds, United Kingdom) and to Professor Manfred Stolte (of the Institute of Pathology, Klinikum Bayreuth, Germany) for their helpful suggestions and to Ms. Masako Hiramatsu and Ms. Chiyo Maruyama for their excellent technical assistance in the endoscopy unit.
Source Information
From the Departments of Gastroenterology (N.U., S.O., S.Y., N.M., S.Y., M.Y.) and Clinical Pathology (K.T., N.S.), Kure Kyosai Hospital, Kure City; and the Department of Internal Medicine, Fukuoka University School of Medicine, Fukuoka (R.J.S.) — both in Japan.
Address reprint requests to Dr. Uemura at the Department of Gastroenterology, Kure Kyosai Hospital, 2-3-28 Nishi-chuo, Kure City, Japan, or at n-uemura@mua.biglobe.ne.jp.
- References
References
1
Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;1:1273-1275
Web of Science | Medline2
Parsonnet J ,Friedman GD ,Vandersteen DP , et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-1131
Full Text | Web of Science | Medline3
Nomura A ,Stemmermann GN ,Chyou P-H ,Kato I ,Perez-Perez GI ,Blaser MJ . Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-1136
Full Text | Web of Science | Medline4
Forman D ,Newell DG ,Fullerton F , et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991;302:1302-1305
CrossRef | Web of Science | Medline5
Infection with Helicobacter pylori. In: IARC monographs on the evaluation of the carcinogenic risks to humans. Vol. 61. Schistosomes, liver flukes and Helicobacter pylori. Lyon, France: International Agency for Research on Cancer, 1994:177-241.
6
Correa P ,Fox J ,Fontham E , et al. Helicobacter pylori and gastric carcinoma: serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990;66:2569-2574
CrossRef | Web of Science | Medline7
Sipponen P ,Hyvarinen H . Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand J Gastroenterol Suppl 1993;196:3-6
CrossRef | Medline8
Huang J-Q ,Sridhar S ,Chen Y ,Hunt RH . Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1999;114:1169-1179
CrossRef | Web of Science9
Danesh J . Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol Ther 1999;13:851-856
CrossRef | Web of Science | Medline10
Miwa H ,Kikuchi S ,Ohtaka K , et al. Insufficient diagnostic accuracy of imported serological kits for Helicobacter pylori infection in Japanese population. Diagn Microbiol Infect Dis 2000;36:95-99
CrossRef | Web of Science | Medline11
Ohara S ,Kato M ,Asaka M ,Toyota T . Studies of 13C-urea breath test for diagnosis of Helicobacter pylori infection in Japan. J Gastroenterol 1998;33:6-13
CrossRef | Web of Science | Medline12
Tabata H ,Fuchigami T ,Kobayashi H , et al. Helicobacter pylori and mucosal atrophy in patients with gastric cancer: a special study regarding the methods for detecting Helicobacter pylori. Dig Dis Sci 1999;44:2027-2034
CrossRef | Web of Science | Medline13
Dixon MF ,Genta RM ,Yardley JH ,Correa P . Classification and grading of gastritis: the updated Sydney System. Am J Surg Pathol 1996;20:1161-1181
CrossRef | Web of Science | Medline14
Kimura K ,Takemoto T . Endoscopic atrophy border. Endoscopy 1969;1:1-3
CrossRef15
Satoh K ,Kimura K ,Taniguchi Y , et al. Distribution of inflammation and atrophy in the stomach of Helicobacter pylori-positive and -negative patients with chronic gastritis. Am J Gastroenterol 1996;91:963-969
Web of Science | Medline16
Ito S ,Azuma T ,Murakita H , et al. Profile of Helicobacter pylori cytotoxin derived from two areas of Japan with different prevalence of atrophic gastritis. Gut 1996;39:800-806
CrossRef | Web of Science | Medline17
Schlemper RJ ,Riddell RH ,Kato Y , et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-255
CrossRef | Web of Science | Medline18
Lauren P . The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49
Medline19
SAS/STAT software: changes and enhancement, through release 6.11. Cary, N.C.: SAS Institute, 1996.
20
Asaka M, ed. Gastric cancer: Helicobacter pylori and gastroduodenal diseases. Tokyo, Japan: Sentan Igakusha, 1999:116-26. (In Japanese.)
21
Enomoto H ,Watanabe H ,Nishikura K ,Umezawa H ,Asakura H . Topographic distribution of Helicobacter pylori in the resected stomach. Eur J Gastroenterol Hepatol 1998;10:473-478
CrossRef | Web of Science | Medline22
Blaser MJ . Hypothesis on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 1992;102:720-727
Web of Science | Medline23
Kuipers EJ ,Uyterlinde AM ,Pena AS , et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525-1528
CrossRef | Web of Science | Medline24
Correa P . Human gastric carcinogenesis: a multistep and multifactorial process -- First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-6740
Web of Science | Medline25
Sipponen M ,Kosunen TU ,Valle J ,Riihela M ,Seppala K . Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol 1992;45:319-323
CrossRef | Web of Science | Medline26
Solcia E ,Fiocca R ,Luinetti O , et al. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol 1996;20:Suppl 1:S8-S22
CrossRef | Web of Science | Medline27
Kikuchi S ,Wada O ,Nakajima T , et al. Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Cancer 1995;75:2789-2793
CrossRef | Web of Science | Medline28
Kokkola A ,Valle J ,Haapiainen R ,Sipponen P ,Kivilaakso E ,Puolakkainen P . Helicobacter pylori infection in young patients with gastric carcinoma. Scand J Gastroenterol 1996;31:643-647
CrossRef | Web of Science | Medline29
Hansson L-E ,Nyren O ,Hsing AW , et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996;335:242-249
Full Text | Web of Science | Medline30
Stolte M ,Eidt S ,Ohnsmann A . Differences in Helicobacter pylori associated gastritis in the antrum and body of the stomach. Z Gastroenterol 1990;28:229-233
Web of Science | Medline31
Meining A ,Stolte M ,Hatz R , et al. Differing degree and distribution of gastritis in Helicobacter pylori-associated diseases. Virchows Arch 1997;431:11-15
CrossRef | Web of Science | Medline32
Graham DY . Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease. J Gastroenterol Hepatol 1991;6:105-113
CrossRef | Web of Science | Medline33
Uemura N ,Mukai T ,Okamoto S , et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997;6:639-642
Web of Science | Medline
- Citing Articles (916)
Citing Articles
1
Salaspuro Mikko. (2012) Interactions of alcohol and tobacco in gastrointestinal cancer. Journal of Gastroenterology and Hepatology 27, 135-139
CrossRef2
Feng Pan, Jing Tian, Yue-Yin Pan, Ying Zhang. (2012) Association of IL-10-1082 promoter polymorphism with susceptibility to gastric cancer: evidence from 22 case–control studies. Molecular Biology Reports
CrossRef3
Lars Agréus, Ernst J Kuipers, Limas Kupcinskas, Peter Malfertheiner, Francesco Di Mario, Marcis Leja, Varocha Mahachai, Niv Yaron, Martijn van Oijen, Guillermo Perez Perez, Massimo Rugge, Jukka Ronkainen, Mikko Salaspuro, Pentti Sipponen, Kentaro Sugano, Joseph Sung. (2012) Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scandinavian Journal of Gastroenterology 47:2, 136-147
CrossRef4
Na Li, Bin Tang, En-Dong Zhu, Bo-sheng Li, Yuan Zhuang, Shu Yu, Dong-shui Lu, Quan-Ming Zou, Bin Xiao, Xu-Hu Mao. (2012) Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK. FEBS Letters
CrossRef5
Sung Noh Hong, Seunghyun Jo, Ju Hyun Jang, Jida Choi, Soohyun Kim, Soo Young Ahn, Jeong Hwan Kim, Won Hyeok Choe, Sun-Young Lee, In Kyung Sung, Hyung Seok Park, Chan Sup Shim. (2012) Clinical Characteristics and the Expression Profiles of Inflammatory Cytokines/Cytokine Regulatory Factors in Asymptomatic Patients with Nodular Gastritis. Digestive Diseases and Sciences
CrossRef6
Sohachi Nanjo, Kiyoshi Asada, Satoshi Yamashita, Takeshi Nakajima, Kazuyuki Nakazawa, Takao Maekita, Masao Ichinose, Toshiro Sugiyama, Toshikazu Ushijima. (2012) Identification of gastric cancer risk markers that are informative in individuals with past H. pylori infection. Gastric Cancer
CrossRef7
Gustaf Edgren, Liming Liang, Hans-Olov Adami, Ellen T. Chang. (2012) Enigmatic sex disparities in cancer incidence. European Journal of Epidemiology
CrossRef8
CHANDRAKANT ANKOLEKAR, KEVIN JOHNSON, MARCIA PINTO, DAVID JOHNSON, RONALD G. LABBE, DUANE GREENE, KALIDAS SHETTY. (2012) FERMENTATION OF WHOLE APPLE JUICE USING LACTOBACILLUS ACIDOPHILUS FOR POTENTIAL DIETARY MANAGEMENT OF HYPERGLYCEMIA, HYPERTENSION, AND MODULATION OF BENEFICIAL BACTERIAL RESPONSES. Journal of Food Biochemistryno-no
CrossRef9
Taiji Matsuo, Masanori Ito, Masana Tatsugami, Tomoyuki Boda, Shunsuke Takata, Shinji Tanaka, Kazuaki Chayama. (2012) Gastric Cancer Development after <i>Helicobacter pylori</i> Eradication Therapy: A New Form of Gastric Neoplasia. Digestion 85:1, 61-67
CrossRef10
Masaaki Kodama, Kazunari Murakami, Tadayoshi Okimoto, Takashi Abe, Yoshifumi Nakagawa, Kazuhiro Mizukami, Masahiro Uchida, Kunimitsu Inoue, Toshio Fujioka. (2012) <i>Helicobacter pylori</i> Eradication Improves Gastric Atrophy and Intestinal Metaplasia in Long-Term Observation. Digestion 85:2, 126-130
CrossRef11
Pelayo Correa, M. Blanca Piazuelo. (2012) Evolutionary History of the Helicobacter pylori Genome: Implications for Gastric Carcinogenesis. Gut and Liver 6:1, 21
CrossRef12
Julián Díaz Sánchez, Lourdes Pulido Izquierdo, José María Casanova Colominas. (2012) Adenocarcinoma gástrico. FMC - Formación Médica Continuada en Atención Primaria 19:1, 49-50
CrossRef13
Shuji Takiguchi, Shinichi Adachi, Kazuyoshi Yamamoto, Eiichi Morii, Hiroshi Miyata, Kiyokazu Nakajima, Makoto Yamasaki, Kenji Kangawa, Masaki Mori, Yuichiro Doki. (2011) Mapping Analysis of Ghrelin Producing Cells in the Human Stomach Associated with Chronic Gastritis and Early Cancers. Digestive Diseases and Sciences
CrossRef14
Masaaki Kodama, Kazunari Murakami, Tadayoshi Okimoto, Ryugo Sato, Masahiro Uchida, Takashi Abe, Seiji Shiota, Yoshifumi Nakagawa, Kazuhiro Mizukami, Toshio Fujioka. (2011) Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication. Journal of Gastroenterology
CrossRef15
R. Y. CHUNG, G. M. LEUNG, B. J. COWLING, C. M. SCHOOLING. (2011) Patterns of and hypotheses for infection-related cancers in a Chinese population with rapid economic development. Epidemiology and Infection1-16
CrossRef16
Le Guo, Xiaokang Li, Feng Tang, Yunmian He, Yingying Xing, Xuepeng Deng, Tao Xi. (2011) Immunological features and the ability of inhibitory effects on enzymatic activity of an epitope vaccine composed of cholera toxin B subunit and B cell epitope from Helicobacter pylori urease A subunit. Applied Microbiology and Biotechnology
CrossRef17
Fulya Oz Puyan, Nuray Can, Filiz Ozyilmaz, Ufuk Usta, Necdet Sut, Ebru Tastekin, Semsi Altaner. (2011) The relationship among PDX1, CDX2, and mucin profiles in gastric carcinomas; correlations with clinicopathologic parameters. Journal of Cancer Research and Clinical Oncology 137:12, 1749-1762
CrossRef18
Ryo NAKASHIMA, Naoyoshi NAGATA, Kazuhiro WATANABE, Masao KOBAYAKAWA, Toshiyuki SAKURAI, Junichi AKIYAMA, Kazufusa HOSHIMOTO, Takuro SHIMBO, Naomi UEMURA. (2011) Histological features of nodular gastritis and its endoscopic classification. Journal of Digestive Diseases 12:6, 436-442
CrossRef19
, Hideki Origasa, Shinya Goto, Kazuyuki Shimada, Shinichiro Uchiyama, Yasushi Okada, Kentaro Sugano, Hideyuki Hiraishi, Naomi Uemura, Yasuo Ikeda. (2011) Prospective Cohort Study of Gastrointestinal Complications and Vascular Diseases in Patients Taking Aspirin: Rationale and Design of the MAGIC Study. Cardiovascular Drugs and Therapy 25:6, 551-560
CrossRef20
Eu-Jin Cho, Hyo-Jin An, Ji-Sun Shin, Hye-Eun Choi, Jane Ko, Young-Wuk Cho, Hyung-Min Kim, Jung-Hye Choi, Kyung-Tae Lee. (2011) Roxatidine suppresses inflammatory responses via inhibition of NF-κB and p38 MAPK activation in LPS-induced RAW 264.7 macrophages. Journal of Cellular Biochemistry 112:12, 3648-3659
CrossRef21
Bruno Annibale, Edith Lahner, Gianfranco Delle Fave. (2011) Diagnosis and Management of Pernicious Anemia. Current Gastroenterology Reports 13:6, 518-524
CrossRef22
Taiji Matsuo, Masanori Ito, Shunsuke Takata, Shinji Tanaka, Masaharu Yoshihara, Kazuaki Chayama. (2011) Low Prevalence of Helicobacter pylori-negative Gastric Cancer among Japanese. Helicobacter 16:6, 415-419
CrossRef23
Hiroshi Kishikawa, Jiro Nishida, Hitoshi Ichikawa, Shogo Kaida, Sakiko Takarabe, Takashi Matsukubo, Soichiro Miura, Tetsuo Morishita, Toshifumi Hibi. (2011) Fasting Gastric pH of Japanese Subjects Stratified by IgG Concentration Against Helicobacter pylori and Pepsinogen Status. Helicobacter 16:6, 427-433
CrossRef24
Chandrabose Sureka, Thiyagarajan Ramesh. (2011) Molecular assessment of c-H-ras p21 expression in Helicobacter pylori-mediated gastric carcinogenesis. Molecular and Cellular Biochemistry
CrossRef25
Dewei Luo, Yan Gao, Shizhi Wang, Meilin Wang, Dongmei Wu, Wei Wang, Ming Xu, Jianwei Zhou, Weida Gong, Yongfei Tan, Zhengdong Zhang. (2011) Genetic variation in PLCE1 is associated with gastric cancer survival in a Chinese population. Journal of Gastroenterology 46:11, 1260-1266
CrossRef26
Barry Schlansky, Amnon Sonnenberg. (2011) Epidemiology of Noncardia Gastric Adenocarcinoma in the United States. The American Journal of Gastroenterology 106:11, 1978-1985
CrossRef27
Zhenming Ge, Qiwen Ben, Junbo Qian, Yamin Wang, Yuming Li. (2011) Diabetes mellitus and risk of gastric cancer. European Journal of Gastroenterology & Hepatology 23:12, 1127-1135
CrossRef28
Chandrakant Ankolekar, David Johnson, Marcia da Silva Pinto, Kevin Johnson, Ronald Labbe, Kalidas Shetty. (2011) Inhibitory Potential of Tea Polyphenolics and Influence of Extraction Time Against Helicobacter pylori and Lack of Inhibition of Beneficial Lactic Acid Bacteria. Journal of Medicinal Food 14:11, 1321-1329
CrossRef29
Xiao Bo Guo, Lei Guo, Qiao Ming Zhi, Jun Ji, Jin Ling Jiang, Rong Juan Zhang, Jia Nian Zhang, Jun Zhang, Xue Hua Chen, Qu Cai, Jian Fang Li, Min Yan, Qin Long Gu, Bing Ya Liu, Zheng Gang Zhu, Ying Yan Yu. (2011) Helicobacter pylori induces promoter hypermethylation and downregulates gene expression of IRX1 transcription factor on human gastric mucosa. Journal of Gastroenterology and Hepatology 26:11, 1685-1690
CrossRef30
Mitsushige Sugimoto, Tomoyuki Ohno, David Y Graham, Yoshio Yamaoka. (2011) Helicobacter pylori outer membrane proteins on gastric mucosal interleukin 6 and 11 expression in Mongolian gerbils. Journal of Gastroenterology and Hepatology 26:11, 1677-1684
CrossRef31
Lisette G. Capelle, Caroline M. den Hoed, Annemarie C. de Vries, Katharina Biermann, Mariel K. Casparie, Gerrit A. Meijer, Ernst J. Kuipers. (2011) Premalignant gastric lesions in patients with gastric mucosa-associated lymphoid tissue lymphoma and metachronous gastric adenocarcinoma. European Journal of Gastroenterology & Hepatology1
CrossRef32
Tsutomu Tanaka, Nirmeen Megahed, Katsuyoshi Takata, Naoko Asano, Yasumasa Niwa, Yoshiki Hirooka, Hidemi Goto. (2011) A case of lymphomatoid gastropathy: An indolent CD56-positive atypical gastric lymphoid proliferation, mimicking aggressive NK/T cell lymphomas. Pathology - Research and Practice
CrossRef33
, Woon Geon Shin, Heung Up Kim, Ho June Song, Su Jin Hong, Ki-Nam Shim, In-Kyung Sung, Jae Gyu Kim. (2011) Surveillance Strategy of Atrophic Gastritis and Intestinal Metaplasia in a Country with a High Prevalence of Gastric Cancer. Digestive Diseases and Sciences
CrossRef34
Jian-Feng Zhang, Zhen-Biao Mao, Zeng-Li Li, Shi-Min Xue, Hui-Jun Zhu, Hong Zhang, Run-Zhou Ni. (2011) Ectopic expression of guanylyl cyclase C and endogenous ligand guanylin correlates significantly with Helicobacter pylori infection in gastric carcinogenesis. Medical Oncology
CrossRef35
Philip Sutton. (2011) Vaccinating Against Helicobacter pylori: Dissecting the Mechanism. Gastroenterology 141:4, 1149-1151
CrossRef36
Hyun Young Kim. (2011) Metabolic syndrome is associated with gastric dysplasia. European Journal of Gastroenterology & Hepatology 23:10, 871-875
CrossRef37
Ali Kuraishy, Michael Karin, Sergei I. Grivennikov. (2011) Tumor Promotion via Injury- and Death-Induced Inflammation. Immunity 35:4, 467-477
CrossRef38
Chandrakant Ankolekar, Marcia Pinto, Duane Greene, Kalidas Shetty. (2011) Phenolic Bioactive Modulation by Lactobacillus acidophilus Mediated Fermentation of Cherry Extracts for Anti-Diabetic Functionality, Helicobacter pylori inhibition and Probiotic Bifidobacterium longum Stimulation. Food Biotechnology 25:4, 305-335
CrossRef39
Hongyan Wang, Yundong Sun, Shili Liu, Han Yu, Wenjuan Li, Jiping Zeng, Chunyan Chen, Jihui Jia. (2011) Upregulation of progranulin by Helicobacter pylori in human gastric epithelial cells via p38MAPK and MEK1/2 signaling pathway: role in epithelial cell proliferation and migration. FEMS Immunology & Medical Microbiology 63:1, 82-92
CrossRef40
Valeska Portela Lima, Isabelle Joyce de Lima Silva-Fernandes, Markênia Kélia Santos Alves, Silvia Helena Barem Rabenhorst. (2011) Prevalence of Helicobacter pylori genotypes (vacA, cagA, cagE and virB11) in gastric cancer in Brazilian's patients: An association with histopathological parameters. Cancer Epidemiology 35:5, e32-e37
CrossRef41
Sabine Krueger, Albert Roessner, Doerthe Kuester. (2011) Murine models of H. pylori-induced gastritis and gastric adenocarcinoma. Pathology - Research and Practice 207:10, 599-607
CrossRef42
Liang-ming Liu, Ming-guo Yan, Dao-hua Yang, Wei-wei Sun, Ji-xiang Zhang. (2011) The expression of protein inhibitor of activated signal transducers and activators of transcription 3 in the evolutionary process of gastric cancer. European Journal of Internal Medicine 22:5, e31-e35
CrossRef43
Kosuke Sakitani, Yoshihiro Hirata, Hirotsugu Watabe, Atsuo Yamada, Takafumi Sugimoto, Yutaka Yamaji, Haruhiko Yoshida, Shin Maeda, Masao Omata, Kazuhiko Koike. (2011) Gastric cancer risk according to the distribution of intestinal metaplasia and neutrophil infiltration. Journal of Gastroenterology and Hepatology 26:10, 1570-1575
CrossRef44
Mitsushige Sugimoto, Tomoyuki Ohno, Yoshio Yamaoka. (2011) Expression of angiotensin II type 1 and type 2 receptor mRNAs in the gastric mucosa of Helicobacter pylori-infected Mongolian gerbils. Journal of Gastroenterology 46:10, 1177-1186
CrossRef45
Pelayo Correa, M. Blanca Piazuelo. (2011) The gastric precancerous cascade. Journal of Digestive Diseasesno-no
CrossRef46
Yuji Maehata, Shotaro Nakamura, Kiyoshi Fujisawa, Motohiro Esaki, Tomohiko Moriyama, Kouichi Asano, Yuta Fuyuno, Kan Yamaguchi, Issei Egashira, Hyonji Kim, Motonobu Kanda, Minako Hirahashi, Takayuki Matsumoto. (2011) Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointestinal Endoscopy
CrossRef47
Hyuk Yoon, Nayoung Kim, Hye Seung Lee, Cheol Min Shin, Young Soo Park, Dong Ho Lee, Hyun Chae Jung, In Sung Song. (2011) Helicobacter pylori-Negative Gastric Cancer in South Korea: Incidence and Clinicopathologic Characteristics. Helicobacter 16:5, 382-388
CrossRef48
Jun Yu, Yanhong Jia, Kin Fai Cheung, Zhirong Zeng, Linwei Tian, Shiyan Wang, Pinjin Hu, Joseph J. Y. Sung. (2011) Polymorphisms in Interleukin-6 -6331 Influences the Susceptibility of a Chinese Population to Gastric Cancer. Cancer Investigation 29:8, 564-572
CrossRef49
Pedro Pimentel-Nunes, Luís Afonso, Paula Lopes, Roberto Roncon-Albuquerque, Nádia Gonçalves, Rui Henrique, Luís Moreira-Dias, Adelino F. Leite-Moreira, Mário Dinis-Ribeiro. (2011) Increased Expression of Toll-like Receptors (TLR) 2, 4 and 5 in Gastric Dysplasia. Pathology & Oncology Research 17:3, 677-683
CrossRef50
Kyoung-Sook Jeong, Yangho Kim, Moon-Chan Kim, Cheol-In Yoo. (2011) Comparison of cancer incidence between production and office workers at a shipyard in Korea: A retrospective cohort study from 1992 to 2005. American Journal of Industrial Medicine 54:9, 719-725
CrossRef51
Xiaohua Li, Ying Zhang, Yongquan Shi, Guanglong Dong, Jie Liang, Ying Han, Xin Wang, Qingchuan Zhao, Jie Ding, Kaichun Wu, Daiming Fan. (2011) MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer. Journal of Cellular and Molecular Medicine 15:9, 1887-1895
CrossRef52
Ji Sun Han, Jin Seok Jang, Seok Reyol Choi, Hyuk Chan Kwon, Min Chan Kim, Jin Sook Jeong, Su Jin Kim, You Jung Sohn, Eun Joo Lee. (2011) A study of metachronous cancer after endoscopic resection of early gastric cancer. Scandinavian Journal of Gastroenterology 46:9, 1099-1104
CrossRef53
Ziping Zhang, Shaoqun Liu, Rongliang Shi, Guangfa Zhao. (2011) miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition. Cancer Genetics 204:9, 486-491
CrossRef54
Rupesh Chaturvedi, Thibaut Sablet, Lori A. Coburn, Alain P. Gobert, Keith T. Wilson. (2011) Arginine and polyamines in Helicobacter pylori-induced immune dysregulation and gastric carcinogenesis. Amino Acids
CrossRef55
Taiji Akamatsu, Shinya Ichikawa, Sadahide Okudaira, Shuichi Yokosawa, Yugo Iwaya, Tomoaki Suga, Hiroyoshi Ota, Eiji Tanaka. (2011) Introduction of an examination and treatment for Helicobacter pylori infection in high school health screening. Journal of Gastroenterology
CrossRef56
F. Siavoshi, A. Asgharzadeh, H. Ghadiri, S. Massarrat, S. Latifi-Navid, M. Zamani. (2011) Helicobacter pylori genotypes and types of gastritis in first-degree relatives of gastric cancer patients. International Journal of Medical Microbiology 301:6, 506-512
CrossRef57
Jan Bornschein, Peter Malfertheiner. (2011) Gastric carcinogenesis. Langenbeck's Archives of Surgery 396:6, 729-742
CrossRef58
Trevor A Graham, Stuart AC McDonald, Nicholas A Wright. (2011) Field cancerization in the GI tract. Future Oncology 7:8, 981-993
CrossRef59
Masahiro Kido, Norihiko Watanabe, Nobuhiro Aoki, Satoru Iwamoto, Hisayo Nishiura, Ryutaro Maruoka, Aki Ikeda, Takeshi Azuma, Tsutomu Chiba. (2011) Dual roles of CagA protein in Helicobacter pylori-induced chronic gastritis in mice. Biochemical and Biophysical Research Communications 412:2, 266-272
CrossRef60
Nirmala Pandeya, David C Whiteman, . (2011) Prevalence and determinants of Helicobacter pylori sero-positivity in the Australian adult community. Journal of Gastroenterology and Hepatology 26:8, 1283-1289
CrossRef61
Jung W. Lee, Nayoung Kim, Ryoung H. Nam, Ji H. Park, Jung M. Kim, Hyun C. Jung, In S. Song. (2011) Mutations of Helicobacter pylori Associated with Fluoroquinolone Resistance in Korea. Helicobacter 16:4, 301-310
CrossRef62
Sarah Kraus, Victoria Lisiansky, Jeffrey Zweig, Elena Kapilevich, Nadir Arber. 2011. Role of Inflammation in Gastrointestinal Diseases. .
CrossRef63
Nitin Kumar, Sushma Drabu, Sambhu Charan Mondal. (2011) NSAID’s and selectively COX-2 inhibitors as potential chemoprotective agents against cancer. Arabian Journal of Chemistry
CrossRef64
Susanne Andres, Klaus Abraham, Klaus Erich Appel, Alfonso Lampen. (2011) Risks and benefits of dietary isoflavones for cancer. Critical Reviews in Toxicology 41:6, 463-506
CrossRef65
Ji Hyung Nam, Il Ju Choi, Soo-Jeong Cho, Chan Gyoo Kim, Jong Yeul Lee, Su Youn Nam, Sook Ryun Park, Myeong-Cherl Kook, Byung-Ho Nam, Young-Woo Kim. (2011) Helicobacter pylori infection and histological changes in siblings of young gastric cancer patients. Journal of Gastroenterology and Hepatology 26:7, 1157-1163
CrossRef66
Mislav Radić, Dušanka Martinović Kaliterna, Josipa Radić. (2011) Helicobacter pylori infection and systemic sclerosis–is there a link?. Joint Bone Spine 78:4, 337-340
CrossRef67
Yong Zhou, Wen Zhuang, Wen Hu, Guan–Jian Liu, Tai–Xiang Wu, Xiao–Ting Wu. (2011) Consumption of Large Amounts of Allium Vegetables Reduces Risk for Gastric Cancer in a Meta-analysis. Gastroenterology 141:1, 80-89
CrossRef68
Hayato Kudo, Tamitake Itoh, Takehiro Kashiwagi, Mitsuru Ishikawa, Hiroaki Takeuchi, Hiroyuki Ukeda. (2011) Surface enhanced Raman scattering spectroscopy of Ag nanoparticle aggregates directly photo-reduced on pathogenic bacterium (Helicobacter pylori). Journal of Photochemistry and Photobiology A: Chemistry 221:2-3, 181-186
CrossRef69
E. Van Cutsem, M. Dicato, R. Geva, N. Arber, Y. Bang, A. Benson, A. Cervantes, E. Diaz-Rubio, M. Ducreux, R. Glynne-Jones, A. Grothey, D. Haller, K. Haustermans, D. Kerr, B. Nordlinger, J. Marshall, B. D. Minsky, Y. K. Kang, R. Labianca, F. Lordick, A. Ohtsu, N. Pavlidis, A. Roth, P. Rougier, H. J. Schmoll, A. Sobrero, J. Tabernero, C. Van de Velde, J. Zalcberg. (2011) The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010. Annals of Oncology 22:Supplement 5, v1-v9
CrossRef70
Penny Jeffery, Victoria McDonald, Emma Tippett, Michael McGuckin. (2011) Ghrelin in gastrointestinal disease. Molecular and Cellular Endocrinology 340:1, 35-43
CrossRef71
Ayako Goto, Minako Hirahashi, Mikako Osada, Kazuhiko Nakamura, Takashi Yao, Masazumi Tsuneyoshi, Ryoichi Takayanagi, Yoshinao Oda. (2011) Aberrant activation-induced cytidine deaminase expression is associated with mucosal intestinalization in the early stage of gastric cancer. Virchows Archiv 458:6, 717-724
CrossRef72
Xiaolin Zhang, Weide Shen, Ye Lu, Xiaojian Zheng, Renyu Xue, Guangli Cao, Zhonghua Pan, Chengliang Gong. (2011) Expression of UreB and HspA of Helicobacter pylori in silkworm pupae and identification of its immunogenicity. Molecular Biology Reports 38:5, 3173-3180
CrossRef73
Insik WON, Yoon Jae KIM, Seong Jin KIM, Eun Hee KIM, Ki Baik HAHM. (2011) Nutrigenomic approach to tackle the unpleasant journey to Helicobacter pylori-associated gastric carcinogenesis. Journal of Digestive Diseases 12:3, 157-164
CrossRef74
Iwona Radziejewska, Małgorzata Borzym-Kluczyk, Zbigniew Namiot, Ewa Stefańska. (2011) Glycosylation of mucins present in gastric juice: the effect of helicobacter pylori eradication treatment. Clinical and Experimental Medicine 11:2, 81-88
CrossRef75
Chiara Porta, Elena Riboldi, Antonio Sica. (2011) Mechanisms linking pathogens-associated inflammation and cancer. Cancer Letters 305:2, 250-262
CrossRef76
Aki Tanaka, Tomoari Kamada, Kazuhiko Inoue, Akiko Shiotani, Hiroaki Kusunoki, Noriaki Manabe, Masanori Ito, Jiro Hata, Ken Haruma. (2011) Histological evaluation of patients with gastritis at high risk of developing gastric cancer using a conventional index. Pathology - Research and Practice 207:6, 354-358
CrossRef77
JiHye Kim, Jung-A Pyun, Sung Won Cho, KwangJae Lee, KyuBum Kwack. (2011) Lymph Node Metastasis of Gastric Cancer Is Associated with the Interaction Between Poly (ADP-Ribose) Polymerase 1 and Matrix Metallopeptidase 2. DNA and Cell Biology110525103826062
CrossRef78
Bernd Frank, Melanie Nicole Weck, Heiko Müller, Norman Klopp, Thomas Illig, Elke Raum, Hermann Brenner. (2011) Polymorphisms in MUC1, MUC2, MUC5B and MUC6 genes are not associated with the risk of chronic atrophic gastritis. European Journal of Cancer
CrossRef79
Duowu Zou, Jia He, Xiuqiang Ma, Wenbin Liu, Jie Chen, Xingang Shi, Ping Ye, Yanfang Gong, Yanfang Zhao, Rui Wang, Xiaoyan Yan, Xiaohua Man, Li Gao, John Dent, Joseph Sung, Börje Wernersson, Saga Johansson, Zhaoshen Li. (2011) Helicobacter pylori infection and gastritis: The Systematic Investigation of gastrointestinaL diseases in China (SILC). Journal of Gastroenterology and Hepatology 26:5, 908-915
CrossRef80
S Perry, R Hussain, J Parsonnet. (2011) The impact of mucosal infections on acquisition and progression of tuberculosis. Mucosal Immunology 4:3, 246-251
CrossRef81
T.T. Priya, M.C. Sabu, C.I. Jolly. (2011) Role of Mangifera indica bark polyphenols on rat gastric mucosa against ethanol and cold-restraint stress. Natural Product Research 25:8, 815-826
CrossRef82
Edward Sheen, George Triadafilopoulos. (2011) Adverse Effects of Long-Term Proton Pump Inhibitor Therapy. Digestive Diseases and Sciences 56:4, 931-950
CrossRef83
Lydia Gutierrez–Gonzalez, Trevor A. Graham, Manuel Rodriguez–Justo, Simon J. Leedham, Marco R. Novelli, Laura J. Gay, Tania Ventayol–Garcia, Alicia Green, Ian Mitchell, David L. Stoker, Sean L. Preston, Shigeki Bamba, Eiji Yamada, Yuuki Kishi, Rebecca Harrison, Janusz A. Jankowski, Nicholas A. Wright, Stuart A.C. McDonald. (2011) The Clonal Origins of Dysplasia From Intestinal Metaplasia in the Human Stomach. Gastroenterology 140:4, 1251-1260.e6
CrossRef84
Takashi Abe, Masaaki Kodama, Kazunari Murakami, Osamu Matsunari, Kazuhiro Mizukami, Kunimitsu Inoue, Masahiro Uchida, Tadayoshi Okimoto, Toshio Fujioka, Tomohisa Uchida, Masatsugu Moriyama, Yoshio Yamaoka. (2011) Impact of Helicobacter pylori CagA diversity on gastric mucosal damage: An immunohistochemical study of East-Asian-type CagA. Journal of Gastroenterology and Hepatology 26:4, 688-693
CrossRef85
Asahi Hishida, Keitaro Matsuo, Yasuyuki Goto, Mariko Naito, Kenji Wakai, Kazuo Tajima, Nobuyuki Hamajima. (2011) Combined Effect of miR-146a rs2910164 G/C Polymorphism and Toll-like Receptor 4 +3725 G/C Polymorphism on the Risk of Severe Gastric Atrophy in Japanese. Digestive Diseases and Sciences 56:4, 1131-1137
CrossRef86
Noriya Uedo. (2011) Do We Need Multiple Biopsies for Assessing Gastric Cancer Risk?. Digestive Diseases and Sciences 56:4, 926-928
CrossRef87
Alshimaa Ahmed Alaboudy, Ashraf Elbahrawy, Shigemi Matsumoto, Akihiko Yoshizawa. (2011) Conventional Narrow-Band Imaging Has Good Correlation with Histopathological Severity of Helicobacter pylori Gastritis. Digestive Diseases and Sciences 56:4, 1127-1130
CrossRef88
Vladislav Vladimirovich Tsukanov, Nikolai Nikolaevich Butorin, Ayas Sergeevich Maady, Olga Vladimirovna Shtygasheva, Olga Sergeevna Amelchugova, Julia Leongardovna Tonkikh, Matteo Fassan, Massimo Rugge. (2011) Helicobacter pylori Infection, Intestinal Metaplasia, and Gastric Cancer Risk in Eastern Siberia. Helicobacter 16:2, 107-112
CrossRef89
Catherine Neto, Joe Vinson. 2011. Cranberry. , 107-130.
CrossRef90
Hideyuki Ubukata, Hiroyuki Nagata, Takanobu Tabuchi, Satoru Konishi, Teruhiko Kasuga, Takafumi Tabuchi. (2011) Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer. Gastric Cancer 14:1, 4-12
CrossRef91
Susumu Take, Motowo Mizuno, Kuniharu Ishiki, Tomowo Yoshida, Nobuya Ohara, Kenji Yokota, Keiji Oguma, Hiroyuki Okada, Kazuhide Yamamoto. (2011) The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori. Journal of Gastroenterology 46:3, 318-324
CrossRef92
Massimo Rugge, Gianmaria Pennelli, Emanuela Pilozzi, Matteo Fassan, Giuseppe Ingravallo, Valentina M. Russo, Francesco Di Mario. (2011) Gastritis: The histology report. Digestive and Liver Disease 43, S373-S384
CrossRef93
Masashi Kawamura, Shu Abe, Keisuke Oikawa, Shiho Terai, Masahiro Saito, Daisuke Shibuya, Katsuaki Kato, Takenobu Shimada, Noriya Uedo, Takayuki Masuda. (2011) Topographic differences in gastric micromucosal patterns observed by magnifying endoscopy with narrow band imaging. Journal of Gastroenterology and Hepatology 26:3, 477-483
CrossRef94
E. Apostolidis, Y- I. Kwon, Rahul Shinde, Reza Ghaedian, K. Shetty. (2011) Inhibition of Helicobacter pylori by Fermented Milk and Soymilk Using Select Lactic Acid Bacteria and Link to Enrichment of Lactic Acid and Phenolic Content. Food Biotechnology 25:1, 58-76
CrossRef95
Junko Aida, Akira Yokoyama, Naotaka Izumiyama, Ken-ichi Nakamura, Naoshi Ishikawa, Steven S Poon, Mutsunori Fujiwara, Motoji Sawabe, Masaaki Matsuura, Tomio Arai, Kaiyo Takubo. (2011) Alcoholics show reduced telomere length in the oesophagus. The Journal of Pathology 223:3, 410-416
CrossRef96
Duc Trong Quach, Huy Minh Le, Oanh Thuy Nguyen, Trung Sao Nguyen, Naomi Uemura. (2011) The severity of endoscopic gastric atrophy could help to predict Operative Link on Gastritis Assessment gastritis stage. Journal of Gastroenterology and Hepatology 26:2, 281-285
CrossRef97
A. M. Ekstrom, M. Serafini, O. Nyren, A. Wolk, C. Bosetti, R. Bellocco. (2011) Dietary quercetin intake and risk of gastric cancer: results from a population-based study in Sweden. Annals of Oncology 22:2, 438-443
CrossRef98
Anton G. Kutikhin. (2011) Impact of Toll-like receptor 4 polymorphisms on risk of cancer. Human Immunology 72:2, 193-206
CrossRef99
Mitsushige Sugimoto, Yoshio Yamaoka. (2011) Review of Helicobacter pylori Infection and Chronic Renal Failure. Therapeutic Apheresis and Dialysis 15:1, 1-9
CrossRef100
A Hamabe, T Omori, T Oyama, H Akamatsu, K Yoshidome, M Tori, S Ueshima, M Tsujimoto, T Nishida. (2011) A case of Helicobacter pylori infection complicated with gastric cancer, gastric mucosa-associated lymphoid tissue lymphoma, and idiopathic thrombocytopenic purpura successfully treated with laparoscopy-assisted total gastrectomy and splenectomy. Asian Journal of Endoscopic Surgery 4:1, 32-35
CrossRef101
Emma C. Skoog, Mathilda Lindberg, Sara K. Lindén. (2011) Strain-Dependent Proliferation in Response to Human Gastric Mucin and Adhesion Properties of Helicobacter pylori are not Affected by Co-isolated Lactobacillus sp.. Helicobacter 16:1, 9-19
CrossRef102
Kayoko Matsushima, Hajime Isomoto, Naoki Inoue, Toshiyuki Nakayama, Tomayoshi Hayashi, Masaaki Nakayama, Kazuhiko Nakao, Toshiya Hirayama, Shigeru Kohno. (2011) MicroRNA signatures in Helicobacter pylori-infected gastric mucosa. International Journal of Cancer 128:2, 361-370
CrossRef103
Y. Hayakawa, Y. Hirata, H. Nakagawa, K. Sakamoto, Y. Hikiba, H. Kinoshita, W. Nakata, R. Takahashi, K. Tateishi, M. Tada, M. Akanuma, H. Yoshida, K. Takeda, H. Ichijo, M. Omata, S. Maeda, K. Koike. (2011) Apoptosis signal-regulating kinase 1 and cyclin D1 compose a positive feedback loop contributing to tumor growth in gastric cancer. Proceedings of the National Academy of Sciences 108:2, 780-785
CrossRef104
Eiichiro Yamamoto, Hiromu Suzuki, Hiroyuki Takamaru, Hiroyuki Yamamoto, Minoru Toyota, Yasuhisa Shinomura. (2011) Role of DNA Methylation in the Development of Diffuse-Type Gastric Cancer. Digestion 83:4, 241-249
CrossRef105
Tomomitsu Tahara, Tomoyuki Shibata, Hiromi Yamashita, Ichiro Hirata, Tomiyasu Arisawa. (2011) Influence of MDR1 Polymorphism on H. pylori-Related Chronic Gastritis. Digestive Diseases and Sciences 56:1, 103-108
CrossRef106
Takahisa Furuta, Mototsugu Kato, Mitsushige Sugimoto, Makoto Sasaki, Toshiro Kamoshida, Kouichi Furukawa, Tomoki Inaba, Takashige Tomita, Takayuki Shirai, Naoki Ishii, Hideyuki Nomura, Yoshitaka Konda, Masahiro Asaka, the JAPAN GAST STUDY GROUP. (2011) Triple Therapy with Ecabet Sodium, Amoxicillin and Lansoprazole for 2 Weeks as the Rescue Regimen for H. pylori Infection. Internal Medicine 50:5, 369-374
CrossRef107
Chiao-Hsiung Chuang, Hsiao-Bai Yang, Shew-Meei Sheu, Kuei-Hsiang Hung, Jiunn-Jong Wu, Hsiu-Chi Cheng, Wei-Lun Chang, Bor-Shyang Sheu. (2011) Helicobacter pylori with stronger intensity of CagA phosphorylation lead to an increased risk of gastric intestinal metaplasia and cancer. BMC Microbiology 11:1, 121
CrossRef108
Kazumasa MIKI. (2011) Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels — “ABC method”. Proceedings of the Japan Academy, Series B 87:7, 405-414
CrossRef109
Séamus Hussey, Nicola L. Jones. 2011. Helicobacter pylori in Childhood. , 293-308.
CrossRef110
Masashi Kawamura, Shu Abe, Keisuke Oikawa, Shiho Terai, Masahiro Saito, Daisuke Shibuya, Katsuaki Kato, Yoshifumi Inomata, Shuichi Ohara, Tooru Shimosegawa. (2011) MAGNIFYING ENDOSCOPIC FINDINGS OF THE SURFACE STRUCTURE OF NON-CANCEROUS MUCOSA SURROUNDING DIFFERENTIATED AND UNDIFFERENTIATED GASTRIC CARCINOMA. Digestive Endoscopy 23:1, 37-42
CrossRef111
Satoshi Baba, Yoshichika Oishi, Yoshiyuki Watanabe, Ritsuko Oikawa, Ryo Morita, Yoshihito Yoshida, Tetsuya Hiraishi, Tadateru Maehata, Yoshihiko Nagase, Yasunobu Fukuda, Midori Nakazawa, Shinya Ishigouoka, Nobuhiro Hattori, Hiromu Suzuki, Minoru Toyota, Hirohumi Niwa, Michihiro Suzuki, Fumio Itoh. (2011) Gastric Wash-Based Molecular Testing for Antibiotic Resistance in Helicobacter pylori. Digestion 84:4, 299-305
CrossRef112
Scott R. Owens, Lauren B. Smith. (2011) Molecular Aspects of H. pylori-Related MALT Lymphoma. Pathology Research International 2011, 1-8
CrossRef113
Masanori Hatakeyama. (2011) Anthropological and clinical implications for the structural diversity of the Helicobacter pylori CagA oncoprotein. Cancer Science 102:1, 36-43
CrossRef114
Jiro Watari, Kentaro Moriichi, Hiroki Tanabe, Shin Kashima, Yoshiki Nomura, Mikihiro Fujiya, Toshihiko Tomita, Tadayuki Oshima, Hirokazu Fukui, Hiroto Miwa, Kiron M. Das, Yutaka Kohgo. (2011) Biomarkers predicting development of metachronous gastric cancer after endoscopic resection: an analysis of molecular pathology of Helicobacter pylori eradication. International Journal of Cancern/a-n/a
CrossRef115
Juozas Kupcinskas, Thomas Wex, Jan Bornschein, Michael Selgrad, Marcis Leja, Elona Juozaityte, Gediminas Kiudelis, Laimas Jonaitis, Peter Malfertheiner. (2011) Lack of association between gene polymorphisms of Angiotensin converting enzyme, Nod-like receptor 1, Toll-like receptor 4, FAS/FASL and the presence of Helicobacter pylori-induced premalignant gastric lesions and gastric cancer in Caucasians. BMC Medical Genetics 12:1, 112
CrossRef116
Maiko Furukawa, Mikiko Fujita, Akira Takinishi, Ryoichi Misaka, Hikaru Nagahara. (2011) Low-dose Aspirin Delays Gastric Healing after Helicobacter pylori Eradication. Internal Medicine 50:9, 951-959
CrossRef117
Masaaki Okubo, Tomomitsu Tahara, Tomoyuki Shibata, Masakatsu Nakamura, Yoshio Kamiya, Daisuke Yoshioka, Yoshiteru Maeda, Joh Yonemura, Takamitsu Ishizuka, Tomiyasu Arisawa, Ichiro Hirata. (2011) Usefulness of Magnifying Narrow-Band Imaging Endoscopy in the <i>Helicobacter pylori</i>-Related Chronic Gastritis. Digestion 83:3, 161-166
CrossRef118
Jae Yeon Kim, Nayoung Kim, Hyun Kyung Park, Hyun Jin Jo, Cheol Min Shin, Sang Hyub Lee, Young Soo Park, Jin-Hyeok Hwang, Jin-Wook Kim, Sook-Hyang Jeong, Dong Ho Lee, Ryoung Hee Nam, Jung Mogg Kim, Ji Hyun Lee, Hyun Chae Jung, In Sung Song. (2011) Primary Antibiotic Resistance of Helicobacter pylori Strains and Eradication Rate according to Gastroduodenal Disease in Korea. The Korean Journal of Gastroenterology 58:2, 74
CrossRef119
Bianca Bauer, Thomas F. Meyer. (2011) The Human Gastric Pathogen Helicobacter pylori and Its Association with Gastric Cancer and Ulcer Disease. Ulcers 2011, 1-23
CrossRef120
Satoshi Matsubara, Shinji Takasu, Tetsuya Tsukamoto, Michihiro Mutoh, Shuichi Masuda, Takashi Sugimura, Keiji Wakabayashi, Yukari Totsuka. (2011) Induction of glandular stomach cancers in Helicobacter pylori-infected Mongolian gerbils by 1-nitrosoindole-3-acetonitrile. International Journal of Cancern/a-n/a
CrossRef121
M. Varbanova, C. Schulz, P. Malfertheiner. (2011) <i>Helicobacter pylori</i> and Other Gastric Bacteria. Digestive Diseases 29:6, 562-569
CrossRef122
M Leja, L Kupcinskas, K Funka, A Sudraba, L Jonaitis, A Ivanauskas, D Janciauskas, G Kuidelis, H M Chiu, J T Lin. (2011) Value of gastrin-17 in detecting antral atrophy. Advances in Medical Sciences 1:-1, 1-6
CrossRef123
Masahide Watada, Seiji Shiota, Osamu Matsunari, Rumiko Suzuki, Kazunari Murakami, Toshio Fujioka, Yoshio Yamaoka. (2011) Association between Helicobacter pylori cagA-related genes and clinical outcomes in Colombia and Japan. BMC Gastroenterology 11:1, 141
CrossRef124
Xianghong Zhang, Liying Xue, Lingxiao Xing, Junling Wang, Jinfeng Cui, Jianmin Mi, Xin Xing, Juan Wang, Zhanjun Du, Junichi Misumi, Qingbao Tian, Liqin Wang. (2011) Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14-year follow up result in a rural Chinese community. International Journal of Cancern/a-n/a
CrossRef125
K. Takeuchi, M. Yokoyama, S. Ishizawa, Y. Terui, K. Nomura, K. Marutsuka, M. Nunomura, N. Fukushima, T. Yagyuu, H. Nakamine, F. Akiyama, K. Hoshi, K. Matsue, K. Hatake, K. Oshimi. (2010) Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation. Blood 116:25, 5631-5637
CrossRef126
Masaaki Okubo, Tomomitsu Tahara, Tomoyuki Shibata, Hiromi Yamashita, Masakatsu Nakamura, Daisuke Yoshioka, Joh Yonemura, Takamitsu Ishizuka, Tomiyasu Arisawa, Ichiro Hirata. (2010) Association Between Common Genetic Variants in Pre-microRNAs and Gastric Cancer Risk in Japanese Population. Helicobacter 15:6, 524-531
CrossRef127
Seiji Shiota, Osamu Matsunari, Masahide Watada, Yoshio Yamaoka. (2010) Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries. Future Microbiology 5:12, 1885-1893
CrossRef128
Carlos A. González, Maria Luisa Pardo, Juan Maria Ruiz Liso, Pablo Alonso, Catalina Bonet, Raul M. Garcia, Núria Sala, Gabriel Capella, José Miguel Sanz-Anquela. (2010) Gastric cancer occurrence in preneoplastic lesions: A long-term follow-up in a high-risk area in Spain. International Journal of Cancer 127:11, 2654-2660
CrossRef129
M. Blanca Piazuelo, Meira Epplein, Pelayo Correa. (2010) Gastric Cancer: An Infectious Disease. Infectious Disease Clinics of North America 24:4, 853-869
CrossRef130
William Nseir, Julnar Khateeb, Imad Tatour, Samah Haiek, Mousa Samara, Nimer Assy. (2010) Long-Term Statin Therapy Affects the Severity of Chronic Gastritis. Helicobacter 15:6, 510-515
CrossRef131
Joseph R. Pisegna, Bijal Surti, David R. Scott. (2010) Clinical Trial Report: Eradication of Helicobacter pylori Reduces the Risk for Subsequent Gastric Cancer. Current Gastroenterology Reports 12:6, 427-430
CrossRef132
S. Imagawa, M. Ito, M. Yoshihara, H. Eguchi, S. Tanaka, K. Chayama. (2010) Helicobacter pylori dupA and gastric acid secretion are negatively associated with gastric cancer development. Journal of Medical Microbiology 59:12, 1484-1489
CrossRef133
Zhaoshen Li, Duowu Zou, Xiuqiang Ma, Jie Chen, Xingang Shi, Yanfang Gong, Xiaohua Man, Li Gao, Yanfang Zhao, Rui Wang, Xiaoyan Yan, John Dent, Joseph J Sung, Börje Wernersson, Saga Johansson, Wenbin Liu, Jia He. (2010) Epidemiology of Peptic Ulcer Disease: Endoscopic Results of the Systematic Investigation of Gastrointestinal Disease in China. The American Journal of Gastroenterology 105:12, 2570-2577
CrossRef134
Soo-Jeong Cho, Il Ju Choi, Chan Gyoo Kim, Myeong-Cherl Kook, Jong Yeul Lee, Byung Chang Kim, Kum Hei Ryu, Su Youn Nam, Young-Woo Kim. (2010) Risk Factors Associated with Gastric Cancer in Patients with a Duodenal Ulcer. Helicobacter 15:6, 516-523
CrossRef135
Amin Talebi Bezmin Abadi, Ashraf M. Mobarez, Tarang Taghvaei, Lutz Wolfram. (2010) Antibiotic Resistance of Helicobacter pylori in Mazandaran, North of Iran. Helicobacter 15:6, 505-509
CrossRef136
Jan Bornschein, Michael Selgrad, Maren Warnecke, Doerthe Kuester, Thomas Wex, Peter Malfertheiner. (2010) H. pylori Infection Is a Key Risk Factor for Proximal Gastric Cancer. Digestive Diseases and Sciences 55:11, 3124-3131
CrossRef137
Shigeto Mizuno, Ikuya Miki, Tsukasa Ishida, Masaru Yoshida, Mitsuko Onoyama, Takeshi Azuma, Yasuki Habu, Hideto Inokuchi, Kotaro Ozasa, Kazumasa Miki, Yoshiyuki Watanabe. (2010) Prescreening of a High-Risk Group for Gastric Cancer by Serologically Determined Helicobacter pylori Infection and Atrophic Gastritis. Digestive Diseases and Sciences 55:11, 3132-3137
CrossRef138
Asahi Hishida, Keitaro Matsuo, Yasuyuki Goto, Mariko Naito, Kenji Wakai, Kazuo Tajima, Nobuyuki Hamajima. (2010) No associations of Toll-like receptor 2 (TLR2) -196 to -174del polymorphism with the risk of Helicobacter pylori seropositivity, gastric atrophy, and gastric cancer in Japanese. Gastric Cancer 13:4, 251-257
CrossRef139
Limas Kupcinskas, Thomas Wex, Juozas Kupcinskas, Marcis Leja, Audrius Ivanauskas, Laimas Virgilijus Jonaitis, Dainius Janciauskas, Gediminas Kiudelis, Konrads Funka, Agnese Sudraba, Han-Mo Chiu, Jaw-Town Lin, Peter Malfertheiner. (2010) Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms are not associated with premalignant gastric conditions: a combined haplotype analysis. European Journal of Gastroenterology & Hepatology 22:10, 1189-1195
CrossRef140
Kumiko Nagata, Sakiko Inatsu, Mamoru Tanaka, Harumi Sato, Tomoaki Kouya, Masayuki Taniguchi, Yoshihiro Fukuda. (2010) The Bifidogenic Growth Stimulator Inhibits the Growth and Respiration of Helicobacter pylori. Helicobacter 15:5, 422-429
CrossRef141
Manish A. Shah, Robert C. Kurtz. (2010) Upper Gastrointestinal Cancer Predisposition Syndromes. Hematology/Oncology Clinics of North America 24:5, 815-835
CrossRef142
Maria Celeste C. Cortes, Akiyo Yamakawa, Cristine R. Casingal, Lindsay Sydney N. Fajardo, Ma. Luisa G. Juan, Blanquita B. De Guzman, Edgardo M. Bondoc, , Varocha Mahachai, Yukinao Yamazaki, Masaru Yoshida, Hiromu Kutsumi, Filipinas F. Natividad, Takeshi Azuma. (2010) Diversity of the cagA gene of Helicobacter pylori strains from patients with gastroduodenal diseases in the Philippines. FEMS Immunology & Medical Microbiology 60:1, 90-97
CrossRef143
Tiziana Larussa, Evelina Suraci, Isabella Leone, Immacolata Nazionale, Ludovico Abenavoli, Olimpio Galasso, Andrea Amorosi, Maria Imeneo, Francesco Luzza. (2010) Short-term Therapy with Celecoxib and Lansoprazole Modulates Th1/ Th2 Immune Response in Human Gastric Mucosa. Helicobacter 15:5, 449-459
CrossRef144
Mi-Ran Ki, Moon-Jung Goo, Jin-Kyu Park, Il-Hwa Hong, Ae-Ri Ji, Seon-Young Han, Sang-Young You, Eun-Mi Lee, Ah-Young Kim, Sang-Joon Park, Hyun-Joo Lee, Shin-Yoon Kim, Kyu-Shik Jeong. (2010) Helicobacter pylori accelerates hepatic fibrosis by sensitizing transforming growth factor-β1-induced inflammatory signaling. Laboratory Investigation 90:10, 1507-1516
CrossRef145
P Thankachan, S Muthayya, A Sierksma, A Eilander, T Thomas, G S Duchateau, L G J Frenken, A V Kurpad. (2010) Helicobacter pylori infection does not influence the efficacy of iron and vitamin B12 fortification in marginally nourished Indian children. European Journal of Clinical Nutrition 64:10, 1101-1107
CrossRef146
Massimo Rugge, David Y. Graham. 2010. Gastritis. , 345-352.
CrossRef147
M. Kato, M. Asaka. (2010) Recent Knowledge of the Relationship Between Helicobacter pylori and Gastric Cancer and Recent Progress of Gastroendoscopic Diagnosis and Treatment for Gastric Cancer. Japanese Journal of Clinical Oncology 40:9, 828-837
CrossRef148
Krister Sjödahl, Jesper Lagergren. (2010) Epidemiological aspects of gastric adenocarcinoma: are predictive diagnostics and targeted preventive measures possible?. The EPMA Journal 1:3, 461-471
CrossRef149
M. Sasako, M. Inoue, J.-T. Lin, C. Khor, H.-K. Yang, A. Ohtsu. (2010) Gastric Cancer Working Group Report. Japanese Journal of Clinical Oncology 40:Supplement 1, i28-i37
CrossRef150
Takahisa Furuta, David Y. Graham. (2010) Pharmacologic Aspects of Eradication Therapy for Helicobacter pylori Infection. Gastroenterology Clinics of North America 39:3, 465-480
CrossRef151
Ruggiero Francavilla, Elena Lionetti, Stefania Castellaneta, Marcella Margiotta, Domenico Piscitelli, Lorenzo Lorenzo, Luciano Cavallo, Enzo Ierardi. (2010) Clarithromycin-Resistant Genotypes and Eradication of Helicobacter Pylori. The Journal of Pediatrics 157:2, 228-232
CrossRef152
Mitsuaki Nishioka, Hiroaki Takeuchi, Sergio A. Con, Yoshio Uehara, Isao Nishimori, Toshika Okumiya, Yoshitaka Kumon, Tetsuro Sugiura. (2010) The mechanical binding strengths of Helicobacter pylori BabA and SabA adhesins using an adhesion binding assay-ELISA, and its clinical relevance in Japan. Microbiology and Immunology 54:8, 442-451
CrossRef153
Min Sun Kwak, Nayoung Kim, Hye Seung Lee, Hee Eun Lee, Hyun Chae Jung, In Sung Song. (2010) Predictive Power of Serum Pepsinogen Tests for the Development of Gastric Cancer in Comparison to the Histologic Risk Index. Digestive Diseases and Sciences 55:8, 2275-2282
CrossRef154
Woo Chul Chung, Sung Hoon Jung, Kang-Moon Lee, Chang Nyol Paik, Jea Wuk Kawk, Ji Han Jung, Min Kyoung Lee, Yun Kyung Lee. (2010) The detection of Helicobacter pylori cag pathogenicity islands (PAIs) and expression of matrix metalloproteinase-7 (MMP-7) in gastric epithelial dysplasia and intramucosal cancer. Gastric Cancer 13:3, 162-169
CrossRef155
Fatih Albayrak, Muhammet H. Uyanik, Hakan Dursun, Yavuz Albayrak, Sare Altas, Abdullah Uyanik, Serkan Cerrah, Yasin Bayir. (2010) Should Increased Levels of Urinary 8-Hydroxydeoxyguanosine in Chronic Gastritis Imply Intestinal Metaplasia or Gastric Atrophy?. Southern Medical Journal 103:8, 753-757
CrossRef156
Satoru Takayama, Hiroki Takahashi, Yoichi Matsuo, Yuji Okada, Hiromitsu Takeyama. (2010) Effect of Helicobacter bilis Infection on Human Bile Duct Cancer Cells. Digestive Diseases and Sciences 55:7, 1905-1910
CrossRef157
Kei Sakamoto, Yohko Hikiba, Hayato Nakagawa, Yoku Hayakawa, Ayako Yanai, Masao Akanuma, Keiji Ogura, Yoshihiro Hirata, Klaus H. Kaestner, Masao Omata, Shin Maeda. (2010) Inhibitor of κB Kinase Beta Regulates Gastric Carcinogenesis via Interleukin-1α Expression. Gastroenterology 139:1, 226-238.e6
CrossRef158
Xiaobo Guo, Lei Guo, Jun Ji, Jianian Zhang, Jun Zhang, Xuehua Chen, Qu Cai, Jianfang Li, Qinlong Gu, Bingya Liu, Zhenggang Zhu, Yingyan Yu. (2010) miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer. Biochemical and Biophysical Research Communications 398:1, 1-6
CrossRef159
Shigeyoshi Imamura, Mitsushige Sugimoto, Kazuyuki Kanemasa, Yoshio Sumida, Takeshi Okanoue, Toshikazu Yoshikawa, Yoshio Yamaoka. (2010) Inverse association between Helicobacter pylori infection and allergic rhinitis in young Japanese. Journal of Gastroenterology and Hepatology 25:7, 1244-1249
CrossRef160
Jing Wen, Jeong Youp Park, Kyung Hwa Park, Hye Won Chung, Seungmin Bang, Seung Woo Park, Si Young Song. (2010) Oct4 and Nanog Expression Is Associated With Early Stages of Pancreatic Carcinogenesis. Pancreas 39:5, 622-626
CrossRef161
Tomomitsu Tahara, Tomoyuki Shibata, Hiromi Yamashita, Daisuke Yoshioka, Ichiro Hirata, Tomiyasu Arisawa. (2010) Promoter Methylation Status of Multidrug Resistance 1 (MDR1) Gene in Noncancerous Gastric Mucosa Correlates With Helicobacter Pylori Infection and Gastric Cancer Occurrence. Cancer Investigation 28:7, 711-716
CrossRef162
So-Jung Lee, Ji-Young Park, Ki-Seok Choi, Chan-Young Ock, Kyung-Sook Hong, Yoon-Jae Kim, Jun-Won Chung, Ki-Baik Hahm. (2010) Efficacy of Korean Red Ginseng Supplementation on Eradication Rate and Gastric Volatile Sulfur Compound Levels after Helicobacter pylori Eradication Therapy. Journal of Ginseng Research 34:2, 122-131
CrossRef163
Jun-Won Chung, Yoon-Jae Kim, So-Jung Lee, Ki-Baik Hahm. (2010) Korean Red Ginseng: Qualitative and Quantitative Benefits on Helicobacter pylori Infection. Journal of Ginseng Research 34:2, 77-88
CrossRef164
P. Malfertheiner, J. Bornschein, M. Büchler. (2010) Magenkarzinom: Früherkennung und Prävention. best practice onkologie 5:3, 28-37
CrossRef165
Kaiyo Takubo, Masahiro Fujita, Naotaka Izumiyama, Ken-ichi Nakamura, Naoshi Ishikawa, Steven S Poon, Mutsunori Fujiwara, Motoji Sawabe, Masaaki Matsuura, Heike Grabsch, Tomio Arai, Junko Aida. (2010) Q-FISH analysis of telomere and chromosome instability in the oesophagus with and without squamous cell carcinoma in situ. The Journal of Pathology 221:2, 201-209
CrossRef166
Banu Kara, Hikmet Akkiz, Figen Doran, Suleyman Bayram, Eren Erken, Yuksel Gumurdullu, Macit Sandikci. (2010) The significance of E266K polymorphism in the NOD1 gene on Helicobacter Pylori infection: an effective force on pathogenesis?. Clinical and Experimental Medicine 10:2, 107-112
CrossRef167
Jason Martin, Jessica M. Donnelly, JeanMarie Houghton, Yana Zavros. (2010) The Role of Sonic Hedgehog Reemergence During Gastric Cancer. Digestive Diseases and Sciences 55:6, 1516-1524
CrossRef168
Andrzej Hnatyszyn, Marlena Szalata, Jerzy Stanczyk, Wojciech Cichy, Ryszard Slomski. (2010) Association of c.802C>T polymorphism of NOD2/CARD15 gene with the chronic gastritis and predisposition to cancer in H. pylori infected patients. Experimental and Molecular Pathology 88:3, 388-393
CrossRef169
Cesare Hassan, Angelo Zullo, Emilio Di Giulio, Bruno Annibale, Edith Lahner, Vincenzo De Francesco, Enzo Ierardi. (2010) Cost-effectiveness of Endoscopic Surveillance for Gastric Intestinal Metaplasia. Helicobacter 15:3, 221-226
CrossRef170
Tomohiro Watanabe, Naoki Asano, Stefan Fichtner-Feigl, Peter L. Gorelick, Yoshihisa Tsuji, Yuko Matsumoto, Tsutomu Chiba, Ivan J. Fuss, Atsushi Kitani, Warren Strober. (2010) NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. Journal of Clinical Investigation 120:5, 1645-1662
CrossRef171
Alisher Eshmuratov, Jong Chun Nah, Nayoung Kim, Hye Seung Lee, Hee Eun Lee, Byoung Hwan Lee, Min Sik Uhm, Young Soo Park, Dong Ho Lee, Hyun Chae Jung, In Sung Song. (2010) The Correlation of Endoscopic and Histological Diagnosis of Gastric Atrophy. Digestive Diseases and Sciences 55:5, 1364-1375
CrossRef172
C. Prinz. (2010) Helicobacter pylori. Der Gastroenterologe 5:3, 269-278
CrossRef173
T. Lampert. (2010) Frühe Weichenstellung. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 53:5, 486-497
CrossRef174
McColl, Kenneth E.L., . (2010) Helicobacter pylori Infection. New England Journal of Medicine 362:17, 1597-1604
Full Text175
Elena Lionetti, Flavia Indrio, Lorenzo Pavone, Giorgia Borrelli, Luciano Cavallo, Ruggiero Francavilla. (2010) Role of Probiotics in Pediatric Patients with Helicobacter pylori Infection: A Comprehensive Review of the Literature. Helicobacter 15:2, 79-87
CrossRef176
Edith Lahner, Giulia Bernardini, Annalisa Santucci, Bruno Annibale. (2010) Helicobacter pylori immunoproteomics in gastric cancer and gastritis of the carcinoma phenotype. Expert Review of Proteomics 7:2, 239-248
CrossRef177
A.E. Dassen, V.E.P.P. Lemmens, L.V. van de Poll-Franse, G.J. Creemers, S.J. Brenninkmeijer, D.J. Lips, A.A.M. vd Wurff, K. Bosscha, J.W.W. Coebergh. (2010) Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: A population-based study in the Netherlands. European Journal of Cancer 46:6, 1101-1110
CrossRef178
Dominique Velin, Pierre Michetti. (2010) Advances in vaccination against Helicobacter pylori. Expert Review of Gastroenterology & Hepatology 4:2, 157-166
CrossRef179
Francesca Lodato, Francesco Azzaroli, Laura Turco, Natalia Mazzella, Federica Buonfiglioli, Marco Zoli, Giuseppe Mazzella. (2010) Adverse effects of proton pump inhibitors. Best Practice & Research Clinical Gastroenterology 24:2, 193-201
CrossRef180
Shouko Ono, Mototsugu Kato, Kikuko Takagi, Junichi Kodaira, Kanako Kubota, Yoshihiro Matsuno, Yoshito Komatsu, Masahiro Asaka. (2010) Long-term treatment of localized gastric marginal zone B-cell mucosa associated lymphoid tissue lymphoma including incidence of metachronous gastric cancer. Journal of Gastroenterology and Hepatology 25:4, 804-809
CrossRef181
Seiichi Kato, Shigeru Fujimura. (2010) Primary antimicrobial resistance of Helicobacter pylori in children during the past 9 years. Pediatrics International 52:2, 187-190
CrossRef182
Seiji Shiota, Kazunari Murakami, Toshio Fujioka, Yoshio Yamaoka. (2010) Population-based strategies for Helicobacter pylori -associated disease management: a Japanese perspective. Expert Review of Gastroenterology & Hepatology 4:2, 149-156
CrossRef183
Asahi Hishida, Keitaro Matsuo, Yasuyuki Goto, Yoko Mitsuda, Akio Hiraki, Mariko Naito, Kenji Wakai, Kazuo Tajima, Nobuyuki Hamajima. (2010) No association between AICDA 7888 C/T polymorphism, Helicobacter pylori seropositivity, and the risk of atrophic gastritis and gastric cancer in Japanese. Gastric Cancer 13:1, 43-49
CrossRef184
Jun-Won Chung, Ki-Baik Hahm. (2010) Rejuvenation of atrophic gastritis in the elderly. Journal of Gastroenterology and Hepatology 25:3, 434-435
CrossRef185
Kwong Ming Fock, Tiing Leong Ang. (2010) Epidemiology of Helicobacter pylori infection and gastric cancer in Asia. Journal of Gastroenterology and Hepatology 25:3, 479-486
CrossRef186
M. Shirin Sabbaghian, Jeffrey Ranaudo, Lin Zeng, Alexandra P. Alongi, Guillermo Perez-Perez, Peter Shamamian. (2010) Identification of Helicobacter spp. in bile and gallbladder tissue of patients with symptomatic gallbladder disease. HPB 12:2, 129-133
CrossRef187
Madamanchi Geethangili, Shih-Hua Fang, Chih-Ho Lai, Yerra Koteswara Rao, Hsiu-Man Lien, Yew-Min Tzeng. (2010) Inhibitory effect of Antrodia camphorata constituents on the Helicobacter pylori-associated gastric inflammation. Food Chemistry 119:1, 149-153
CrossRef188
Tomomitsu Tahara, Tomoyuki Shibata, Masakatsu Nakamura, Masaaki Okubo, Daisuke Yoshioka, Tomiyasu Arisawa, Ichiro Hirata. (2010) The mucosal pattern in the non-neoplastic gastric mucosa by using magnifying narrow-band imaging endoscopy significantly correlates with gastric cancer risk. Gastrointestinal Endoscopy 71:2, 429-430
CrossRef189
Meghna Waghray, Yana Zavros, Milena Saqui–Salces, Mohamad El–Zaatari, C. Bharath Alamelumangapuram, Andrea Todisco, Kathryn A. Eaton, Juanita L. Merchant. (2010) Interleukin-1β Promotes Gastric Atrophy Through Suppression of Sonic Hedgehog. Gastroenterology 138:2, 562-572.e2
CrossRef190
Yanbin Jia, Christina Persson, Lifang Hou, Zongli Zheng, Meredith Yeager, Jolanta Lissowska, Stephen J. Chanock, Wong-Ho Chow, Weimin Ye. (2010) A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancer. Cancer Causes & Control 21:2, 313-321
CrossRef191
Peter MALFERTHEINER, Jan BORNSCHEIN, Michael SELGRAD. (2010) Role of Helicobacter pylori infection in gastric cancer pathogenesis: A chance for prevention. Journal of Digestive Diseases 11:1, 2-11
CrossRef192
Masahiro Asaka, Mototsugu Kato, Shin-ichi Takahashi, Yoshihiro Fukuda, Toshiro Sugiyama, Hiroyoshi Ota, Naomi Uemura, Kazunari Murakami, Kiichi Satoh, Kentaro Sugano. (2010) Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition. Helicobacter 15:1, 1-20
CrossRef193
Fernando M. Silva, Tomas Navarro-Rodriguez, Ricardo C. Barbuti, Rejane Mattar, Claudio L. Hashimoto, Jaime N. Eisig. (2010) Helicobacter pylori Reinfection in Brazilian Patients with Peptic Ulcer Disease: A 5-Year Follow-Up. Helicobacter 15:1, 46-52
CrossRef194
Warner AlpÃzar-AlpÃzar, Boye Schnack Nielsen, Rafaela Sierra, Martin Illemann, Jose A. RamÃrez, Adriana Arias, Sundry Durán, Arne Skarstein, Kjell Ovrebo, Leif R. Lund, Ole D. Laerum. (2010) Urokinase plasminogen activator receptor is expressed in invasive cells in gastric carcinomas from high- and low-risk countries. International Journal of Cancer 126:2, 405-415
CrossRef195
Soo-Jeong Cho, Il Ju Choi, Chan Gyoo Kim, Jong Yeul Lee, Myeong-Cherl Kook, Moon-Woo Seong, Sook Ryun Park, Jong Seok Lee, Young-Woo Kim, Keun Won Ryu, Jun Ho Lee, Byung-Ho Nam, Young-Iee Park. (2010) Helicobacter pylori Seropositivity Is Associated with Gastric Cancer Regardless of Tumor Subtype in Korea. Gut and Liver 4:4, 466
CrossRef196
Leila Shokrzadeh, Kaveh Baghaei, Yoshio Yamaoka, Hossein Dabiri, Fereshteh Jafari, Navid Sahebekhtiari, Ali Tahami, Mitsushige Sugimoto, Homayon Zojaji, Mohammad Reza Zali. (2010) Analysis of 3â²-end variable region of the cagA gene in Helicobacter pylori isolated from Iranian population. Journal of Gastroenterology and Hepatology 25:1, 172-177
CrossRef197
Sang Gyun Kim, Ho June Song, Il Ju Choi, Joo Young Cho, Hwoon-Yong Jung, Bora Keum, Jae Hee Cheon, Yong Chan Lee, Jae Gyu Kim, Sue K. Park, Byung Joo Park, Hyun Chae Jung, . (2010) A Planned Prospective, Randomized, Placebo-Controlled Multicenter Trial Assessing the Effect of Helicobacter pylori Eradication on the Healing of Iatrogenic Ulcer after Endoscopic Resection of Gastric Neoplasm. Gut and Liver 4:4, 514
CrossRef198
Cesare Hassan, Angelo Zullo, Francesca Cristofari, Roberto Lorenzetti. (2010) Upper Endoscopy in Europe: Are We Missing Gastric Cancer?. Journal of Clinical Gastroenterology 44:1, 73
CrossRef199
Tomohiro Watanabe, Naoki Asano, Atsushi Kitani, Ivan J. Fuss, Tsutomu Chiba, Warren Strober. (2010) NOD1-Mediated Mucosal Host Defense against Helicobacter pylori. International Journal of Inflammation 2010, 1-6
CrossRef200
R. Allem, FZ. Elkebir. (2010) Infection à Helicobacter pylori et cancer gastrique. Médecine & Nutrition 46:3-4, 80-84
CrossRef201
Masahiro Asaka, Mototsugu Kato, David Y. Graham. (2010) Prevention of Gastric Cancer by Helicobacter pylori Eradication. Internal Medicine 49:7, 633-636
CrossRef202
Kee Myung Lee, Jeong Sang Lee, Hyeon Sik Jung, Dong Kyun Park, Hyun Sun Park, Ki-Baik Hahm. (2010) Late reactivation of sonic hedgehog by Helicobacter pylori results in population of gastric epithelial cells that are resistant to apoptosis: Implication for gastric carcinogenesis. Cancer Letters 287:1, 44-53
CrossRef203
Zhen Jiang, Junming Guo, Bingxiu Xiao, Ying Miao, Rong Huang, Dong Li, Yuanyuan Zhang. (2010) Increased expression of miR-421 in human gastric carcinoma and its clinical association. Journal of Gastroenterology 45:1, 17-23
CrossRef204
Yuan Wenzhen, Li Yumin, Guan Quanlin, Yang Kehu, Jiang Lei, Wang Donghai, Yang Lijuan. (2010) Is Antimicrobial Susceptibility Testing Necessary Before First-line Treatment for Helicobacter pylori Infection? -Meta-analysis of Randomized Controlled Trials-. Internal Medicine 49:12, 1103-1109
CrossRef205
Ho June Song, Se Jin Jang, Sung-Cheol Yun, Young Soo Park, Mi-Jung Kim, Sun-Mi Lee, Kee Don Choi, Gin Hyug Lee, Hwoon-Yong Jung, Jin-Ho Kim. (2010) Low Levels of Pepsinogen I and Pepsinogen I/II Ratio are Valuable Serologic Markers for Predicting Extensive Gastric Corpus Atrophy in Patients Undergoing Endoscopic Mucosectomy. Gut and Liver 4:4, 475
CrossRef206
Jacqueline I. Keenan, Nina Salm, Mark B. Hampton, Alison J. Wallace. (2010) Individual and combined effects of foods on helicobacter pylori growth. Phytotherapy Researchn/a-n/a
CrossRef207
Dong-Wook Park, Kyu-Jae Lee, Sung-Ho Jin, Jae-Hwan Lee, Jae-Seok Min, Sun-Hoo Park, Hang-Jong Yu, Ho-Yoon Bang, Jong-Inn Lee. (2010) Phenotypic Differences of Gastric Cancer according to the Helicobacter pylori Infection in Korean Patients. Journal of Gastric Cancer 10:4, 168
CrossRef208
Scott Altschuler, David A. Peura. 2010. Helicobacter Pylori and Peptic Ulcer Disease. , 73-78.
CrossRef209
George Sachs, Yi Wen, David R. Scott. (2009) Gastric infection by Helicobacter pylori. Current Gastroenterology Reports 11:6, 455-461
CrossRef210
Wiebke Schirrmeister, Thorsten Gnad, Thomas Wex, Shigeki Higashiyama, Carmen Wolke, Michael Naumann, Uwe Lendeckel. (2009) Ectodomain shedding of E-cadherin and c-Met is induced by Helicobacter pylori infection. Experimental Cell Research 315:20, 3500-3508
CrossRef211
Kimihiko Yanaoka, Masashi Oka, Hiroshi Ohata, Noriko Yoshimura, Hisanobu Deguchi, Chizu Mukoubayashi, Shotaro Enomoto, Izumi Inoue, Mikitaka Iguchi, Takao Maekita, Kazuki Ueda, Hirotoshi Utsunomiya, Hideyuki Tamai, Mitsuhiro Fujishiro, Masataka Iwane, Tatsuya Takeshita, Osamu Mohara, Masao Ichinose. (2009) Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels. International Journal of Cancer 125:11, 2697-2703
CrossRef212
Manas Kumar Roy, Sagar Sadhu, Sanjay Kumar Dubey. (2009) Advances in the management of gastric cancer. Indian Journal of Surgery 71:6, 342-349
CrossRef213
Ryota Hokari, Nanae Nagata, Chie Kurihara, Chikako Watanabe, Shunsuke Komoto, Yoshikiyo Okada, Atsushi Kawaguchi, Shigeaki Nagao, Toshifumi Hibi, Kinya Nagata, Yoshihiro Urade, Soichiro Miura. (2009) Increased expression and cellular localization of lipocalin-type prostaglandin D synthase in Helicobacter pylori -induced gastritis. The Journal of Pathology 219:4, 417-426
CrossRef214
Takashi Ando, Takeshi Ishikawa, Haruki Kato, Norimasa Yoshida, Yuji Naito, Satoshi Kokura, Nobuaki Yagi, Tomohisa Takagi, Osamu Handa, Jo Kitawaki, Naoto Nakamura, Goji Hasegawa, Michiaki Fukui, Eiko Imamoto, Chie Nakamura, Hirokazu Oyamada, Yutaka Isozaki, Naohito Matsumoto, Yasuyuki Nagao, Mika Okita, Yoshihiro Nakajima, Manabu Kurokawa, Masafumi Nukina, Mitsuhiro Ohta, Shigeto Mizuno, Masakazu Ogata, Hiroshi Obayashi, Hyohun Park, Yoshihiro Kitagawa, Koji Nakano, Toshikazu Yoshikawa. (2009) Synergistic effect of HLA class II loci and cytokine gene polymorphisms on the risk of gastric cancer in Japanese patients with Helicobacter pylori infection. International Journal of Cancer 125:11, 2595-2602
CrossRef215
Gen Suzuki, Harry Cullings, Saeko Fujiwara, Shinsuke Matsuura, Takeshi Kishi, Waka Ohishi, Masazumi Akahoshi, Tomonori Hayashi, Eiichi Tahara. (2009) LTA 252G G and GA Genotypes are Associated with Diffuse-Type Noncardia Gastric Cancer Risk in the Japanese Population. Helicobacter 14:6, 571-579
CrossRef216
Danica K. Hickey, Frank E. Aldwell, Zi Yan Tan, Shisan Bao, Kenneth W. Beagley. (2009) Transcutaneous immunization with novel lipid-based adjuvants induces protection against gastric Helicobacter pylori infection. Vaccine 27:50, 6983-6990
CrossRef217
Mitsushige Sugimoto, Tomoyuki Ohno, David Y. Graham, Yoshio Yamaoka. (2009) Gastric mucosal interleukin-17 and -18 mRNA expression in Helicobacter pylori -induced Mongolian gerbils. Cancer Science 100:11, 2152-2159
CrossRef218
Jatinder P. Ahluwalia. (2009) Helicobacter pylori and Gastric Cancer: A Marital Risk?. Southern Medical Journal 102:11, 1104-1105
CrossRef219
Tomomitsu Tahara, Tomoyuki Shibata, Masakatsu Nakamura, Hiromi Yamashita, Daisuke Yoshioka, Ichiro Hirata, Tomiyasu Arisawa. (2009) Effect of polymorphisms in the 3′ untranslated region (3′-UTR) of vascular endothelial growth factor gene on gastric cancer and peptic ulcer diseases in Japan. Molecular Carcinogenesis 48:11, 1030-1037
CrossRef220
Marcis Leja, Limas Kupcinskas, Konrads Funka, Agnese Sudraba, Laimas Jonaitis, Audrius Ivanauskas, Dainius Janciauskas, Gediminas Kiudelis, Han-Mo Chiu, Jaw-Town Lin. (2009) The Validity of a Biomarker Method for Indirect Detection of Gastric Mucosal Atrophy Versus Standard Histopathology. Digestive Diseases and Sciences 54:11, 2377-2384
CrossRef221
V. Herrera, J. Parsonnet. (2009) Helicobacter pylori and gastric adenocarcinoma. Clinical Microbiology and Infection 15:11, 971-976
CrossRef222
Chun–Ying Wu, Ken N. Kuo, Ming–Shiang Wu, Yi–Ju Chen, Chang–Bi Wang, Jaw–Town Lin. (2009) Early Helicobacter pylori Eradication Decreases Risk of Gastric Cancer in Patients With Peptic Ulcer Disease. Gastroenterology 137:5, 1641-1648.e2
CrossRef223
Mitsushige Sugimoto, Takahisa Furuta, Yoshio Yamaoka. (2009) Influence of inflammatory cytokine polymorphisms on eradication rates of Helicobacter pylori. Journal of Gastroenterology and Hepatology 24:11, 1725-1732
CrossRef224
Takeshi Toyoda, Tetsuya Tsukamoto, Shinji Takasu, Liang Shi, Naoki Hirano, Hisayo Ban, Toshiko Kumagai, Masae Tatematsu. (2009) Anti-inflammatory effects of caffeic acid phenethyl ester (CAPE), a nuclear factor-κB inhibitor, on Helicobacter pylori -induced gastritis in Mongolian gerbils. International Journal of Cancer 125:8, 1786-1795
CrossRef225
Farhad Pourfarzi, Anna Whelan, John Kaldor, Reza Malekzadeh. (2009) The role of diet and other environmental factors in the causation of gastric cancer in Iran-A population based study. International Journal of Cancer 125:8, 1953-1960
CrossRef226
Kazunori Kasama, Nobumi Tagaya, Eiji Kanehira, Takashi Oshiro, Yosuke Seki, Makoto Kinouchi, Akiko Umezawa, Yuka Negishi, Yoshimochi Kurokawa. (2009) Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass: Technique and Preliminary Results. Obesity Surgery 19:10, 1341-1345
CrossRef227
I. TANEIKE, A. NAMI, A. O’CONNOR, N. FITZGERALD, P. MURPHY, A. QASIM, H. O’CONNOR, C. O’MORAIN. (2009) Analysis of drug resistance and virulence-factor genotype of Irish Helicobacter pylori strains: is there any relationship between resistance to metronidazole and cagA status?. Alimentary Pharmacology & Therapeutics 30:7, 784-790
CrossRef228
S. Reggoug, L. Ouazzani, N. Benzzoubeir, I. Errabih, H. Krami, H. Ouazzani. (2009) Polypose gastrique hyperplasique et maladie cœliaque: une association inédite. Acta Endoscopica 39:5, 348-352
CrossRef229
Aki Tanaka, Tomoari Kamada, Kenji Yokota, Akiko Shiotani, Jiro Hata, Keiji Oguma, Ken Haruma. (2009) Helicobacter pylori heat shock protein 60 antibodies are associated with gastric cancer. Pathology - Research and Practice 205:10, 690-694
CrossRef230
Hui Liu, D. Scott Merrell, Cristina Semino–Mora, Matthew Goldman, Arifur Rahman, Steven Mog, Andre Dubois. (2009) Diet Synergistically Affects Helicobacter pylori–Induced Gastric Carcinogenesis in Nonhuman Primates. Gastroenterology 137:4, 1367-1379.e6
CrossRef231
M. Sugimoto, M. R. Zali, Y. Yamaoka. (2009) The association of vacA genotypes and Helicobacter pylori-related gastroduodenal diseases in the Middle East. European Journal of Clinical Microbiology & Infectious Diseases 28:10, 1227-1236
CrossRef232
Yasumi Katayama, Morio Takahashi, Hajime Kuwayama. (2009) Helicobacter pylori causes runx3 gene methylation and its loss of expression in gastric epithelial cells, which is mediated by nitric oxide produced by macrophages. Biochemical and Biophysical Research Communications 388:3, 496-500
CrossRef233
Noriyuki Horiki, Fumio Omata, Masayo Uemura, Shoko Suzuki, Naoki Ishii, Yusuke Iizuka, Katsuyuki Fukuda, Yoshiyuki Fujita, Masaki Katsurahara, Toshiyuki Ito, Gabazza Esteban Cesar, Ichiro Imoto, Yoshiyuki Takei. (2009) Annual Change of Primary Resistance to Clarithromycin among Helicobacter pylori Isolates from 1996 through 2008 in Japan. Helicobacter 14:5, 438-442
CrossRef234
Seiji Shiota, Kazunari Murakami, Akiko Takayama, Shigeaki Yasaka, Tadayoshi Okimoto, Aoi Yoshiiwa, Masaaki Kodama, Toshio Fujioka. (2009) Evaluation of Helicobacter pylori status and endoscopic findings among new outpatients with dyspepsia in Japan. Journal of Gastroenterology 44:9, 930-934
CrossRef235
Sicheng Wen, Steven F. Moss. (2009) Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Letters 282:1, 1-8
CrossRef236
M. Sugimoto, Y. Yamaoka. (2009) The association of vacA genotype and Helicobacter pylori- related disease in Latin American and African populations. Clinical Microbiology and Infection 15:9, 835-842
CrossRef237
Warner Alpízar-Alpízar, Ole Didrik Laerum, Martin Illemann, José A. Ramírez, Adriana Arias, Wendy Malespín-Bendaña, Vanessa Ramírez, Leif R. Lund, Niels Borregaard, Boye Schnack Nielsen. (2009) Neutrophil gelatinase-associated lipocalin (NGAL/Lcn2) is upregulated in gastric mucosa infected with Helicobacter pylori. Virchows Archiv 455:3, 225-233
CrossRef238
Li-Ping Sun, Xiao-Lin Guo, Ye Zhang, Wei Chen, Xue-Lei Bai, Jin Liu, Yuan Yuan. (2009) Impact of pepsinogen C polymorphism on individual susceptibility to gastric cancer and its precancerous conditions in a Northeast Chinese population. Journal of Cancer Research and Clinical Oncology 135:8, 1033-1039
CrossRef239
Henk H Hartgrink, Edwin PM Jansen, Nicole CT van Grieken, Cornelis JH van de Velde. (2009) Gastric cancer. The Lancet 374:9688, 477-490
CrossRef240
Tomomitsu Tahara, Tomoyuki Shibata, Masakatsu Nakamura, Daisuke Yoshioka, Masaaki Okubo, Tomiyasu Arisawa, Ichiro Hirata. (2009) Gastric mucosal pattern by using magnifying narrow-band imaging endoscopy clearly distinguishes histological and serological severity of chronic gastritis. Gastrointestinal Endoscopy 70:2, 246-253
CrossRef241
Yeganeh Talebkhan, Marjan Mohammadi, Naser Rakhshani, Afshin Abdirad, Katayoun Fayaz Moughadam, Foruzandeh Fereidooni. (2009) Interobserver variations in histopathological assessment of gastric pathology. Pathology 41:5, 428-432
CrossRef242
Wei-Ying Zhou, Yun Shi, Chao Wu, Wei-Jun Zhang, Xu-Hu Mao, Gang Guo, Hai-Xia Li, Quan-Ming Zou. (2009) Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model. Vaccine 27:36, 5013-5019
CrossRef243
K. A. Ryan, A. M. O'Hara, J.-P. van Pijkeren, F. P. Douillard, P. W. O'Toole. (2009) Lactobacillus salivarius modulates cytokine induction and virulence factor gene expression in Helicobacter pylori. Journal of Medical Microbiology 58:8, 996-1005
CrossRef244
L.S. Takemura, P.L. Camargo, A.A. Alfieri, A.P.F.R.L. Bracarense. (2009) Helicobacter spp. in Cats: Association between Infecting Species and Epithelial Proliferation within the Gastric Lamina Propria. Journal of Comparative Pathology 141:2-3, 127-134
CrossRef245
Tomomitsu Tahara, Tomoyuki Shibata, Ichiro Hirata, Hiroshi Nakano, Tomiyasu Arisawa. (2009) CD14 Promoter-159 Polymorphism Is Associated with Reduced Risk of Intestinal-Type Gastric Cancer in a Japanese Population. Digestive Diseases and Sciences 54:7, 1508-1512
CrossRef246
Nashwa A. Elsaied, Aymn T. Abbas, Samar N. El-Beshbishi, Hany M. Elsheikha. (2009) Increased Helicobacter pylori-associated pathology in outbred mice coinfected with schistosomiasis. Parasitology Research 105:2, 297-299
CrossRef247
Ye Wu, Jiang-Feng Guo. (2009) Expression and purification of 15N-labeled 2-SH2 protein domain of SHP-2 from Homo sapiens in Escherichia coli for NMR studies and applications. International Journal of Biological Macromolecules 45:1, 1-7
CrossRef248
Juan Wu, Yan Lu, Yan-bing Ding, Qiao Ke, Zhi-bin Hu, Zhi-gang Yan, Yan Xue, Yan Zhou, Zhao-lai Hua, Yong-qian Shu, Ping liu, Jing Shen, Yao-chu Xu, Hong-bing Shen. (2009) Promoter polymorphisms of IL2, IL4, and risk of gastric cancer in a high-risk Chinese population. Molecular Carcinogenesis 48:7, 626-632
CrossRef249
Shinji Matsuzaki, Fumiaki Tanaka, Koshi Mimori, Kouichirou Tahara, Hiroshi Inoue, Masaki Mori. (2009) Clinicopathologic Significance of KIAA1199 Overexpression in Human Gastric Cancer. Annals of Surgical Oncology 16:7, 2042-2051
CrossRef250
Tomomitsu Tahara, Tomoyuki Shibata, Fang-Yu Wang, Masakatsu Nakamura, Hiromi Yamashita, Daisuke Yoshioka, Masaaki Okubo, Naoko Maruyama, Yoshio Kamiya, Masahiko Nakamura, Hiroshi Fujita, Mitsuo Nagasaka, Masami Iwata, Kazuya Takahama, Makoto Watanabe, Hiroshi Nakano, Ichiro Hirata, Tomiyasu Arisawa. (2009) Mannan-binding lectin B allele is associated with a risk of developing more severe gastric mucosal atrophy in Helicobacter pylori-infected Japanese patients. European Journal of Gastroenterology & Hepatology 21:7, 781-786
CrossRef251
Shahjahan Kabir. (2009) Effect of Helicobacter pylori Eradication on Incidence of Gastric Cancer in Human and Animal Models: Underlying Biochemical and Molecular Events. Helicobacter 14:3, 159-171
CrossRef252
Tomomitsu Tahara, Tomiyasu Arisawa, Tomoyuki Shibata, Masakatsu Nakamura, Daisuke Yoshioka, Masaaki Okubo, Naoko Maruyama, Toshiaki Kamano, Yoshio Kamiya, Hiroshi Fujita, Yoshihito Nakagawa, Mitsuo Nagasaka, Masami Iwata, Kazuya Takahama, Makoto Watanabe, Hiromi Yamashita, Ichiro Hirata. (2009) Increased number of methylated CpG islands correlates with Helicobacter pylori infection, histological and serological severity of chronic gastritis. European Journal of Gastroenterology & Hepatology 21:6, 613-619
CrossRef253
Masayuki Tatemichi, Shizuka Sasazuki, Manami Inoue, Shoichiro Tsugane, . (2009) Clinical Significance of IgG Antibody Titer against Helicobacter pylori. Helicobacter 14:3, 231-236
CrossRef254
Tomoyuki Koike, Shuichi Ohara, Tooru Shimosegawa. (2009) Role of gastric acid secretion in the pathogenesis of Barrett’s esophageal cancer in a Japanese population. Clinical Journal of Gastroenterology 2:3, 143-148
CrossRef255
Tomomitsu Tahara, Tomiyasu Arisawa, Tomoyuki Shibata, Masakatsu Nakamura, Hiromi Yamashita, Daisuke Yoshioka, Masaaki Okubo, Naoko Maruyama, Toshiaki Kamano, Yoshio Kamiya, Hiroshi Fujita, Mitsuo Nagasaka, Masami Iwata, Kazuya Takahama, Makoto Watanabe, Hiroshi Nakano, Ichiro Hirata. (2009) Effect of RANTES Promoter Genotype on the Severity of Intestinal Metaplasia in Helicobacter pylori-Infected Japanese Subjects. Digestive Diseases and Sciences 54:6, 1247-1252
CrossRef256
A C de Vries, E J Kuipers, E A J Rauws. (2009) Helicobacter pylori Eradication and Gastric Cancer: When Is the Horse Out of the Barn?. The American Journal of Gastroenterology 104:6, 1342-1345
CrossRef257
Hidekazu Suzuki, Eisuke Iwasaki, Toshifumi Hibi. (2009) Helicobacter pylori and gastric cancer. Gastric Cancer 12:2, 79-87
CrossRef258
Guanghai Wang, Dianke Yu, Wen Tan, Dan Zhao, Chen Wu, Dongxin Lin. (2009) Genetic polymorphism in chemokine CCL22 and susceptibility to Helicobacter pylori infection-related gastric carcinoma. Cancer 115:11, 2430-2437
CrossRef259
Asima Bhattacharyya, Ranajoy Chattopadhyay, Brent R. Burnette, Janet V. Cross, Sankar Mitra, Peter B. Ernst, Kishor K. Bhakat, Sheila E. Crowe. (2009) Acetylation of Apurinic/Apyrimidinic Endonuclease-1 Regulates Helicobacterpylori-Mediated Gastric Epithelial Cell Apoptosis. Gastroenterology 136:7, 2258-2269
CrossRef260
Takayuki Ando, Takeichi Yoshida, Shotaro Enomoto, Kiyoshi Asada, Masae Tatematsu, Masao Ichinose, Toshiro Sugiyama, Toshikazu Ushijima. (2009) DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: Its possible involvement in the formation of epigenetic field defect. International Journal of Cancer 124:10, 2367-2374
CrossRef261
A H Poulsen, S Christensen, J K McLaughlin, R W Thomsen, H T Sørensen, J H Olsen, S Friis. (2009) Proton pump inhibitors and risk of gastric cancer: a population-based cohort study. British Journal of Cancer 100:9, 1503-1507
CrossRef262
Hirotsugu Watabe, Toru Mitsushima, Mohammad H. Derakhshan, Yutaka Yamaji, Makoto Okamoto, Takao Kawabe, Masao Omata, Kenneth E. L. McColl. (2009) Study of Association Between Atrophic Gastritis and Body Mass Index: A Cross-Sectional Study in 10,197 Japanese Subjects. Digestive Diseases and Sciences 54:5, 988-995
CrossRef263
Xin-Yuan Gao, Hong-Yu Kuang, Xiao-Min Liu, Peng Duan, Yi Yang, Zhi-Bin Ma. (2009) Circulating ghrelin/obestatin ratio in subjects with Helicobacter pylori infection. Nutrition 25:5, 506-511
CrossRef264
Masanori Ito, Shunsuke Takata, Masana Tatsugami, Yoshihiro Wada, Shinobu Imagawa, Yoshiaki Matsumoto, Akemi Takamura, Shosuke Kitamura, Taiji Matsuo, Shinji Tanaka, Ken Haruma, Kazuaki Chayama. (2009) Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review. Journal of Gastroenterology 44:5, 365-371
CrossRef265
Louis M. Lin, Domenico Ricucci, Jarshen Lin, Paul A. Rosenberg. (2009) Nonsurgical Root Canal Therapy of Large Cyst-like Inflammatory Periapical Lesions and Inflammatory Apical Cysts. Journal of Endodontics 35:5, 607-615
CrossRef266
Yuk Kei Yee, Ka Wah Wong, Chee Kin Hui, Chi Kuen Chan, Annie O O Chan, Shiu Kam Lam, Fiona M Y Fung, Ivan Hung, Benjamin C Y Wong. (2009) Prevalence and time trend of intestinal metaplasia in Hong Kong. Journal of Gastroenterology and Hepatology 24:5, 896-899
CrossRef267
Jung Mook Kang, Nayoung Kim, Dong Ho Lee, Ji Hyun Park, Mi Kyoung Lee, Joo Sung Kim, Hyun Chae Jung, In Sung Song. (2009) The Effects of Genetic Polymorphisms of IL-6, IL-8, and IL-10 on Helicobacter pylori-induced Gastroduodenal Diseases in Korea. Journal of Clinical Gastroenterology 43:5, 420-428
CrossRef268
Shunsuke Takata, Masanori Ito, Yoshihiro Wada, Masaharu Yoshihara, Shinji Tanaka, Kazuaki Chayama. (2009) Pathogenetic role of the tyrosine-phosphorylated CagA EPIYA sequence of Helicobacter pylori in histological gastritis in Japanese patients. Journal of Gastroenterology 44:5, 405-411
CrossRef269
Akira Yokoyama, Tai Omori, Tetsuji Yokoyama, Hirofumi Kawakubo, Shuka Mori, Toshifumi Matsui, Katsuya Maruyama. (2009) Chronic Atrophic Gastritis and Metachronous Gastric Cancer in Japanese Alcoholic Men With Esophageal Squamous Cell Carcinoma. Alcoholism: Clinical and Experimental Research 33:5, 898-905
CrossRef270
Hong Cheng, Fulian Hu, Lian Zhang, Guibin Yang, Junling Ma, Jichun Hu, Weihong Wang, Wen Gao, Xinhong Dong. (2009) Prevalence of Helicobacter pylori Infection and Identification of Risk Factors in Rural and Urban Beijing, China. Helicobacter 14:2, 128-133
CrossRef271
Yutaka Yamaji, Hirotsugu Watabe, Haruhiko Yoshida, Takao Kawabe, Ryoichi Wada, Toru Mitsushima, Masao Omata. (2009) High-risk Population for Gastric Cancer Development Based on Serum Pepsinogen Status and Lifestyle Factors. Helicobacter 14:2, 81-86
CrossRef272
J. Dicksved, M. Lindberg, M. Rosenquist, H. Enroth, J. K. Jansson, L. Engstrand. (2009) Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. Journal of Medical Microbiology 58:4, 509-516
CrossRef273
Masanori Hatakeyama. (2009) Helicobacter pylori and gastric carcinogenesis. Journal of Gastroenterology 44:4, 239-248
CrossRef274
Tadashi Shimoyama, Takao Oyama, Masashi Matsuzaka, Kazuma Danjo, Shigeyuki Nakaji, Shinsaku Fukuda. (2009) Comparison of a Stool Antigen Test and Serology for the Diagnosis of Helicobacter pylori Infection in Mass Survey. Helicobacter 14:2, 87-90
CrossRef275
Rodrigo Muñoz, Luis Ibáñez, José Salinas, Alex Escalona, Gustavo Pérez, Fernando Pimentel, Sergio Guzmán, Camilo Boza. (2009) Importance of Routine Preoperative Upper GI Endoscopy: Why All Patients Should Be Evaluated?. Obesity Surgery 19:4, 427-431
CrossRef276
H. H. Hartgrink. (2009) Improving outcome for scirrhous gastric cancer. Gastric Cancer 12:1, 3-5
CrossRef277
Rie Kakinoki, Ryoji Kushima, Akiko Matsubara, Yasuharu Saito, Hidetoshi Okabe, Yoshihide Fujiyama, Takanori Hattori. (2009) Re-evaluation of Histogenesis of Gastric Carcinomas: A Comparative Histopathological Study Between Helicobacter pylori-Negative and H. pylori-Positive Cases. Digestive Diseases and Sciences 54:3, 614-620
CrossRef278
Byong Duk Ye, Sang Gyun Kim, Ji Hyun Park, Joo Sung Kim, Hyun Chae Jung, In Sung Song. (2009) The Interleukin-8–251 A Allele is Associated With Increased Risk of Noncardia Gastric Adenocarcinoma in Helicobacter pylori-infected Koreans. Journal of Clinical Gastroenterology 43:3, 233-239
CrossRef279
Peter J Ramsey, Yasser H Shaib, David Y Graham. (2009) Appropriate Use or Overutilization of the CORI Database?. The American Journal of Gastroenterology 104:3, 785-786
CrossRef280
Gregory W. Broussard, Michelle B. Norris, Adam R. Schwindt, John W. Fournie, Richard N. Winn, Michael L. Kent, Don G. Ennis. (2009) Chronic Mycobacterium marinum infection acts as a tumor promoter in Japanese Medaka (Oryzias latipes). Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 149:2, 152-160
CrossRef281
Lee Yeong Yeh, Mahendra Raj, Syed Hassan, Syed Abdul Aziz, Nor Hayati Othman, Samarendra Singh Mutum, Ventakesh R. Naik. (2009) Chronic atrophic antral gastritis and risk of metaplasia and dysplasia in an area with low prevalence of Helicobacter pylori. Indian Journal of Gastroenterology 28:2, 49-52
CrossRef282
Tomoyuki Ohno, Mitsushige Sugimoto, Aiko Nagashima, Hiroaki Ogiwara, Ratha-Korn Vilaichone, Varocha Mahachai, David Y Graham, Yoshio Yamaoka. (2009) Relationship between Helicobacter pylori hopQ genotype and clinical outcome in Asian and Western populations. Journal of Gastroenterology and Hepatology 24:3, 462-468
CrossRef283
Eric Chak, George W. Rutherford, Craig Steinmaus. (2009) The Role of Breast‐Feeding in the Prevention of Helicobacter pylori Infection: A Systematic Review. Clinical Infectious Diseases 48:4, 430-437
CrossRef284
Takeshi Nakajima, Satoshi Yamashita, Takao Maekita, Tohru Niwa, Kazuyuki Nakazawa, Toshikazu Ushijima. (2009) The presence of a methylation fingerprint of Helicobacter pylori infection in human gastric mucosae. International Journal of Cancer 124:4, 905-910
CrossRef285
J.-M. Otte, H. M. Neumann, S. Brand, H. Schrader, W. E. Schmidt, F. Schmitz. (2009) Expression of beta-defensin 4 is increased in human gastritis. European Journal of Clinical Investigation 39:2, 126-138
CrossRef286
Helena T.J.I. De Leest, Kirsti S. Steen, Elisabeth Bloemena, Willem F. Lems, Ernst J. Kuipers, Mart A.F.J. Van de Laar, J.W.J. Bijlsma, Matthijs Janssen, Harry H.M.L. Houben, Piet J. Kostense, Maarten Boers, Ben A.C. Dijkmans. (2009) Helicobacter pylori Eradication in Patients on Long-term Treatment With NSAIDs Reduces the Severity of Gastritis. Journal of Clinical Gastroenterology 43:2, 140-146
CrossRef287
Robin de Vries, Rogier M. Klok, Jacobus R.B.J. Brouwers, Maarten J. Postma. (2009) Cost-effectiveness of a potential future Helicobacter pylori vaccine in the Netherlands: The impact of varying the discount rate for health. Vaccine 27:6, 846-852
CrossRef288
Bingxiu Xiao, Junming Guo, Ying Miao, Zhen Jiang, Rong Huan, Yuanyuan Zhang, Dong Li, Jiuchang Zhong. (2009) Detection of miR-106a in gastric carcinoma and its clinical significance. Clinica Chimica Acta 400:1-2, 97-102
CrossRef289
Bolin Geng, Gregory Basarab, Janelle Comita-Prevoir, Madhusudhan Gowravaram, Pamela Hill, Andrew Kiely, James Loch, Lawrence MacPherson, Marshall Morningstar, George Mullen, Ekundayo Osimboni, Alexander Satz, Charles Eyermann, Tomas Lundqvist. (2009) Potent and selective inhibitors of Helicobacter pylori glutamate racemase (MurI): Pyridodiazepine amines. Bioorganic & Medicinal Chemistry Letters 19:3, 930-936
CrossRef290
Lin Lü, Hong-Dan Cao, Han-Qing Zeng, Pi-Long Wang, Li-Juan Wang, Shao-Ning Liu, Ting-Xiu Xiang. (2009) Recombinant Mycobacterium smegmatis mc2155 vaccine expressing outer membrane protein 26kDa antigen affords therapeutic protection against Helicobacter pylori infection. Vaccine 27:7, 972-978
CrossRef291
Mitsushige Sugimoto, Yoshio Yamaoka. (2009) Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy. Archivum Immunologiae et Therapiae Experimentalis 57:1, 45-56
CrossRef292
Asahi Hishida, Keitaro Matsuo, Yasuyuki Goto, Yoko Mitsuda, Akio Hiraki, Mariko Naito, Kenji Wakai, Kazuo Tajima, Nobuyuki Hamajima. (2009) Toll-Like Receptor 4 + 3725 G/C Polymorphism, Helicobacter pylori Seropositivity, and the Risk of Gastric Atrophy and Gastric Cancer in Japanese. Helicobacter 14:1, 47-53
CrossRef293
Alessandro Angelini, Tommaso Tosi, Philippe Mas, Samira Acajjaoui, Giuseppe Zanotti, Laurent Terradot, Darren J. Hart. (2009) Expression of Helicobacter pylori CagA domains by library-based construct screening. FEBS Journal 276:3, 816-824
CrossRef294
S H Lee, J Kim, W-H Kim, Y M Lee. (2009) Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Oncogene 28:2, 184-194
CrossRef295
Yuan Wenzhen, Yang Kehu, Ma Bin, Li Yumin, Guan Quanlin, Wang Donghai, Yang Lijuan. (2009) Moxifloxacin-Based Triple Therapy Versus Clarithromycin-Based Triple Therapy for First-Line Treatment of Helicobacter pylori Infection: A Meta-Analysis of Randomized Controlled Trials. Internal Medicine 48:24, 2069-2076
CrossRef296
Susumu Take, Motowo Mizuno, Kuniharu Ishiki, Yasuhiro Nagahara, Tomowo Yoshida, Kenji Yokota, Keij Oguma, Hiroyuki Okada, Kazuhide Yamamoto. (2009) Helicobacter pylori eradication may induce de novo, but transient and mild, reflux esophagitis: Prospective endoscopic evaluation. Journal of Gastroenterology and Hepatology 24:1, 107-113
CrossRef297
Junichi Akiyama, Naomi Uemura. (2009) Intestinal metaplasia subtype and gastric cancer risk. Journal of Gastroenterology and Hepatology 24:1, 4-6
CrossRef298
Nayoung Kim, Jae J Kim, Yon Ho Choe, Hyun Soo Kim, Jin Il Kim, In-Sik Chung, , . (2009) Diagnosis and Treatment Guidelines for Helicobacter pylori Infection in Korea. The Korean Journal of Gastroenterology 54:5, 269
CrossRef299
Miyoko Yamaoka, Shigemi Nakajima. (2009) Prevalence of Subjects at a High or Very High Risk of Gastric Cancer in Japan. Gut and Liver 3:2, 95
CrossRef300
JERROLD R. TURNER, ROBERT D. ODZE. 2009. Polyps of the Stomach. , 415-445.
CrossRef301
Yousef Bafandeh, Sara Farhang. (2009) Subsite Distribution of Gastric Cancer in an Area of High Prevalence—Northwest Iran. Journal of Epidemiology 19:4, 202-205
CrossRef302
Kazunori Kasama, Nobumi Tagaya, Eiji Kanehira, Takashi Oshiro, Yosuke Seki, Makoto Kinouchi, Akiko Umezawa, Yuka Negishi, Yoshimochi Kurokawa. (2009) Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass: Technique and Preliminary Results. Obesity Surgery
CrossRef303
Kyung P Kang, Hye S Lee, Nayoung Kim, Hyung M Kang, Young S Park, Dong H Lee, Gheeyoung Choe, Joo S Kim, Hyun C Jung, In S Song. (2009) Role of intestinal metaplasia subtyping in the risk of gastric cancer in Korea. Journal of Gastroenterology and Hepatology 24:1, 140-148
CrossRef304
Mitsushige Sugimoto, Kyoko Sakai, Masakazu Kita, Jiro Imanishi, Yoshio Yamaoka. (2009) Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney International 75:1, 96-103
CrossRef305
Tetsuya Tanigawa, Toshio Watanabe, Kazuhide Higuchi, Kazunari Tominaga, Yasuhiro Fujiwara, Nobuhide Oshitani, Andrzej S. Tarnawski, Tetsuo Arakawa. (2009) Long-term use of nonsteroidal anti-inflammatory drugs normalizes the kinetics of gastric epithelial cells in patients with Helicobacter pylori infection via attenuation of gastric mucosal inflammation. Journal of Gastroenterology 44:S19, 8-17
CrossRef306
D SILVA, R STEVENS, J MACEDO, R HIRATA, A PINTO, L ALVES, E VEERMAN, E TINOCO. (2009) Higher levels of salivary MUC5B and MUC7 in individuals with gastric diseases who harbor Helicobacter pylori. Archives of Oral Biology 54:1, 86-90
CrossRef307
Jalal Rezaii, Hassan Tavakoli, Khalil Esfandiari, Hossein Ashegh, Mehrdad Hasibi, Gholamreza Ghanei, Mahnaz Khosh-Batn, Armin Rashidi. (2008) Association between Helicobacter pylori infection and laryngohypopharyngeal carcinoma: A case-control study and review of the literature. Head & Neck 30:12, 1624-1627
CrossRef308
Tomomitsu Tahara, Tomoyuki Shibata, Hiromi Yamashita, Ichiro Hirata, Tomiyasu Arisawa. (2008) Effect of cyclin D1 ( CCND1 ) polymorphism on gastric premalignant condition. Clinical Chemistry and Laboratory Medicine 46:12, 1696-1701
CrossRef309
Akiko Shiotani, Tomoari Kamada, Yoshiyuki Yamanaka, Noriaki Manabe, Hiroaki Kusunoki, Jiro Hata, Ken Haruma. (2008) Sonic hedgehog and CDX2 expression in the stomach. Journal of Gastroenterology and Hepatology 23, S161-S166
CrossRef310
L. T. Nguyen, T. Uchida, K. Murakami, T. Fujioka, M. Moriyama. (2008) Helicobacter pylori virulence and the diversity of gastric cancer in Asia. Journal of Medical Microbiology 57:12, 1445-1453
CrossRef311
Masashi Matsushima, Takayoshi Suzuki, Aya Masui, Kouichi Kasai, Tomoko Kouchi, Atsushi Takagi, Takayuki Shirai, Tetsuya Mine. (2008) Growth inhibitory action of cranberry on Helicobacter pylori. Journal of Gastroenterology and Hepatology 23, S175-S180
CrossRef312
M Hatakeyama. (2008) Linking epithelial polarity and carcinogenesis by multitasking Helicobacter pylori virulence factor CagA. Oncogene 27:55, 7047-7054
CrossRef313
Marino Venerito, Doerthe Kuester, Thomas Wex, Albert Roessner, Peter Malfertheiner, Gerhard Treiber. (2008) The long-term effect of Helicobacter pylori eradication on COX-1/2, 5-LOX and leukotriene receptors in patients with a risk gastritis phenotype – A link to gastric carcinogenesis. Cancer Letters 270:2, 218-228
CrossRef314
Evangelos Chandanos, Jesper Lagergren. (2008) Oestrogen and the enigmatic male predominance of gastric cancer. European Journal of Cancer 44:16, 2397-2403
CrossRef315
Fang-Yu Wang, Tomomitsu Tahara, Tomiyasu Arisawa, Tomoyuki Shibata, Hiromi Yamashita, Masakatsu Nakamura, Daisuke Yoshioka, Masaaki Okubo, Naoko Maruyama, Toshiaki Kamano, Yoshio Kamiya, Masahiko Nakamura, Hiroshi Fujita, Mitsuo Nagasaka, Masami Iwata, Kazuya Takahama, Makoto Watanabe, Hiroshi Nakano, Ichiro Hirata. (2008) Mannan-binding Lectin (MBL) Polymorphism and Gastric Cancer Risk in Japanese Population. Digestive Diseases and Sciences 53:11, 2904-2908
CrossRef316
Mutsuko Konno, Shin-ichi Yokota, Toshihiro Suga, Michiko Takahashi, Kohei Sato, Nobuhiro Fujii. (2008) Predominance of Mother-to-Child Transmission of Helicobacter pylori Infection Detected by Random Amplified Polymorphic DNA Fingerprinting Analysis in Japanese Families. The Pediatric Infectious Disease Journal 27:11, 999-1003
CrossRef317
B Sun, M Karin. (2008) NF-κB signaling, liver disease and hepatoprotective agents. Oncogene 27:48, 6228-6244
CrossRef318
P. Zhang, J.-Z. Di, Z.-Z. Zhu, H.-M. Wu, Y. Wang, G. Zhu, Q. Zheng, L. Hou. (2008) Association of Transforming Growth Factor-beta 1 Polymorphisms with Genetic Susceptibility to TNM Stage I or II Gastric Cancer. Japanese Journal of Clinical Oncology 38:12, 861-866
CrossRef319
Woon Geon Shin, Ji Sun Jang, Hyoung Su Kim, Sung Jung Kim, Kyung Ho Kim, Myoung Kuk Jang, Jin Heon Lee, Ha Jung Kim, Hak Yang Kim. (2008) Polymorphisms of interleukin-1 and interleukin-2 genes in patients with gastric cancer in Korea. Journal of Gastroenterology and Hepatology 23:10, 1567-1573
CrossRef320
Shouko Ono, Mototsugu Kato, Yuji Ono, Tomoo Itoh, Kanako Kubota, Manabu Nakagawa, Yuichi Shimizu, Masahiro Asaka. (2008) Characteristics of magnified endoscopic images of gastric extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue, including changes after treatment. Gastrointestinal Endoscopy 68:4, 624-631
CrossRef321
Meira Epplein, Abraham M. Y. Nomura, Jean H. Hankin, Martin J. Blaser, Guillermo Perez-Perez, Grant N. Stemmermann, Lynne R. Wilkens, Laurence N. Kolonel. (2008) Association of Helicobacter pylori infection and diet on the risk of gastric cancer: a case–control study in Hawaii. Cancer Causes & Control 19:8, 869-877
CrossRef322
Iwona Radziejewska, Małgorzata Borzym-Kluczyk, Dariusz G. Kisiel, Zbigniew Namiot, Joanna Wosek, Andrzej Gindzieński. (2008) The Effect of Helicobacter pylori Eradication Treatment on the MUC 1 and Lewis Antigens Level in Human Gastric Juice: Preliminary Study. Digestive Diseases and Sciences 53:10, 2641-2645
CrossRef323
Yasuhiro Sone, Takashi Kumada, Hidenori Toyoda, Mitsuyoshi Yokoyama, Mototsugu Kato, Masahiro Asaka. (2008) Eradicating Helicobacter pylori in Peptic Ulcer Disease Reduces Medical Costs in the Community. Helicobacter 13:5, 346-351
CrossRef324
Woojin Kim, Steven F. Moss. (2008) The role of Helicobacter pylori in the pathogenesis of gastric malignancies. Oncology Reviews 2:3, 131-140
CrossRef325
M. CHOY, P. SWITZER, C. De MARTEL, J. PARSONNET. (2008) Estimating disease prevalence using census data. Epidemiology and Infection 136:09,
CrossRef326
Charles L. Wiggins, David G. Perdue, Jeffrey A. Henderson, Michael G. Bruce, Anne P. Lanier, Janet J. Kelley, Brenda F. Seals, David K. Espey. (2008) Gastric cancer among American Indians and Alaska Natives in the United States, 1999-2004. Cancer 113:S5, 1225-1233
CrossRef327
T. Moujaber, C.R. MacIntyre, J. Backhouse, H. Gidding, H. Quinn, G.L. Gilbert. (2008) The seroepidemiology of Helicobacter pylori infection in Australia. International Journal of Infectious Diseases 12:5, 500-504
CrossRef328
Kimihiko Yanaoka, Masashi Oka, Noriko Yoshimura, Chizu Mukoubayashi, Shotaro Enomoto, Mikitaka Iguchi, Hirohito Magari, Hirotoshi Utsunomiya, Hideyuki Tamai, Kenji Arii, Nobutake Yamamichi, Mitsuhiro Fujishiro, Tatsuya Takeshita, Osamu Mohara, Masao Ichinose. (2008) Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels. International Journal of Cancer 123:4, 917-926
CrossRef329
M. Rugge, P. Correa, F. Di Mario, E. El-Omar, R. Fiocca, K. Geboes, R.M. Genta, D.Y. Graham, T. Hattori, P. Malfertheiner, S. Nakajima, P. Sipponen, J. Sung, W. Weinstein, M. Vieth. (2008) OLGA staging for gastritis: A tutorial. Digestive and Liver Disease 40:8, 650-658
CrossRef330
A. Kandulski, M. Selgrad, P. Malfertheiner. (2008) Helicobacter pylori infection: A clinical overview. Digestive and Liver Disease 40:8, 619-626
CrossRef331
Kazutoshi Fukase, Mototsugu Kato, Shogo Kikuchi, Kazuhiko Inoue, Naomi Uemura, Shiro Okamoto, Shuichi Terao, Kenji Amagai, Shunji Hayashi, Masahiro Asaka. (2008) Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. The Lancet 372:9636, 392-397
CrossRef332
Jung Hoon Lee, Nayoung Kim, Jae Il Chung, Kyung Phil Kang, Sang Hyup Lee, Young Soo Park, Jin-Hyeok Hwang, Jin-Wook Kim, Sook-Hyang Jeong, Dong Ho Lee, Hyun Chae Jung, In Sung Song. (2008) Long-term Follow up of Helicobacter pylori IgG Serology After Eradication and Reinfection Rate of H. pylori in South Korea. Helicobacter 13:4, 288-294
CrossRef333
Toshifumi Mitani, Daisuke Shirasaka, Nobuo Aoyama, Ikuya Miki, Yoshinori Morita, Nobunao Ikehara, Yuko Matsumoto, Tatsuya Okuno, Masanori Toyoda, Hideyuki Miyachi, Shiei Yoshida, Naoko Chayahara, Junko Hori, Takao Tamura, Takeshi Azuma, Masato Kasuga. (2008) Role of metallothionein in Helicobacter pylori -positive gastric mucosa with or without early gastric cancer and the effect on its expression after eradication therapy. Journal of Gastroenterology and Hepatology 23:8pt2, e334-e339
CrossRef334
Nayoung Kim, Young Soo Park, Sung-Il Cho, Hye Seung Lee, Gheeyoung Choe, In Wook Kim, Yoo-Deok Won, Ji Hyun Park, Joo Sung Kim, Hyun Chae Jung, In Sung Song. (2008) Prevalence and Risk Factors of Atrophic Gastritis and Intestinal Metaplasia in a Korean Population Without Significant Gastroduodenal Disease. Helicobacter 13:4, 245-255
CrossRef335
Nicholas J Talley. (2008) Is it time to screen and treat H pylori to prevent gastric cancer?. The Lancet 372:9636, 350-352
CrossRef336
Gregory S. Basarab, Pamela J. Hill, Abdullah Rastagar, Peter J.H. Webborn. (2008) Design of Helicobacter pylori glutamate racemase inhibitors as selective antibacterial agents: A novel pro-drug approach to increase exposure. Bioorganic & Medicinal Chemistry Letters 18:16, 4716-4722
CrossRef337
Tsutomu Chiba, Hiroyuki Marusawa, Hiroshi Seno, Norihiko Watanabe. (2008) Mechanism for gastric cancer development by Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 23:8pt1, 1175-1181
CrossRef338
A. Roujeinikova. (2008) Crystal structure of the cell wall anchor domain of MotB, a stator component of the bacterial flagellar motor: Implications for peptidoglycan recognition. Proceedings of the National Academy of Sciences 105:30, 10348-10353
CrossRef339
Daniel Mendoza, Phabiola Herrera, Robert H. Gilman, Julio Lanfranco, Martín Tapia, Alejandro Bussalleu, Jorge Huerta-Mercado Tenorio, Carlos Enrique Guillén-Rodríguez, Martín Tagle Arróspide, Alejandro Piscoya, Angel Rosas-Aguirre, José Watanabe-Yamamoto, Juan Carlos Ferrufino, Yolanda Scavino, Alberto Ramírez-Ramos. (2008) Variation in the prevalence of gastric cancer in Perú. International Journal of Cancer 123:2, 414-420
CrossRef340
Shinobu Imagawa, Masaharu Yoshihara, Masanori Ito, Shigeto Yoshida, Yoshihiro Wada, Masana Tatsugami, Akemi Takamura, Shinji Tanaka, Ken Haruma, Kazuaki Chayama. (2008) Evaluation of Gastric Cancer Risk Using Topography of Histological Gastritis: A Large-scaled Cross-sectional Study. Digestive Diseases and Sciences 53:7, 1818-1823
CrossRef341
Marc Roger Couturier, Markus Stein. (2008) Helicobacter pylori produces unique filaments upon host contact in vitro. Canadian Journal of Microbiology 54:7, 537-548
CrossRef342
Yuki I. Kawamura, Minoru Toyota, Rei Kawashima, Teruki Hagiwara, Hiromu Suzuki, Kohzoh Imai, Yasuhisa Shinomura, Takashi Tokino, Reiji Kannagi, Taeko Dohi. (2008) DNA Hypermethylation Contributes to Incomplete Synthesis of Carbohydrate Determinants in Gastrointestinal Cancer. Gastroenterology 135:1, 142-151.e3
CrossRef343
Kazuhito Rokutan, Tsukasa Kawahara, Yuki Kuwano, Kumiko Tominaga, Keisei Nishida, Shigetada Teshima-Kondo. (2008) Nox enzymes and oxidative stress in the immunopathology of the gastrointestinal tract. Seminars in Immunopathology 30:3, 315-327
CrossRef344
L. Gutiérrez-González, N.A. Wright. (2008) Biology of intestinal metaplasia in 2008: More than a simple phenotypic alteration. Digestive and Liver Disease 40:7, 510-522
CrossRef345
Shinya Toyokuni. (2008) Molecular mechanisms of oxidative stress-induced carcinogenesis: From epidemiology to oxygenomics. IUBMB Life 60:7, 441-447
CrossRef346
Satohiro Matsumoto, Kazumi Yamasaki, Kenichiro Tsuji, Satoshi Shirahama. (2008) Human T Lymphotropic Virus Type 1 Infection and Gastric Cancer Development in Japan. The Journal of Infectious Diseases 198:1, 10-15
CrossRef347
P. Correa, M.B. Piazuelo. (2008) Natural history of Helicobacter pylori infection. Digestive and Liver Disease 40:7, 490-496
CrossRef348
Luciana Rigoli, Chiara Di Bella, Fabio Verginelli, Mario Falchetti, Alessandra Bersiga, Alba Rocco, Gerardo Nardone, Renato Mariani-Costantini, Rosario A Caruso. (2008) Histological heterogeneity and somatic mtDNA mutations in gastric intraepithelial neoplasia. Modern Pathology 21:6, 733-741
CrossRef349
R Yanaru-Fujisawa, T Matsumoto, Y Ushijima, M Esaki, M Hirahashi, M Gushima, T Yao, Y Nakabeppu, M Iida. (2008) Genomic and functional analyses of MUTYH in Japanese patients with adenomatous polyposis. Clinical Genetics 73:6, 545-553
CrossRef350
J. Rezaii, H. Ashegh, M. Hasibi, M. Behzadi, F. Khodadadi, M. Heidarali. (2008) The Investigation of p53 and Ki-67 Gene Mutations in Relation with Helicobacter pylori Infection in Patients with Gastric Cancer. Journal of Medical Sciences(Faisalabad) 8:6, 564-568
CrossRef351
Catherine C. Neto, Jon W. Amoroso, Anne M. Liberty. (2008) Anticancer activities of cranberry phytochemicals: An update. Molecular Nutrition & Food Research
CrossRef352
M. Douraghi, M. Mohammadi, A. Oghalaie, A. Abdirad, M. A. Mohagheghi, M. E. Hosseini, H. Zeraati, A. Ghasemi, M. Esmaieli, N. Mohajerani. (2008) dupA as a risk determinant in Helicobacter pylori infection. Journal of Medical Microbiology 57:5, 554-562
CrossRef353
Albert Abad. (2008) New drugs in the treatment of gastric tumors. Clinical and Translational Oncology 10:5, 256-261
CrossRef354
Shin Maeda, Masao Omata. (2008) Inflammation and cancer: Role of nuclear factor-kappaB activation. Cancer Science 99:5, 836-842
CrossRef355
Jie Ge, Zhikang Chen, Shaobin Wu, Weijie Yuan, Bin Hu, Zihua Chen. (2008) A Clinicopathological Study on the Expression of Cadherin-17 and Caudal-related Homeobox Transcription Factor (CDX2) in Human Gastric Carcinoma. Clinical Oncology 20:4, 275-283
CrossRef356
Nayoung Kim, Ran Young Park, Sung-Il Cho, Seon Hee Lim, Kye Heui Lee, Wooseung Lee, Hyung Min Kang, Hye Seung Lee, Hyun Chae Jung, In Sung Song. (2008) Helicobacter pylori Infection and Development of Gastric Cancer in Korea. Journal of Clinical Gastroenterology 42:5, 448-454
CrossRef357
U. Kiltz, J. Zochling, W. E. Schmidt, J. Braun. (2008) Use of NSAIDs and infection with Helicobacter pylori--what does the rheumatologist need to know?. Rheumatology 47:9, 1342-1347
CrossRef358
Jiro Watari, Koushik K. Das, Peter S. Amenta, Hiroki Tanabe, Atsumi Tanaka, Xin Geng, Jim J.–C. Lin, Yutaka Kohgo, Kiron M. Das. (2008) Effect of Eradication of Helicobacter pylori on the Histology and Cellular Phenotype of Gastric Intestinal Metaplasia. Clinical Gastroenterology and Hepatology 6:4, 409-417
CrossRef359
Annemarie C. de Vries, Nicole C.T. van Grieken, Caspar W.N. Looman, Mariël K. Casparie, Esther de Vries, Gerrit A. Meijer, Ernst J. Kuipers. (2008) Gastric Cancer Risk in Patients With Premalignant Gastric Lesions: A Nationwide Cohort Study in the Netherlands. Gastroenterology 134:4, 945-952
CrossRef360
Gerardo Nardone, Debora Compare. (2008) Epigenetic alterations due to diet and Helicobacter pylori infection in gastric carcinogenesis. Expert Review of Gastroenterology & Hepatology 2:2, 243-248
CrossRef361
Matthias Ernst, Meri Najdovska, Dianne Grail, Therese Lundgren-May, Michael Buchert, Hazel Tye, Vance B. Matthews, Jane Armes, Prithi S. Bhathal, Norman R. Hughes, Eric G. Marcusson, James G. Karras, Songqing Na, Jonathon D. Sedgwick, Paul J. Hertzog, Brendan J. Jenkins. (2008) STAT3 and STAT1 mediate IL-11–dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. Journal of Clinical Investigation
CrossRef362
Ryoko Kanada, Tomohisa Uchida, Yoshiyuki Tsukamoto, Lam Tung Nguyen, Naoki Hijiya, Keiko Matsuura, Masaaki Kodama, Tadayoshi Okimoto, Kazunari Murakami, Toshio Fujioka, Shigetaka Yanagisawa, Masatsugu Moriyama. (2008) Genotyping of the cagA gene of Helicobacter pylori on immunohistochemistry with East Asian CagA-specific antibody. Pathology International 58:4, 218-225
CrossRef363
Ruggiero Francavilla, Elena Lionetti, Stefania Paola Castellaneta, Anna Maria Magistà, Giovanni Maurogiovanni, Nunzia Bucci, Angela De Canio, Flavia Indrio, Luciano Cavallo, Enzo Ierardi, Vito Leonardo Miniello. (2008) Inhibition of Helicobacter pylori Infection in Humans by Lactobacillus reuteri ATCC 55730 and Effect on Eradication Therapy: A Pilot Study. Helicobacter 13:2, 127-134
CrossRef364
Satkiran S. Grewal, John P. Hunt, Stephen C. O'Connor, Laurie E. Gianturco, Matthew W. Richardson, Leslie E. Lehmann. (2008) Helicobacter pylori associated gastric Burkitt lymphoma. Pediatric Blood & Cancer 50:4, 888-890
CrossRef365
Yeganeh Talebkhan, Marjan Mohammadi, Mohammad Ali Mohagheghi, Hamid Reza Vaziri, Mahmoud Eshagh Hosseini, Nazanin Mohajerani, Akbar Oghalaei, Maryam Esmaeili, Leili Zamaninia. (2008) cagA Gene and Protein Status Among Iranian Helicobacter pylori Strains. Digestive Diseases and Sciences 53:4, 925-932
CrossRef366
Xueyuan Cao, Tetsuya Tsukamoto, Takahiro Seki, Harunari Tanaka, Shigeru Morimura, Liyu Cao, Tsutomu Mizoshita, Hisayo Ban, Takeshi Toyoda, Hiroshi Maeda, Masae Tatematsu. (2008) 4-Vinyl-2,6-dimethoxyphenol (canolol) suppresses oxidative stress and gastric carcinogenesis in Helicobacter pylori-infected carcinogen-treated Mongolian gerbils. International Journal of Cancer 122:7, 1445-1454
CrossRef367
Tomomitsu Tahara, Tomiyasu Arisawa, Fangyu Wang, Tomoyuki Shibata, Masakatsu Nakamura, Mikijyu Sakata, Ichiro Hirata, Hiroshi Nakano. (2008) Toll-like Receptor 2 (TLR) −196 to 174del Polymorphism in Gastro-duodenal Diseases in Japanese Population. Digestive Diseases and Sciences 53:4, 919-924
CrossRef368
K. N. Prasad, A. Saxena, U. C. Ghoshal, M. R. Bhagat, N. Krishnani. (2008) Analysis of Pro12Ala PPAR gamma polymorphism and Helicobacter pylori infection in gastric adenocarcinoma and peptic ulcer disease. Annals of Oncology 19:7, 1299-1303
CrossRef369
Masaki Miyamoto, Ken Haruma, Masao Kuwabara, Makoto Nagano, Takeshi Okamoto, Mio Tanaka. (2008) High incidence of newly-developed gastroesophageal reflux disease in the Japanese community: A 6-year follow-up study. Journal of Gastroenterology and Hepatology 23:3, 393-397
CrossRef370
Judith Romero-Gallo, Elizabeth J Harris, Uma Krishna, Mary Kay Washington, Guillermo I Perez-Perez, Richard M Peek. (2008) Effect of Helicobacter pylori eradication on gastric carcinogenesis. Laboratory Investigation 88:3, 328-336
CrossRef371
Kwong Ming Fock, Nick Talley, Paul Moayyedi, Richard Hunt, Takeshi Azuma, Kentaro Sugano, Shu Dong Xiao, Shiu Kum Lam, Khean Lee Goh, Tsutomu Chiba, Naomi Uemura, Jae G Kim, Nayoung Kim, Tiing Leong Ang, Varocha Mahachai, Hazel Mitchell, Abdul Aziz Rani, Jyh Ming Liou, Ratha-korn Vilaichone, Jose Sollano. (2008) Asia–Pacific consensus guidelines on gastric cancer prevention. Journal of Gastroenterology and Hepatology 23:3, 351-365
CrossRef372
Mustafa Altay, Faruk Turgut, Hatice Akay, Mehmet Kanbay, Aysegul Babali, Ali Akcay, Murat Duranay, Ramazan Yigitoglu, Adrian Covic. (2008) Dyspepsia in Turkish patients on continuous ambulatory peritoneal dialysis. International Urology and Nephrology 40:1, 211-217
CrossRef373
Wai K Leung, Ming-shiang Wu, Yasuo Kakugawa, Jae J Kim, Khay-guan Yeoh, Khean Lee Goh, Kai-chun Wu, Deng-chyang Wu, Jose Sollano, Udom Kachintorn, Takuji Gotoda, Jaw-town Lin, Wei-cheng You, Enders KW Ng, Joseph JY Sung. (2008) Screening for gastric cancer in Asia: current evidence and practice. The Lancet Oncology 9:3, 279-287
CrossRef374
Fabio Petrocca, Rosa Visone, Mariadele Rapazzotti Onelli, Manisha H. Shah, Milena S. Nicoloso, Ivana de Martino, Dimitrios Iliopoulos, Emanuela Pilozzi, Chang-Gong Liu, Massimo Negrini, Luigi Cavazzini, Stefano Volinia, Hansjuerg Alder, Luigi P. Ruco, Gustavo Baldassarre, Carlo M. Croce, Andrea Vecchione. (2008) E2F1-Regulated MicroRNAs Impair TGFβ-Dependent Cell-Cycle Arrest and Apoptosis in Gastric Cancer. Cancer Cell 13:3, 272-286
CrossRef375
Zoya B. Kurago, Aroonwan Lam-ubol, Anton Stetsenko, Chris De La Mater, Yiyi Chen, Deborah V. Dawson. (2008) Lipopolysaccharide-Squamous Cell Carcinoma-Monocyte Interactions Induce Cancer-Supporting Factors Leading to Rapid STAT3 Activation. Head and Neck Pathology 2:1, 1-12
CrossRef376
Tomomitsu Tahara, Tomiyasu Arisawa, Tomoyuki Shibata, Masakatsu Nakamura, Fangyu Wang, Naoko Maruyama, Yoshio Kamiya, Masahiko Nakamura, Hiroshi Fujita, Mitsuo Nagasaka, Masami Iwata, Kazuya Takahama, Makoto Watanabe, Ichiro Hirata, Hiroshi Nakano. (2008) Influence of Peroxisome Proliferator-activated Receptor (PPAR)γ Plo12Ala Polymorphism as a Shared Risk Marker for Both Gastric Cancer and Impaired Fasting Glucose (IFG) in Japanese. Digestive Diseases and Sciences 53:3, 614-621
CrossRef377
Yo Kurashima, Naoko Murata-Kamiya, Kenji Kikuchi, Hideaki Higashi, Takeshi Azuma, Satoshi Kondo, Masanori Hatakeyama. (2008) Deregulation of β-catenin signal byHelicobacter pylori CagA requires the CagA-multimerization sequence. International Journal of Cancer 122:4, 823-831
CrossRef378
Arghavan Haj–sheykholeslami, Naser Rakhshani, Aliakbar Amirzargar, Reza Rafiee, S. Mehdi Shahidi, Behrouz Nikbin, Farideh Khosravi, Sadegh Massarrat. (2008) Serum Pepsinogen I, Pepsinogen II, and Gastrin 17 in Relatives of Gastric Cancer Patients: Comparative Study With Type and Severity of Gastritis. Clinical Gastroenterology and Hepatology 6:2, 174-179
CrossRef379
Aaron J. Schetter, Wei-cheng You, Evelyne T. Lennette, Mitchell T. Gail, Charles S. Rabkin. (2008) Association of Epstein–Barr virus antibody levels with precancerous gastric lesions in a high-risk cohort. Cancer Science 99:2, 350-354
CrossRef380
Ting Kin CHEUNG, Benjamin CY WONG. (2008) Treatment of Helicobacter pylori and prevention of gastric cancer. Journal of Digestive Diseases 9:1, 8-13
CrossRef381
Mitsuru Kaise, Takuji Yamasaki, Jin Yonezawa, Jun Miwa, Yasuhiko Ohta, Hisao Tajiri. (2008) CpG Island Hypermethylation of Tumor-Suppressor Genes in H. pylori-Infected Non-Neoplastic Gastric Mucosa Is Linked with Gastric Cancer Risk. Helicobacter 13:1, 35-41
CrossRef382
Paulo Canedo, Abel J. Castanheira-Vale, Nuno Lunet, Fábio Pereira, Céu Figueiredo, Lydie Gioia-Patricola, Federico Canzian, Herculano Moreira, Gianpaolo Suriano, Henrique Barros, Fátima Carneiro, Raquel Seruca, José C. Machado. (2008) The interleukin-8-251*T/*A polymorphism is not associated with risk for gastric carcinoma development in a Portuguese population. European Journal of Cancer Prevention 17:1, 28-32
CrossRef383
Masanori HATAKEYAMA. (2008) Oncogenic mechanism of Helicobacter pylori. Japanese Journal of Clinical Immunology 31:3, 132-140
CrossRef384
Chan Gyoo Kim, Ho June Song, Myeong-Cherl Kook, Eun Kyung Hong, Sohee Park, Jong Yeul Lee, Jun Ho Lee, Keun Won Ryu, Young-Woo Kim, Jae-Moon Bae, Il Ju Choi. (2008) Preoperative Versus Postoperative Helicobacter pylori Eradication Therapy in Gastric Cancer Patients: A Randomized Trial. The American Journal of Gastroenterology 103:1, 48-54
CrossRef385
Manish A. Shah, David P. Kelsen. 2008. Gastric and Gastroesophageal Adenocarcinoma. , 511-517.
CrossRef386
Takeshi Nakajima, Shotaro Enomoto, Toshikazu Ushijima. (2008) DNA methylation: a marker for carcinogen exposure and cancer risk. Environmental Health and Preventive Medicine 13:1, 8-15
CrossRef387
Francia Ivonne Campos, Chihaya Koriyama, Suminori Akiba, Gabriel Carrasquilla, Mauricio Serra, Edwin Carrascal, Megumi Yamamoto, Atsuhiro Nakano. (2007) Toenail zinc level and gastric cancer risk in Cali, Colombia. Journal of Cancer Research and Clinical Oncology 134:2, 169-178
CrossRef388
Masaaki Satake, Jun Nishikawa, Yuki Fukagawa, Keiko Akashi, Takeshi Okamoto, Tomoharu Yoshida, Atsuyoshi Hirano, Noboru Maetani, Youzou Iida, Isao Sakaida. (2007) The long-term efficacy of Helicobacter pylori eradication therapy in patients with idiopathic thrombocytopenic purpura. Journal of Gastroenterology and Hepatology 22:12, 2233-2237
CrossRef389
Bruno Annibale, Edith Lahner. (2007) Assessing the severity of atrophic gastritis. European Journal of Gastroenterology & Hepatology 19:12, 1059-1063
CrossRef390
A. C. DE VRIES, E. J. KUIPERS. (2007) Review article: Helicobacter pylori eradication for the prevention of gastric cancer. Alimentary Pharmacology & Therapeutics 26, 25-35
CrossRef391
Kumiko Tominaga, Tsukasa Kawahara, Toshiaki Sano, Kazunori Toida, Yuki Kuwano, Hideyuki Sasaki, Tomoko Kawai, Shigetada Teshima-Kondo, Kazuhito Rokutan. (2007) Evidence for cancer-associated expression of NADPH oxidase 1 (Nox1)-based oxidase system in the human stomach. Free Radical Biology and Medicine 43:12, 1627-1638
CrossRef392
Shotaro Enomoto, Takao Maekita, Tetsuya Tsukamoto, Takeshi Nakajima, Kazuyuki Nakazawa, Masae Tatematsu, Masao Ichinose, Toshikazu Ushijima. (2007) Lack of association between CpG island methylator phenotype in human gastric cancers and methylation in their background non-cancerous gastric mucosae. Cancer Science 98:12, 1853-1861
CrossRef393
Keiji Ogura, Yuzo Mitsuno, Shin Maeda, Yoshihiro Hirata, Ayako Yanai, Wataru Shibata, Tomoya Ohmae, Haruhiko Yoshida, Takao Kawabe, Masao Omata. (2007) Efficacy and Safety of Faropenem in Eradication Therapy of Helicobacter pylori. Helicobacter 12:6, 618-622
CrossRef394
Tetsuo Hirata, Manabu Nakamoto, Masamoto Nakamura, Nagisa Kinjo, Akira Hokama, Fukunori Kinjo, Jiro Fujita. (2007) Low prevalence of human T cell lymphotropic virus type 1 infection in patients with gastric cancer. Journal of Gastroenterology and Hepatology 22:12, 2238-2241
CrossRef395
Nao Yoshizawa, Yoshiharu Takenaka, Hirokazu Yamaguchi, Tsukamoto Tetsuya, Harunari Tanaka, Masae Tatematsu, Sachiyo Nomura, James R Goldenring, Michio Kaminishi. (2007) Emergence of spasmolytic polypeptide-expressing metaplasia in Mongolian gerbils infected with Helicobacter pylori. Laboratory Investigation 87:12, 1265-1276
CrossRef396
Amanda J. MacFarlane, Patrick J. Stover. (2007) Convergence of Genetic, Nutritional and Inflammatory Factors in Gastrointestinal Cancers. Nutrition Reviews 65, S157-S166
CrossRef397
Yu-Ting Liu, Donghao Shang, Shinya Akatsuka, Hiroki Ohara, Khokon Kumar Dutta, Katsura Mizushima, Yuji Naito, Toshikazu Yoshikawa, Masashi Izumiya, Kouichiro Abe, Hitoshi Nakagama, Noriko Noguchi, Shinya Toyokuni. (2007) Chronic Oxidative Stress Causes Amplification and Overexpression of ptprz1 Protein Tyrosine Phosphatase to Activate β-Catenin Pathway. The American Journal of Pathology 171:6, 1978-1988
CrossRef398
Antonio Tucci, Michele Bisceglia, Massimo Rugge, Primiano Tucci, Attilio Marchegiani, Giovanni Papadopoli, Alessia Spada, Antonio Villani, Gianmaria Pennelli, Pietro Fusaroli, Giancarlo Caravelli, Tiziana Catalano, Vincenzo Cennamo, Massimo Cianci, Corrado De Fanis, Carlo Fabbri, Giuseppe Feliciangeli, Giuseppe Gizzi, Antonio Spadaccini, Giancarlo Caletti. (2007) Clinical usefulness of gastric-juice analysis in 2007: the stone that the builders rejected has become the cornerstone. Gastrointestinal Endoscopy 66:5, 881-890
CrossRef399
Takahisa Furuta, Yoshihiro Soya, Mitsushige Sugimoto, Naohito Shirai, Akiko Nakamura, Chise Kodaira, Masafumi Nishino, Masumi Okuda, Tadayoshi Okimoto, Kazunari Murakami, Toshio Fujioka, Akira Hishida. (2007) Modified allele-specific primer–polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycin. Journal of Gastroenterology and Hepatology 22:11, 1810-1815
CrossRef400
Annemarie C. de Vries, Ernst J. Kuipers. (2007) Epidemiology of Premalignant Gastric Lesions: Implications for the Development of Screening and Surveillance Strategies. Helicobacter 12:s2, 22-31
CrossRef401
Mitsushige Sugimoto, Takahisa Furuta, Naohito Shirai, Chise Kodaira, Masafumi Nishino, Mihoko Yamade, Mutsuhiro Ikuma, Hiroshi Watanabe, Kyoichi Ohashi, Akira Hishida, Takashi Ishizaki. (2007) Treatment strategy to eradicate Helicobacter pylori infection: impact of pharmacogenomics-based acid inhibition regimen and alternative antibiotics. Expert Opinion on Pharmacotherapy 8:16, 2701-2717
CrossRef402
Anthony Axon. (2007) How to Influence Health Providers. Helicobacter 12:s2, 80-84
CrossRef403
Takeshi Toyoda, Tetsuya Tsukamoto, Tsutomu Mizoshita, Sansei Nishibe, Takeshi Deyama, Yoshiharu Takenaka, Naoki Hirano, Harunari Tanaka, Shinji Takasu, Hisayo Ban, Toshiko Kumagai, Ken-ichi Inada, Hirotoshi Utsunomiya, Masae Tatematsu. (2007) Inhibitory effect of nordihydroguaiaretic acid, a plant lignan, on Helicobacter pylori-associated gastric carcinogenesis in Mongolian gerbils. Cancer Science 98:11, 1689-1695
CrossRef404
Tomomitsu Tahara, Tomiyasu Arisawa, Fangyu Wang, Tomoyuki Shibata, Masakatsu Nakamura, Mikijyu Sakata, Ichiro Hirata, Hiroshi Nakano. (2007) Toll-like receptor 2 ?196 to 174del polymorphism influences the susceptibility of Japanese people to gastric cancer. Cancer Science 98:11, 1790-1794
CrossRef405
Y Minegishi, H Suzuki, M Arakawa, Y Fukushima, T Masaoka, T Ishikawa, NA Wright, T Hibi. (2007) Reduced Shh expression in TFF2-overexpressing lesions of the gastric fundus under hypochlorhydric conditions. The Journal of Pathology 213:2, 161-169
CrossRef406
Tomomitsu Tahara, Tomiyasu Arisawa, Tomoyuki Shibata, Ichiro Hirata, Hiroshi Nakano. (2007) Multi-drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population. Journal of Gastroenterology and Hepatology 22:10, 1678-1682
CrossRef407
Mário Dinis-Ribeiro, Altamiro da Costa-Pereira, Carlos Lopes, Luís Moreira-Dias. (2007) Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia. Journal of Gastroenterology and Hepatology 22:10, 1594-1604
CrossRef408
Tomoari Kamada, Aki Tanaka, Yoshiyuki Yamanaka, Noriaki Manabe, Hiroaki Kusunoki, Masaki Miyamoto, Shinji Tanaka, Jiro Hata, Kazuaki Chayama, Ken Haruma. (2007) NODULAR GASTRITIS WITH HELICOBACTER PYLORI INFECTION IS STRONGLY ASSOCIATED WITH DIFFUSE-TYPE GASTRIC CANCER IN YOUNG PATIENTS. Digestive Endoscopy 19:4, 180-184
CrossRef409
Tamana Miyazaki, Yoko Murayama, Yasuhisa Shinomura, Takahiro Yamamoto, Kenji Watabe, Shusaku Tsutsui, Tatsuya Kiyohara, Shinji Tamura, Norio Hayashi. (2007) E-cadherin Gene Promoter Hypermethylation in H. pylori-Induced Enlarged Fold Gastritis. Helicobacter 12:5, 523-531
CrossRef410
Jun Tashiro, Jun Miwa, Takashige Tomita, Yasuo Matsubara, Yasuhiko Oota. (2007) GASTRIC CANCER DETECTED AFTER HELICOBACTER PYLORI ERADICATION. Digestive Endoscopy 19:4, 167-173
CrossRef411
Kenneth E. L. McColl, Hirotsugu Watabe, Mohammad H. Derakhshan. (2007) Sporadic Gastric Cancer; a Complex Interaction of Genetic and Environmental Risk Factors. The American Journal of Gastroenterology 102:9, 1893-1895
CrossRef412
Chan-Han Wu, Ming-Yii Huang, Ching-Sheng Yeh, Jaw-Yuan Wang, Tian-Lu Cheng, Shiu-Ru Lin. (2007) Overexpression of Helicobacter pylori –Associated Urease mRNAs in Human Gastric Cancer. DNA and Cell Biology 26:9, 641-648
CrossRef413
P. Malfertheiner, J. Bornschein. (2007) Magenkarzinom: Früherkennung und Prävention. Der Gastroenterologe 2:5, 330-338
CrossRef414
J. Nkondi Nsenga, B. Longo-Mbenza, J. -M. Kabongo Mpolesha, L. Mabwa, S. Mbungu, D. Vangu. (2007) Séropositivité pour Helicobacter pylori, gastrite à Helicobacter pylori, composantes de la pression artérielle : réalité du risque cardiovasculaire. Journal Africain d'Hépato-Gastroentérologie 1:2, 87-92
CrossRef415
Ming-Jen Chen, Tsang-En Wang, Wen-Hsiung Chang, Ta-Chuan Liao, Ching-Chung Lin, Shou-Chuan Shih. (2007) Nodular Gastritis: An Endoscopic Indicator of Helicobacter Pylori Infection. Digestive Diseases and Sciences 52:10, 2662-2666
CrossRef416
Takahisa Furuta, Mitsushige Sugimoto, Naohito Shirai, Takashi Ishizaki. (2007) CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor. Pharmacogenomics 8:9, 1199-1210
CrossRef417
Ji Youn Yoo, Nayoung Kim, Young Soo Park, Jin-Hyeok Hwang, Jin-Wook Kim, Sook Hyang Jeong, Hye Seung Lee, Cheeyoung Choe, Dong Ho Lee, Hyun Chae Jung, In Sung Song. (2007) Detection Rate of Helicobacter pylori Against a Background of Atrophic Gastritis and/or Intestinal Metaplasia. Journal of Clinical Gastroenterology 41:8, 751-755
CrossRef418
P. I. Hsu, K. H. Lai, C. J. Wu, H. H. Tseng, F. W. Tsay, N. J. Peng, T. A. Chen, S. K. Chuah, W. S. Lin, G. H. Lo. (2007) High-dose versus low-dose esomeprazole-based triple therapy for Helicobacter pylori infection. European Journal of Clinical Investigation 37:9, 724-730
CrossRef419
María Asunción García-González, Angel Lanas, Enrique Quintero, David Nicolás, Adolfo Parra-Blanco, Mark Strunk, Rafael Benito, Miguel Angel Simón, Santos Santolaria, Federico Sopeña, Elena Piazuelo, Pilar Jiménez, Cristina Pascual, Eva Mas, Pilar Irún, Jesús Espinel, Rafael Campo, Marisa Manzano, Fernando Geijo, Maria Pellisé, Ferrán González-Huix, Miguel Nieto, Jorge Espinós, LLúcia Titó, Luis Bujanda, Manuel Zaballa, . (2007) Gastric Cancer Susceptibility Is Not Linked to Pro-and Anti-Inflammatory Cytokine Gene Polymorphisms in Whites: A Nationwide Multicenter Study in Spain. The American Journal of Gastroenterology 102:9, 1878-1892
CrossRef420
Masanori Yamato, Toshio Watanabe, Kazuhide Higuchi, Koichi Taira, Tetsuya Tanigawa, Masatsugu Shiba, Kazunari Tominaga, Yasuhiro Fujiwara, Nobuhide Oshitani, Koji Takeuchi, Tetsuo Arakawa. (2007) Anti-Inflammatory Effects of Pravastatin on Helicobacter Pylori-Induced Gastritis in Mice. Digestive Diseases and Sciences 52:10, 2833-2839
CrossRef421
James R. Ramus, Piers A. C. Gatenby, Christine P. J. Caygill, Anthony Watson. (2007) Helicobacter pylori Infection and Severity of Reflux-Induced Esophageal Disease in a Cohort of Patients with Columnar-Lined Esophagus. Digestive Diseases and Sciences 52:10, 2821-2825
CrossRef422
Mitsushige Sugimoto, Takahisa Furuta, Naohito Shirai, Akiko Nakamura, Masayoshi Kajimura, Haruhiko Sugimura, Akira Hishida. (2007) Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. Journal of Gastroenterology and Hepatology 22:9, 1443-1449
CrossRef423
M. Caselli, A. Zullo, G. Maconi, F. Parente, V. Alvisi, T. Casetti, D. Sorrentino, G. Gasbarrini. (2007) “Cervia II Working Group Report 2006”: Guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy. Digestive and Liver Disease 39:8, 782-789
CrossRef424
Mitsushige Sugimoto, Takahisa Furuta, Naohito Shirai, Chise Kodaira, Masafumi Nishino, Mutsuhiro Ikuma, Takashi Ishizaki, Akira Hishida. (2007) Evidence that the Degree and Duration of Acid Suppression are Related to Helicobacter pylori Eradication by Triple Therapy. Helicobacter 12:4, 317-323
CrossRef425
Pelayo Correa, JeanMarie Houghton. (2007) Carcinogenesis of Helicobacter pylori. Gastroenterology 133:2, 659-672
CrossRef426
Changcheng Wang, Yuhong Yuan, Richard H. Hunt. (2007) The Association Between Helicobacter pylori Infection and Early Gastric Cancer: A Meta-Analysis. The American Journal of Gastroenterology 102:8, 1789-1798
CrossRef427
Shinya Toyokuni, Shinya Akatsuka. (2007) Pathological investigation of oxidative stress in the post-genomic era. Pathology International 57:8, 461-473
CrossRef428
Tod P Holler, Artem G Evdokimov, Lakshmi Narasimhan. (2007) Structural biology approaches to antibacterial drug discovery. Expert Opinion on Drug Discovery 2:8, 1085-1101
CrossRef429
Naohito Shirai, Mitsushige Sugimoto, Chise Kodaira, Masafumi Nishino, Mutsuhiro Ikuma, Masayoshi Kajimura, Kyoichi Ohashi, Takashi Ishizaki, Akira Hishida, Takahisa Furuta. (2007) Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy. European Journal of Clinical Pharmacology 63:8, 743-749
CrossRef430
Diklar Makola, David A. Peura, Sheila E. Crowe. (2007) Helicobacter pylori Infection and Related Gastrointestinal Diseases. Journal of Clinical Gastroenterology 41:6, 548-558
CrossRef431
T Isaka, T Nakamura, M Tajika, H Kawai, H Imaoka, Y Okamoto, M Aoki, H Inoue, K Takahashi, N Mizuno, A Sawaki, K Yamao, M Seto, T Yokoi, Y Yatabe, S Nakamura. (2007) API2-MALT1 chimeric transcript-positive gastroduodenal MALT lymphoma with subsequent development of adenocarcinoma as a collision tumour over a clinical course of 7
years. Histopathology 51:1, 119-122
CrossRef432
Akihiko Oguri, Naoki Ohmiya, Ayumu Taguchi, Akihiro Itoh, Yoshiki Hirooka, Yasumasa Niwa, Osamu Maeda, Takafumi Ando, Hidemi Goto. (2007) Rugal hyperplastic gastritis increases the risk of gastric carcinoma, especially diffuse and p53-independent subtypes. European Journal of Gastroenterology & Hepatology 19:7, 561-566
CrossRef433
Kenneth E. L. McColl. (2007) Hostile Environment of the Gastroesophageal Junction. Journal of Clinical Gastroenterology 41:Supplement 2, S102-S107
CrossRef434
Akiko Nakamura, Takahisa Furuta, Naohito Shirai, Mitsushige Sugimoto, Masayoshi Kajimura, Yoshihiro Soya, Akira Hishida. (2007) Determination of mutations of the 23S rRNA gene of Helicobacter
CrossRef435
Gotaro Masuda, Akira Tokunaga, Takashi Shirakawa, Akiyoshi Togashi, Teruo Kiyama, Shunji Kato, Norio Matsukura, Hideki Bou, Masanori Watanabe, Takashi Tajiri. (2007) Helicobacter pylori infection, but not genetic polymorphism of CYP2E1, is highly prevalent in gastric cancer patients younger than 40 years. Gastric Cancer 10:2, 98-103
CrossRef436
J.-D. de Korwin. (2007) Infection à Helicobacter pylori: quoi de neuf après le prix Nobel?. La Revue de Médecine Interne 28:6, 359-362
CrossRef437
Tomiyasu Arisawa, Tomomitsu Tahara, Tomoyuki Shibata, Mitsuo Nagasaka, Masakatsu Nakamura, Yoshio Kamiya, Hiroshi Fujita, Shin Hasegawa, Tamaki Takagi, Fang-Yu Wang, Ichiro Hirata, Hiroshi Nakano. (2007) A Polymorphism of microRNA 27a Genome Region Is Associated With the Development of Gastric Mucosal Atrophy in Japanese Male Subjects. Digestive Diseases and Sciences 52:7, 1691-1697
CrossRef438
K. Miki, Y. Urita, F. Ishikawa, T. Iino, H. Shibahara-Sone, R. Akahoshi, S. Mizusawa, A. Nose, D. Nozaki, K. Hirano, C. Nonaka, T. Yokokura. (2007) Effect of Bifidobacterium bifidum Fermented Milk on Helicobacter pylori and Serum Pepsinogen Levels in Humans. Journal of Dairy Science 90:6, 2630-2640
CrossRef439
Shunji Kato, Norio Matsukura, Katsuya Tsukada, Noriko Matsuda, Tsutomu Mizoshita, Tetsuya Tsukamoto, Masae Tatematsu, Yuichi Sugisaki, Zenya Naito, Takashi Tajiri. (2007) Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: Incidence and pathological characteristics. Cancer Science 98:6, 790-794
CrossRef440
Tomotaro Kawazoe, Takashi Sakagami, Kazuhiko Nakajima, Kazutoshi Hori, Yoshihiro Fukuda, Takayuki Matsumoto, Hiroto Miwa. (2007) Role of Bacterial Strain Diversity of Helicobacter pylori in Gastric Carcinogenesis Induced by N-Methyl-N-nitrosourea in Mongolian Gerbils. Helicobacter 12:3, 213-223
CrossRef441
Dong Soo Lee, Steven F Moss. (2007) Targeting Helicobacter pylori in gastric carcinogenesis. Expert Opinion on Therapeutic Targets 11:6, 757-769
CrossRef442
Jae Min Song, Baik Lin Seong. (2007) Tea catechins as a potential alternative anti-infectious agent. Expert Review of Anti-infective Therapy 5:3, 497-506
CrossRef443
Guangfu Jin, Ruifen Miao, Yimei Deng, Zhibin Hu, Yan Zhou, Yongfei Tan, Jianming Wang, Zhaolai Hua, Weiliang Ding, Lina Wang, Wensen Chen, Jing Shen, Xinru Wang, Yaochu Xu, Hongbing Shen. (2007) Variant genotypes and haplotypes of the epidermal growth factor gene promoter are associated with a decreased risk of gastric cancer in a high-risk Chinese population. Cancer Science 98:6, 864-868
CrossRef444
Shahram Bahmanyar, Weimin Ye, Paul W. Dickman, Olof Nyrén. (2007) Long-Term Risk of Gastric Cancer by Subsite in Operated and Unoperated Patients Hospitalized for Peptic Ulcer. The American Journal of Gastroenterology 102:6, 1185-1191
CrossRef445
S. Nagai, H. Mimuro, T. Yamada, Y. Baba, K. Moro, T. Nochi, H. Kiyono, T. Suzuki, C. Sasakawa, S. Koyasu. (2007) Role of Peyer's patches in the induction of Helicobacter pylori-induced gastritis. Proceedings of the National Academy of Sciences 104:21, 8971-8976
CrossRef446
Andrew S. Giraud. (2007) Metaplasia as a Premalignant Pathology in the Stomach. Gastroenterology 132:5, 2053-2056
CrossRef447
Hiroshi Seno, Kiichi Satoh, Shingo Tsuji, Takayuki Shiratsuchi, Yosuke Harada, Nobuyuki Hamajima, Kentaro Sugano, Sunao Kawano, Tsutomu Chiba. (2007) Novel interleukin-4 and interleukin-1 receptor antagonist gene variations associated with non-cardia gastric cancer in Japan: Comprehensive analysis of 207 polymorphisms of 11 cytokine genes. Journal of Gastroenterology and Hepatology 22:5, 729-737
CrossRef448
K Hemminki, J Sundquist, J Ji. (2007) Familial risk for gastric carcinoma: an updated study from Sweden. British Journal of Cancer 96:8, 1272-1277
CrossRef449
Shahjahan Kabir. (2007) The Current Status of Helicobacter pylori Vaccines: A Review. Helicobacter 12:2, 89-102
CrossRef450
J. -D. Korwin. (2007) Helicobacter pylori et néoplasies gastriques. Journal Africain d’Hépato-Gastroentérologie 1:1, 1-4
CrossRef451
R. TAKENAKA, H. OKADA, J. KATO, C. MAKIDONO, S. HORI, Y. KAWAHARA, M. MIYOSHI, E. YUMOTO, A. IMAGAWA, T. TOYOKAWA, K. SAKAGUCHI, Y. SHIRATORI. (2007) Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type. Alimentary Pharmacology & Therapeutics 25:7, 805-812
CrossRef452
Paul Lochhead, Emad M. El-Omar. (2007) Helicobacter pylori infection and gastric cancer. Best Practice & Research Clinical Gastroenterology 21:2, 281-297
CrossRef453
B. J. Egan, C. A. O’Morain. (2007) Cancer gastrique: quelle est la meilleure stratégie dans les pays à faible prévalence?. Acta Endoscopica 37:2, 149-157
CrossRef454
Brian J. Egan, Colm A. O'Morain. (2007) A historical perspective of Helicobacter gastroduodenitis and its complications. Best Practice & Research Clinical Gastroenterology 21:2, 335-346
CrossRef455
Shinichi Nakamura, Atsushi Mitsunaga, Ryujiro Imai, Ichiro Ishikawa, Izumi Shirato, Shohei Shimizu, Maiko Kishino, Hiroyuki Konishi, Itaru Oi, Keiko Shiratori. (2007) CLINICAL EVALUATION OF NODULAR GASTRITIS IN ADULTS. Digestive Endoscopy 19:2, 74-79
CrossRef456
Xueyuan Cao, Tetsuya Tsukamoto, Koji Nozaki, Harunari Tanaka, Liyu Cao, Takeshi Toyoda, Shinji Takasu, Hisayo Ban, Toshiko Kumagai, Masae Tatematsu. (2007) Severity of gastritis determines glandular stomach carcinogenesis in Helicobacter pylori-infected Mongolian gerbils. Cancer Science 98:4, 478-483
CrossRef457
Yongliang Zhu, Caihua Wang, Jian Huang, Zhen Ge, Qi Dong, Xian Zhong, Yanyan Su, Shu Zheng. (2007) The Helicobacter pylori virulence factor CagA promotes Erk1/2-mediated Bad phosphorylation in lymphocytes: a mechanism of CagA-inhibited lymphocyte apoptosis. Cellular Microbiology 9:4, 952-961
CrossRef458
T Furuta, N Shirai, M Kodaira, M Sugimoto, A Nogaki, S Kuriyama, M Iwaizumi, M Yamade, I Terakawa, K Ohashi, T Ishizaki, A Hishida. (2007) Pharmacogenomics-based Tailored Versus Standard Therapeutic Regimen for Eradication of H. pylori. Clinical Pharmacology & Therapeutics 81:4, 521-528
CrossRef459
Shunsuke Takata, Masanori Ito, Masaharu Yoshihara, Shinji Tanaka, Shinobu Imagawa, Ken Haruma, Kazuaki Chayama. (2007) Host factors contributing to the discovery of gastric cancer after successful eradication therapy of Helicobacter pylori: Preliminary report. Journal of Gastroenterology and Hepatology 22:4, 571-576
CrossRef460
Toshikazu Ushijima. (2007) Epigenetic Field for Cancerization. Journal of Biochemistry and molecular biology 40:2, 142-150
CrossRef461
Brian R. Smith, Bruce E. Stabile. (2007) Gastric Adenocarcinoma: Reduction of Perioperative Mortality by Avoidance of Nontherapeutic Laparotomy. Journal of Gastrointestinal Surgery 11:2, 127-132
CrossRef462
Kee Don Choi, Nayoung Kim, Dong Ho Lee, Jung Mogg Kim, Joo Sung Kim, Hyun Chae Jung, In Sung Song. (2007) Analysis of the 3′ Variable Region of the cagA Gene of Helicobacter pylori Isolated in Koreans. Digestive Diseases and Sciences 52:4, 960-966
CrossRef463
Soojin Park, Marie Yeo, Joo-Hyun Jin, Kee-Myung Lee, Sung Soo Kim, Sang Yoon Choi, Ki-Baik Hahm. (2007) Inhibitory Activities and Attenuated Expressions of 5-LOX with Red Ginseng in Helicobacter pylori-Infected Gastric Epithelial Cells. Digestive Diseases and Sciences 52:4, 973-982
CrossRef464
Guangfu Jin, Lina Wang, Wensen Chen, Zhibin Hu, Yan Zhou, Yongfei Tan, Jianming Wang, Zhaolai Hua, Weiliang Ding, Jing Shen, Zuofeng Zhang, Xinru Wang, Yaochu Xu, Hongbing Shen. (2007) Variant alleles ofTGFB1 andTGFBR2 are associated with a decreased risk of gastric cancer in a Chinese population. International Journal of Cancer 120:6, 1330-1335
CrossRef465
Marguerite Clyne, Brendan Dolan, Emer P. Reeves. (2007) Bacterial factors that mediate colonization of the stomach and virulence of Helicobacter pylori. FEMS Microbiology Letters 268:2, 135-143
CrossRef466
Hai Ying Fu, Kayoko Asahi, Yujiro Hayashi, Hiroshi Eguchi, Hiroaki Murata, Masahiko Tsujii, Shingo Tsuji, Takeshi Azuma, Sunao Kawano. (2007) East Asian-type Helicobacter pylori cytotoxin-associated gene A protein has a more significant effect on growth of rat gastric mucosal cells than the Western type. Journal of Gastroenterology and Hepatology 22:3, 355-362
CrossRef467
Shigeo Takaishi, Timothy C. Wang. (2007) Gene expression profiling in a mouse model of Helicobacter-induced gastric cancer. Cancer Science 98:3, 284-293
CrossRef468
Schlioma Zaterka, Jaime N. Eisig, Decio Chinzon, Wolfgang Rothstein. (2007) Factors Related to Helicobacter pylori Prevalence in an Adult Population in Brazil. Helicobacter 12:1,
CrossRef469
A. C. de Vries, J. Haringsma, E. J. Kuipers. (2007) The Detection, Surveillance and Treatment of Premalignant Gastric Lesions Related to Helicobacter pylori Infection. Helicobacter 12:1,
CrossRef470
Bruno Annibale, Edith Lahner, Annalisa Santucci, Dino Vaira, Amelia Pasquali, Carola Severi, Roberta Mini, Natale Figura, Gianfranco Delle Fave. (2007) CagA and VacA are Immunoblot Markers of Past Helicobacter pylori Infection in Atrophic Body Gastritis. Helicobacter 12:1,
CrossRef471
Gerhard Treiber, Peter Malfertheiner, Ulrich Klotz. (2007) Treatment and dosing of Helicobacter pylori infection: when pharmacology meets clinic. Expert Opinion on Pharmacotherapy 8:3, 329-350
CrossRef472
Chun Li, Harry Hua-Xiang Xia, Wei Xie, Zhengguo Hu, Mei Ye, Jin Li, Hong Cheng, Xiaolian Zhang, Bing Xia. (2007) Association between interleukin-1 gene polymorphisms and Helicobacter pylori infection in gastric carcinogenesis in a Chinese population. Journal of Gastroenterology and Hepatology 22:2, 234-239
CrossRef473
Yi-Qian Sun, Hans-Jürg Monstein, Anna Ryberg, Kurt Borch. (2007) Multiple strand displacement amplification of DNA isolated from human archival plasma/serum: Identification of cytokine polymorphism by pyrosequencing analysis. Clinica Chimica Acta 377:1-2, 108-113
CrossRef474
Toshio Fujioka, Aoi Yoshiiwa, Tadayoshi Okimoto, Masaaki Kodama, Kazunari Murakami. (2007) Guidelines for the management of Helicobacter pylori infection in Japan: current status and future prospects. Journal of Gastroenterology 42:S17, 3-6
CrossRef475
Susumu Take, Motowo Mizuno, Kuniharu Ishiki, Yasuhiro Nagahara, Tomowo Yoshida, Kenji Yokota, Keiji Oguma. (2007) Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases. Journal of Gastroenterology 42:S17, 21-27
CrossRef476
Ting Kin Cheung, Harry H.X. Xia, Benjamin C.Y. Wong. (2007) Helicobacter pylori eradication for gastric cancer prevention. Journal of Gastroenterology 42:S17, 10-15
CrossRef477
Motosugu Kato, Masahiro Asaka, Shouko Ono, Manabu Nakagawa, Souichi Nakagawa, Yuichi Shimizu, Makoto Chuma, Hiroshi Kawakami, Yoshito Komatsu, Shuhei Hige, Hiroshi Takeda. (2007) Eradication of Helicobacter pylori for primary gastric cancer and secondary gastric cancer after endoscopic mucosal resection. Journal of Gastroenterology 42:S17, 16-20
CrossRef478
Akira Tari, Yasuhiko Kitadai, Masaharu Sumii, Atsunori Sasaki, Hiroshi Tani, Sinji Tanaka, Kazuaki Chayama. (2007) Basis of Decreased Risk of Gastric Cancer in Severe Atrophic Gastritis with Eradication of Helicobacter pylori. Digestive Diseases and Sciences 52:1, 232-239
CrossRef479
James G. Fox, Timothy C. Wang. (2007) Inflammation, atrophy, and gastric cancer. Journal of Clinical Investigation 117:1, 60-69
CrossRef480
Karin Enarsson, B. Samuel Lundin, Erik Johnsson, Thomas Brezicka, Marianne Quiding-Järbrink. (2007) CD4+CD25high regulatory T cells reduce T cell transendothelial migration in cancer patients. European Journal of Immunology 37:1, 282-291
CrossRef481
Tomomitsu Tahara, Tomiyasu Arisawa, Tomoyuki Shibata, Fang Yu Wang, Masakatsu Nakamura, Mikijyu Sakata, Mitsuo Nagasaka, Tamaki Takagi, Yoshio Kamiya, Hiroshi Fujita, Masahiko Nakamura, Shin Hasegawa, Masami Iwata, Kazuya Takahama, Makoto Watanabe, Ichiro Hirata, Hiroshi Nakano. (2007) Risk Prediction of Gastric Cancer by Analysis of Aberrant DNA Methylation in Non-Neoplastic Gastric Epithelium. Digestion 75:1, 54-61
CrossRef482
Mitsushige Sugimoto, Takahisa Furuta, Naohito Shirai, Akiko Nakamura, Fang Xiao, Masayoshi Kajimura, Haruhiko Sugimura, Akira Hishida. (2007) Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancer. Journal of Gastroenterology and Hepatology 22:1, 51-59
CrossRef483
Paloma Sánchez-Fayos, María Jesús Martín Relloso, Agustina González Guirado, Juan Carlos Porres Cubero. (2007) Adenocarcinoma gástrico: intento de aproximación a una realidad biológica compleja. Medicina Clínica 128:1, 21-30
CrossRef484
Hidekazu Suzuki, Toshifumi Hibi, Barry James Marshall. (2007) Helicobacter pylori: present status and future prospects in Japan. Journal of Gastroenterology 42:1, 1-15
CrossRef485
L. FUCCIO, R. M. ZAGARI, M. E. MINARDI, F. BAZZOLI. (2007) Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer. Alimentary Pharmacology & Therapeutics 25:2, 133-141
CrossRef486
Minako Hirahashi, Takashi Yao, Takayuki Matsumoto, Ken-ichi Nishiyama, Masafumi Oya, Mitsuo Iida, Masazumi Tsuneyoshi. (2007) Intramucosal gastric adenocarcinoma of poorly differentiated type in the young is characterized by Helicobacter pylori infection and antral lymphoid hyperplasia. Modern Pathology 20:1, 29-34
CrossRef487
Hidetaka YAMANAKA, Kaname ONO, Tatsuro SATO, Satoshi KAMIYA. (2007) A CASE OF DOUBLE CANCER OF MULTIPLE ESOPHAGEAL CANCER AND MULTIPLE GASTRIC CANCER. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 68:8, 1937-1942
CrossRef488
Masashi Matsuzaka, Shinsaku Fukuda, Ippei Takahashi, Sen Shimaya, Takao Oyama, Makoto Yaegaki, Tadashi Shimoyama, Juichi Sakamoto, Shigeyuki Nakaji, Takashi Umeda. (2007) The Decreasing Burden of Gastric Cancer in Japan. The Tohoku Journal of Experimental Medicine 212:3, 207-219
CrossRef489
Zunwu Zhang. (2007) The Risk of Gastric Cancer in Patients with Duodenal and Gastric Ulcer: Research Progresses and Clinical Implications. Journal of Gastrointestinal Cancer 38:1, 38-45
CrossRef490
Masaru OBA, Nobuo MATSUKI, Hideyuki AJISAKA, Toru II, Koichi MIWA. (2007) THREE CASES OF CARCINOMA OF THE REMNANT STOMACH AFTER PROXIMAL GASTRECTOMY FOR GASTRIC CANCER. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 68:4, 850-855
CrossRef491
Mototsugu KATO, Masahiro ASAKA. (2007) Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 38:4, 183-187
CrossRef492
Shinkan Tokudome, Reza Ghadimi, Sadao Suzuki, Akihiro Hosono, Tsutomu Tanaka, Kazuyuki Arakawa, Yang Zhao, Nami Hattori, Hiroyuki Agawa, Mitsuhiro Marumoto, Ryosuke Ando, Malcolm A. Moore. (2006) Helicobacter pylori infection appears the prime risk factor for stomach cancer. International Journal of Cancer 119:12, 2991-2991
CrossRef493
Hae Yeon Kang, Nayoung Kim, Young Soo Park, Jin-Hyeok Hwang, Jin-Wook Kim, Sook Hyang Jeong, Dong Ho Lee, Hyun Chae Jung, In Sung Song. (2006) Progression of Atrophic Gastritis and Intestinal Metaplasia Drives Helicobacter pylori Out of the Gastric Mucosa. Digestive Diseases and Sciences 51:12, 2310-2315
CrossRef494
S. KATO, N. MATSUKURA, N. MATSUDA, K. TSUKADA, Z. NAITO, T. TAJIRI. (2006) Helicobacter pylori eradication therapy modulates acidity and interleukin-1β mRNA levels in un-operated stomach and in remnant stomach after gastrectomy in gastric cancer patients. Alimentary Pharmacology & Therapeutics 24, 278-284
CrossRef495
S. NAKAGAWA, M. ASAKA, M. KATO, T. NAKAMURA, C. KATO, T. FUJIOKA, M. TATSUTA, K. KEIDA, S. TERAO, S. TAKAHASHI, N. UEMURA, T. KATO, N. AOYAMA, D. SAITO, M. SUZUKI, A. IMAMURA, K. SATO, H. MIWA, H. NOMURA, M. KAISE, S. OOHARA, T. KAWAI, K. URABE, N. SAKAKI, S. ITO, Y. NODA, A. YANAKA, K. KUSUGAMI, H. GOTO, T. FURUTA, M. FUJINO, F. KINJYOU, T. OOKUSA. (2006) Helicobacter pylori eradication and metachronous gastric cancer after endoscopic mucosal resection of early gastric cancer. Alimentary Pharmacology & Therapeutics 24, 214-218
CrossRef496
Jean-Charles Delchier. (2006) Quelles recommandations pour le management de l’infection à Helicobacter pylori après la troisième conférence de consensus européenne (Maastricht 3) ?. Gastroentérologie Clinique et Biologique 30:12, 1361-1364
CrossRef497
J. TANAKA, T. OHKUSA, T. YOKOYAMA, T. MATSUHISA, T. KAWAI, H. HASHIMOTO, T. TOMITA, K. HORI, K. NAKAJIMA, T. MATSUMOTO, H. MIWA. (2006) Host serological response to Helicobacter pylori after successful eradication: long-term follow-up in patients with cured and persistent infection. Alimentary Pharmacology & Therapeutics 24, 239-248
CrossRef498
T. KAWAI, K. KAWAKAMI, M. KATAOKA, K. TAKEI, S. TAIRA, T. ITOI, F. MORIYASU, Y. TAKAGI, T. AOKI, H. SERIZAWA, E. RIMBARA, N. NOGUCHI, M. SASATSU. (2006) Correlation of serum pepsinogen with histological atrophy following successful Helicobacter pylori eradication. Alimentary Pharmacology & Therapeutics 24, 23-30
CrossRef499
Susan A. Watson, Anna M. Grabowska, Mohamad El-Zaatari, Arjun Takhar. (2006) Gastrin — active participant or bystander in gastric carcinogenesis?. Nature Reviews Cancer 6:12, 936-946
CrossRef500
T. MASAOKA, H. SUZUKI, K. KURABAYASHI, Y. NOMOTO, T. NISHIZAWA, M. MORI, T. HIBI. (2006) Could frameshift mutations in the frxA and rdxA genes of Helicobacter pylori be a marker for metronidazole resistance?. Alimentary Pharmacology & Therapeutics 24, 81-87
CrossRef501
M A Garcia-Gonzalez, M Strunk, E Piazuelo, R Benito, S Santolaria, P Jiménez, F Sopeña, C Pascual, M A Simón, R Sainz, A Lanas. (2006) TGFB1 gene polymorphisms: their relevance in the susceptibility to Helicobacter pylori-related diseases. Genes and Immunity 7:8, 640-646
CrossRef502
M. KATO, M. ASAKA, T. NAKAMURA, T. AZUMA, E. TOMITA, T. KAMOSHIDA, K. SATO, T. INABA, D. SHIRASAKA, S. OKAMOTO, S. TAKAHASHI, S. TERAO, K. SUWAKI, H. ISOMOTO, H. YAMAGATA, H. NOMURA, K. YAGI, Y. SONE, T. URABE, T. AKAMATSU, S. OHARA, A. TAKAGI, J. MIWA, S. INATSUCHI. (2006) Helicobacter pylori eradication prevents the development of gastric cancer - results of a long-term retrospective study in Japan. Alimentary Pharmacology & Therapeutics 24, 203-206
CrossRef503
A. TANAKA, J. WATARI, H. TANABE, A. MAEMOTO, M. FUJIYA, T. ASHIDA, K. M. DAS, Y. KOHGO. (2006) Effect of eradication of Helicobacter pylori on genetic instabilities in gastric intestinal metaplasia. Alimentary Pharmacology & Therapeutics 24, 194-202
CrossRef504
Lei Huang, Kai-Li Zhang, Hong Li, Xiao-Yan Chen, Qing-You Kong, Yuan Sun, Xue Gao, Hong-Wei Guan, Jia Liu. (2006) Infrequent COX-2 expression due to promoter hypermethylation in gastric cancers in Dalian, China. Human Pathology 37:12, 1557-1567
CrossRef505
Sayo Kawai, Yasuyuki Goto, Lucy S. Ito, Sueli M. Oba-Shinjo, Miyuki Uno, Samuel K. Shinjo, Suely K.N. Marie, Yoshiko Ishida, Kazuko Nishio, Mariko Naito, Nobuyuki Hamajima. (2006) Significant association between PTPN11 polymorphism and gastric atrophy among Japanese Brazilians. Gastric Cancer 9:4, 277-283
CrossRef506
Jose Luiz Bertoli Neto, Laercio Gomes Lourenço, Cícero Fernando Bertoli, Fábio Samsonowski Ulbrich, Antoninho Ricardo Sabbi, Alexandre Galvão Bueno. (2006) Evaluation of the efficacy of triple therapy regimen for Helicobacter pylori eradication in gastrectomized patients with gastric adenocarcinoma. Gastric Cancer 9:4, 291-294
CrossRef507
Hiroyuki Osawa, Hiroto Kita, Hirohide Ohnishi, Masamitsu Nakazato, Yukari Date, Christopher L. Bowlus, Yumiko Ishino, Eiko Watanabe, Tomomi Shiiya, Hiroaki Ueno, Hiroko Hoshino, Kiichi Satoh, Kentaro Sugano. (2006) Changes in plasma ghrelin levels, gastric ghrelin production, and body weight after Helicobacter pylori cure. Journal of Gastroenterology 41:10, 954-961
CrossRef508
Daniel Satgé, Annie J. Sasco, Michel J. J. Vekemans, Marie-Laure Portal, Jean-François Fléjou. (2006) Aspects of Digestive Tract Tumors in Down Syndrome: A Literature Review. Digestive Diseases and Sciences 51:11, 2053-2061
CrossRef509
Marco Romano, Vittorio Ricci, Raffaele Zarrilli. (2006) Mechanisms of Disease: Helicobacter pylori-related gastric carcinogenesis—implications for chemoprevention. Nature Clinical Practice Gastroenterology & Hepatology 3:11, 622-632
CrossRef510
J. C. Delchier, C. Copie-Bergman. (2006) Les gastrites: comment réagir devant une gastrite ? Aspect endoscopique et corrélation histologique. Acta Endoscopica 36:S2, 471-472
CrossRef511
G. CAPURSO, A. CARNUCCIO, E. LAHNER, F. PANZUTO, F. BACCINI, G. D. FAVE, B. ANNIBALE. (2006) Corpus-predominant gastritis as a risk factor for false-negative 13 C-urea breath test results. Alimentary Pharmacology and Therapeutics 24:10, 1453-1460
CrossRef512
Li Jiang, Yi Zhong, Shinya Akatsuka, Yu-Ting Liu, Khokon Kumar Dutta, Wen-Hua Lee, Janice Onuki, Ken-ichi Masumura, Takehiko Nohmi, Shinya Toyokuni. (2006) Deletion and single nucleotide substitution at G:C in the kidney of gpt delta transgenic mice after ferric nitrilotriacetate treatment. Cancer Science 97:11, 1159-1167
CrossRef513
A. Leodolter, J. Labenz. (2006) Diagnostik der Helicobacter-pylori-Infektion. Der Gastroenterologe 1:4, 253-258
CrossRef514
M. Ogura, Y. Yamaji, Y. Hikiba, S. Maeda, M. Matsumura, K. Okano, R. Sassa, H. Yoshida, T. Kawabe, M. Omata. (2006) Gastric cancer among peptic ulcer patients: Retrospective, long-term follow-up. Digestive and Liver Disease 38:11, 811-814
CrossRef515
K. Mönkemüller, L. Fry, P. Malfertheiner. (2006) Magenkarzinom – eine Infektionskrankheit. Der Gastroenterologe 1:4, 272-278
CrossRef516
T. T. H. Hoang, A.-S. Rehnberg, T.-U. Wheeldon, C. Bengtsson, D. C. Phung, R. Befrits, M. Sörberg, M. Granström. (2006) Comparison of the performance of serological kits for Helicobacter pylori infection with European and Asian study populations. Clinical Microbiology and Infection 12:11, 1112-1117
CrossRef517
Sanae Kabata Ikehara, Yuzuru Ikehara, Keitaro Matsuo, Kaoru Hirose, Toru Niwa, Hidemi Ito, Seiji Ito, Yasuhiro Kodera, Yoshitaka Yamamura, Hayao Nakanishi, Masae Tatematsu, Kazuo Tajima. (2006) A polymorphism of C-to-T substitution at −31 IL1B is associated with the risk of advanced gastric adenocarcinoma in a Japanese population. Journal of Human Genetics 51:11, 927-933
CrossRef518
F. Kamangar, S. M. Dawsey, M. J. Blaser, G. I. Perez-Perez, P. Pietinen, C. J. Newschaffer, C. C. Abnet, D. Albanes, J. Virtamo, P. R. Taylor. (2006) Opposing Risks of Gastric Cardia and Noncardia Gastric Adenocarcinomas Associated With Helicobacter pylori Seropositivity. JNCI Journal of the National Cancer Institute 98:20, 1445-1452
CrossRef519
Francesco Mario, Lucas Giovanni Cavallaro, Ali Mahamat Moussa, Pietro Caruana, Roberta Merli, Andrea Maini, Simone Bertolini, Nadia Bó, Massimo Rugge, Giulia Martina Cavestro, Giovanni Aragona, Mario Plebani, Angelo Franzé, Giorgio Nervi. (2006) Usefulness of Serum Pepsinogens in Helicobacter pylori Chronic Gastritis: Relationship With Inflammation, Activity, and Density of the Bacterium. Digestive Diseases and Sciences 51:10, 1791-1795
CrossRef520
MJ Friedrich, R Rad, R Langer, P Voland, H Hoefler, RM Schmid, C Prinz, M Gerhard. (2006) Lack of RUNX3 regulation in human gastric cancer. The Journal of Pathology 210:2, 141-146
CrossRef521
Eliette Touati, Valerie Michel, Jean-Michel Thiberge, Patrick Ave, Michel Huerre, Franck Bourgade, Arne Klungland, Agnes Labigne. (2006) Deficiency in OGG1 Protects against Inflammation and Mutagenic Effects Associated with H. pylori Infection in Mouse. Helicobacter 11:5, 494-505
CrossRef522
Kazunari Murakami, Tadayoshi Okimoto, Masaaki Kodama, Ryugo Sato, Hajime Miyajima, Masami Ono, Kunimitsu Inoue, Koichiro Watanabe, Satoshi Otsu, Toshio Fujioka. (2006) Comparison of Amoxicillin?Metronidazole Plus Famotidine or Lansoprazole for Amoxicillin?Clarithromycin?Proton Pump Inhibitor Treatment Failures for Helicobacter pylori Infection. Helicobacter 11:5, 436-440
CrossRef523
Sosuke Kato, Tetsuya Tsukamoto, Tsutomu Mizoshita, Harunari Tanaka, Toshiko Kumagai, Hiroyoshi Ota, Tsutomu Katsuyama, Masahiro Asaka, Masae Tatematsu. (2006) High salt diets dose-dependently promote gastric chemical carcinogenesis inHelicobacter pylori-infected Mongolian gerbils associated with a shift in mucin production from glandular to surface mucous cells. International Journal of Cancer 119:7, 1558-1566
CrossRef524
Mariela Quesada, Xavier Calvet, Angelina Dosal, Victoria Calvet, Isabel Sanfeliu, Laura Ribera, Theresa Choat, Barbara Fallowfield, Ant??nia Montserrat, Valent?? Puig, Ferran Segura. (2006) Evaluation of Four Different Fecal Tests for Determination of Cure After Helicobacter pylori Treatment. Journal of Clinical Gastroenterology 40:9, 790-794
CrossRef525
Masanori Hatakeyama. (2006) Helicobacter pylori CagA—a bacterial intruder conspiring gastric carcinogenesis. International Journal of Cancer 119:6, 1217-1223
CrossRef526
J Gwack, A Shin, C-S Kim, K-P Ko, Y Kim, J K Jun, J Bae, S K Park, Y-C Hong, D Kang, S-H Chang, H-R Shin, K-Y Yoo. (2006) CagA-producing Helicobacter pylori and increased risk of gastric cancer: a nested case–control study in Korea. British Journal of Cancer 95:5, 639-641
CrossRef527
A. O. O. CHAN, C. HUANG, W. M. HUI, C. H. CHO, M. F. YUEN, S. K. LAM, A. RASHID, B. C.-Y. WONG. (2006) Stability of E-cadherin methylation status in gastric mucosa associated with histology changes. Alimentary Pharmacology and Therapeutics 24:5, 831-836
CrossRef528
Ernst J. Kuipers. (2006) Proton Pump Inhibitors and Helicobacter pylori Gastritis: Friends or Foes?. Basic & Clinical Pharmacology & Toxicology 99:3, 187-194
CrossRef529
Yasuo Egi, Sunjin Kim, Masanori Ito, Shinji Tanaka, Masaharu Yoshihara, Ken Haruma, Kazuaki Chayama. (2006) Helicobacter pylori Infection Is the Major Risk Factor for Gastric Inflammation in the Cardia. Digestive Diseases and Sciences 51:9, 1582-1588
CrossRef530
K. Eto, S. Ohyama, T. Yamaguchi, T. Wada, Y. Suzuki, N. Mitsumori, H. Kashiwagi, S. Anazawa, K. Yanaga, M. Urashima. (2006) Familial clustering in subgroups of gastric cancer stratified by histology, age group and location. European Journal of Surgical Oncology (EJSO) 32:7, 743-748
CrossRef531
Shinkan Tokudome, Akihiro Hosono, Sadao Suzuki. (2006) Population-attributable fractions in gastric cancer risk factors: the necessity to focus on Helicobacter pylori infection. Gastric Cancer 9:3, 240-241
CrossRef532
Tetsuya Tsukamoto, Tsutomu Mizoshita, Masae Tatematsu. (2006) Gastric-and-intestinal mixed-type intestinal metaplasia: aberrant expression of transcription factors and stem cell intestinalization. Gastric Cancer 9:3, 156-166
CrossRef533
Martin Goetz, Arthur Hoffman, Peter R Galle, Markus F Neurath, Ralf Kiesslich. (2006) Confocal laser endoscopy: new approach to the early diagnosis of tumors of the esophagus and stomach. Future Oncology 2:4, 469-476
CrossRef534
Karianne Terry, Alvin C. Go, Karen M. Ottemann. (2006) Proteomic mapping of a suppressor of non-chemotactic cheW mutants reveals that Helicobacter pylori contains a new chemotaxis protein. Molecular Microbiology 61:4, 871-882
CrossRef535
J. Ignasi Elizalde, Josep M. Piqu??. (2006) Risk assessment in relatives of gastric cancer patients: hyperproliferation, genetics, and Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology 18:8, 877-879
CrossRef536
Angelo Zullo, Cesare Hassan, Stefania Marangi, Osvaldo Burattini, Adriana Romiti, Vincenzo De Francesco, Carmine Panella, Sergio Morini, Enzo Ierardi. (2006) Gastric epithelial cell proliferation and ras oncogene p21 expression in first-degree relatives of gastric cancer patients: a case???control study. European Journal of Gastroenterology & Hepatology 18:8, 921-926
CrossRef537
Yuan Yao, Hong Tao, Dong Il Park, Jorge L. Sepulveda, Antonia R. Sepulveda. (2006) Demonstration and Characterization of Mutations Induced by Helicobacter pylori Organisms in Gastric Epithelial Cells. Helicobacter 11:4, 272-286
CrossRef538
Yih K. Tan, John W.L. Fielding. (2006) Early diagnosis of early gastric cancer. European Journal of Gastroenterology & Hepatology 18:8, 821-829
CrossRef539
Hideyuki Miyachi, Ikuya Miki, Nobuo Aoyama, Daisuke Shirasaka, Yuko Matsumoto, Masanori Toyoda, Toshifumi Mitani, Yoshinori Morita, Takao Tamura, Shohiro Kinoshita, Yoshie Okano, Shunichi Kumagai, Masato Kasuga. (2006) Primary Levofloxacin Resistance and gyrA/B Mutations Among Helicobacter pylori in Japan. Helicobacter 11:4, 243-249
CrossRef540
A. KORSTANJE, S. VAN EEDEN, G. J. A. OFFERHAUS, L. J. M. SABBE, G. DEN HARTOG, I. BIEMOND, C. B. H. W. LAMERS. (2006) The 13 carbon urea breath test for the diagnosis of Helicobacter pylori infection in subjects with atrophic gastritis: evaluation in a primary care setting. Alimentary Pharmacology & Therapeutics 24:4, 643-650
CrossRef541
Dominique Lamarque, Michael Levy, Mane-Therese Chaumette, Francoise Roudot-Thoraval, Maryan Cavicchi, Jean Auroux, Anne Courillon-Mallet, Corinne Haioun, Jean-Charles Delchier. (2006) Frequent and Rapid Progression of Atrophy and Intestinal Metaplasia in Gastric Mucosa of Patients with MALT Lymphoma. The American Journal of Gastroenterology 101:8, 1886-1893
CrossRef542
Andr?? Korstanje, Gijsbert den Hartog, Izak Biemond, Freek W.C. Roelandse, John H.M. Souverijn, Cornelis B.H.W. Lamers. (2006) Role of Helicobacter pylori and autoimmunity in serological atrophic corpus gastritis in a Dutch primary care community. European Journal of Gastroenterology & Hepatology 18:8, 911-916
CrossRef543
Alex Cho, Amina Chaudhry, Lisa Minsky-Primus, Alan Tso, Guillermo Perez-Perez, David Diehl, Stuart G. Marcus, Francesca M. Gany. (2006) Acceptance of Repeat Esophagogastroduodenoscopy to Detect Gastric Cancer in a Chinese Immigrant Cohort. Journal of Clinical Gastroenterology 40:7, 606-611
CrossRef544
Masayuki Mashimo, Manabu Nishikawa, Kazuhide Higuchi, Masaki Hirose, Qian Wei, Anwarul Haque, Eiji Sasaki, Masatsugu Shiba, Kazunari Tominaga, Toshio Watanabe, Yasuhiro Fujiwara, Tetsuo Arakawa, Masayasu Inoue. (2006) Production of Reactive Oxygen Species in Peripheral Blood is Increased in Individuals with Helicobacter pylori Infection and Decreased after its Eradication. Helicobacter 11:4, 266-271
CrossRef545
Michiro Otaka, Noriaki Konishi, Masaru Odashima, Mario Jin, Isao Wada, Tamotsu Matsuhashi, Youhei Horikawa, Reina Ohba, Sumio Watanabe. (2006) Is Mongolian gerbil really adequate host animal for study of Helicobacter pylori infection-induced gastritis and cancer?. Biochemical and Biophysical Research Communications 347:1, 297-300
CrossRef546
W.-c. You, L. M. Brown, L. Zhang, J.-y. Li, M.-l. Jin, Y.-s. Chang, J.-l. Ma, K.-f. Pan, W.-d. Liu, Y. Hu, S. Crystal-Mansour, D. Pee, W. J. Blot, J. F. Fraumeni, G.-w. Xu, M. H. Gail. (2006) Randomized Double-Blind Factorial Trial of Three Treatments To Reduce the Prevalence of Precancerous Gastric Lesions. JNCI Journal of the National Cancer Institute 98:14, 974-983
CrossRef547
S. NAKAGAWA, M. ASAKA, M. KATO, T. NAKAMURA, C. KATO, T. FUJIOKA, M. TATSUTA, K. KEIDA, S. TERAO, S. TAKAHASHI, N. UEMURA, T. KATO, N. AOYAMA, D. SAITO, M. SUZUKI, A. IMAMURA, K. SATO, H. MIWA, H. NOMURA, M. KAISE, S. OOHARA, T. KAWAI, K. URABE, N. SAKAKI, S. ITO, Y. NODA, A. YANAKA, K. KUSUGAMI, H. GOTO, T. FURUTA, M. FUJINO, F. KINJYOU, T. OOKUSA. (2006) Helicobacter pylori eradication and metachronous gastric cancer after endoscopic mucosal resection of early gastric cancer. Alimentary Pharmacology <html_ent glyph="@amp;" ascii="&"/> Therapeutics Symposium Series 2:1, 214-218
CrossRef548
S. KATO, N. MATSUKURA, N. MATSUDA, K. TSUKADA, Z. NAITO, T. TAJIRI. (2006) Helicobacter pylori eradication therapy modulates acidity and interleukin-1beta mRNA levels in un-operated stomach and in remnant stomach after gastrectomy in gastric cancer patients. Alimentary Pharmacology <html_ent glyph="@amp;" ascii="&"/> Therapeutics Symposium Series 2:1, 278-284
CrossRef549
M. KATO, M. ASAKA, T. NAKAMURA, T. AZUMA, E. TOMITA, T. KAMOSHIDA, K. SATO, T. INABA, D. Shirasaka, S. OKAMOTO, S. TAKAHASHI, S. TERAO, K. SUWAKI, H. ISOMOTO, H. YAMAGATA, H. NOMURA, K. YAGI, Y. SONE, T. URABE, T. AKAMATSU, S. OHARA, A. TAKAGI, J. MIWA, S. INATSUCHI. (2006) Helicobacter pylori eradication prevents the development of gastric cancer - results of a long-term retrospective study in Japan. Alimentary Pharmacology <html_ent glyph="@amp;" ascii="&"/> Therapeutics Symposium Series 2:1, 203-206
CrossRef550
Maria A. Orengo, Claudia Casella, Vincenzo Fontana, Rosangela Filiberti, Massimo Conio, Stefano Rosso, Rosario Tumino, Paolo Crosignani, Vincenzo De Lisi, Fabio Falcini, Marina Vercelli. (2006) Trends in incidence rates of oesophagus and gastric cancer in Italy by subsite and histology, 1986???1997. European Journal of Gastroenterology & Hepatology 18:7, 739-746
CrossRef551
J. TANAKA, T. OHKUSA, T. YOKOYAMA, T. MATSUHISA, T. KAWAI, H. HASHIMOTO, T. TOMITA, K. HORI, K. NAKAJIMA, T. MATSUMOTO, H. MIWA. (2006) Host serological response to Helicobacter pylori after successful eradication: long-term follow-up in patients with cured and persistent infection. Alimentary Pharmacology <html_ent glyph="@amp;" ascii="&"/> Therapeutics Symposium Series 2:1, 239-248
CrossRef552
T. MASAOKA, H. SUZUKI, K. KURABAYASHI, Y. NOMOTO, T. NISHIZAWA, M. MORI, T. HIBI. (2006) Could frameshift mutations in the frxA and rdxA genes of Helicobacter pylori be a marker for metronidazole resistance?. Alimentary Pharmacology <html_ent glyph="@amp;" ascii="&"/> Therapeutics Symposium Series 2:1, 81-87
CrossRef553
A. TANAKA, J. WATARI, H. TANABE, A. MAEMOTO, M. FUJIYA, T. ASHIDA, K. M. DAS, Y. KOHGO. (2006) Effect of eradication of Helicobacter pylori on genetic instabilities in gastric intestinal metaplasia. Alimentary Pharmacology <html_ent glyph="@amp;" ascii="&"/> Therapeutics Symposium Series 2:1, 194-202
CrossRef554
T. KAWAI, K. KAWAKAMI, M. KATAOKA, K. TAKEI, S. TAIRA, T. ITOI, F. MORIYASU, Y. TAKAGI, T. AOKI, H. SERIZAWA, E. RIMBARA, N. NOGUCHI, M. SASATSU. (2006) Correlation of serum pepsinogen with histological atrophy following successful Helicobacter pylori eradication. Alimentary Pharmacology <html_ent glyph="@amp;" ascii="&"/> Therapeutics Symposium Series 2:1, 23-30
CrossRef555
Thomas Wex, Gerhard Treiber, Marino Venerito, Andreas Leodolter, Ulrich Peitz, Doerthe Kuester, Istvan Hritz, Sabine Krueger, Albert Roessner, Peter Malfertheiner. (2006) Helicobacter pylori -induced downregulation of the secretory leukocyte protease inhibitor (SLPI) in gastric epithelial cell lines and its functional relevance for H. pylori -mediated diseases. Biological Chemistry 387:7, 893-901
CrossRef556
Kentaro Sugano. (2006) Long-term outcome and surveillance policy after endoscopic therapy for early gastric cancer. Gastric Cancer 9:2, 67-69
CrossRef557
Takeshi Matsuhisa, Takashi Kawai, Tatsuhiro Masaoka, Hidekazu Suzuki, Masayoshi Ito, Yo Kawamura, Kengo Tokunaga, Masayuki Suzuki, Tetsuya Mine, Shin-ichi Takahashi, Nobuhiro Sakaki. (2006) Efficacy of Metronidazole as Second-Line Drug for the Treatment of Helicobacter pylori Infection in the Japanese Population: A Multicenter Study in the Tokyo Metropolitan Area. Helicobacter 11:3, 152-158
CrossRef558
Shogo Kikuchi, Mototsugu Kato, Tsutomu Katsuyama, Suketami Tominaga, Masahiro Asaka. (2006) Design and Planned Analyses of an Ongoing Randomized Trial Assessing the Preventive Effect of Helicobacter pylori Eradication on Occurrence of New Gastric Carcinomas After Endoscopic Resection. Helicobacter 11:3, 147-151
CrossRef559
Dorte Ejg Jarbol, Jakob Kragstrup, Henrik Stovring, Troels Havelund, Ove B. Schaffalitzky de Muckadell. (2006) Proton Pump Inhibitor or Testing for Helicobacter pylori as the First Step for Patients Presenting with Dyspepsia? A Cluster-Randomized Trial. The American Journal of Gastroenterology 101:6, 1200-1208
CrossRef560
David Y. Graham, Naomi Uemura. (2006) Natural History of Gastric Cancer After Helicobacter pylori Eradication in Japan: After Endoscopic Resection, After Treatment of the General Population, and Naturally. Helicobacter 11:3, 139-143
CrossRef561
J.-D. de Korwin. (2006) La gastrite à Helicobacter pylori, une pathologie frontière. La Revue de Médecine Interne 27, S61-S63
CrossRef562
Yoshifumi Inomata, Tomoyuki Koike, Shuichi Ohara, Yasuhiko Abe, Hitoshi Sekine, Katsunori Iijima, Ken Ariizumi, Hatsushi Yamagishi, Yasushi Kitagawa, Akira Imatani, Tooru Shimosegawa. (2006) Preservation of Gastric Acid Secretion May Be Important for the Development of Gastroesophageal Junction Adenocarcinoma in Japanese People, Irrespective of the H. pylori Infection Status. The American Journal of Gastroenterology 101:5, 926-933
CrossRef563
Roland Rad, Christian Prinz, Roland M Schmid. (2006) Helicobacter pylori and prognosis of gastric carcinoma. The Lancet Oncology 7:5, 364-365
CrossRef564
F. Di Mario, L.G. Cavallaro, G.M. Cavestro, A. Franzé. (2006) Are there useful biomarkers for gastric cancer?. Digestive and Liver Disease 38:5, 308-309
CrossRef565
Catherine McCaig, Cedric Duval, Elaine Hemers, Islay Steele, D. Mark Pritchard, Sabine Przemeck, Rod Dimaline, Suhail Ahmed, Keith Bodger, David D. Kerrigan, Timothy C. Wang, Graham J. Dockray, Andrea Varro. (2006) The Role of Matrix Metalloproteinase-7 in Redefining the Gastric Microenvironment in Response to Helicobacter pylori. Gastroenterology 130:6, 1754-1763
CrossRef566
Seiichi Kato, Shigeru Fujimura, Katsunori Kimura, Tomoko Nishio, Shiro Hamada, Takanori Minoura, Munehiro Oda. (2006) Non-Helicobacter Bacterial Flora Rarely Develops in the Gastric Mucosal Layer of Children. Digestive Diseases and Sciences 51:4, 641-646
CrossRef567
Taiji Akamatsu, Taro Mochizuki, Yoko Okiyama, Akihiro Matsumoto, Hideharu Miyabayashi, Hiroyoshi Ota. (2006) Comparison of Localized Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma with and without Helicobacter pylori Infection. Helicobacter 11:2, 86-95
CrossRef568
Masanori Naito, Takeshi Yamazaki, Ryouhei Tsutsumi, Hideaki Higashi, Kazunori Onoe, Shiho Yamazaki, Takeshi Azuma, Masanori Hatakeyama. (2006) Influence of EPIYA-Repeat Polymorphism on the Phosphorylation-Dependent Biological Activity of Helicobacter pylori CagA. Gastroenterology 130:4, 1181-1190
CrossRef569
Tomoari Kamada, Jiro Hata, Aki Tanaka, Hiroaki Kusunoki, Masaki Miyamoto, Kazuhiko Inoue, Yoshito Sadahira, Ken Haruma. (2006) NODULAR GASTRITIS AND GASTRIC CANCER. Digestive Endoscopy 18:2, 79-83
CrossRef570
Caterina Hatzifoti, Yvonne Roussel, Andrew G. Harris, Brendan W. Wren, John W. Morrow, Mona Bajaj-Elliott. (2006) Mucosal Immunization with a Urease B DNA Vaccine Induces Innate and Cellular Immune Responses Against Helicobacter pylori. Helicobacter 11:2, 113-122
CrossRef571
Wai K. Leung, Martin C.W. Chan, Ka-Fai To, Ellen P.S. Man, Enders K.W. Ng, Eagle S.H. Chu, James Y.W. Lau, San-ren Lin, Joseph J.Y. Sung. (2006) H. pylori Genotypes and Cytokine Gene Polymorphisms Influence the Development of Gastric Intestinal Metaplasia in a Chinese Population. The American Journal of Gastroenterology 101:4, 714-720
CrossRef572
Hiroyuki Ueda, Masanori Ito, Shinji Tanaka, Shiro Oka, Shunsuke Takata, Shinobu Imagawa, Xue Fei Xie, Masaharu Yoshihara, Ken Haruma, Kazuaki Chayama. (2006) The Effect of Helicobacter Pylori Eradication Therapy on Gastric Ulcer Healing After Endoscopic Mucosal Resection. Journal of Clinical Gastroenterology 40:4, 293-296
CrossRef573
Yoko Murayama, Yasuhisa Shinomura, Tamana Miyazaki, Shinji Tamura, Norio Hayashi. (2006) IS HELICOBACTER PYLORI-INDUCED ENLARGED FOLD GASTRITIS A HIGH-RISK FACTOR FOR GASTRIC CARCINOMA?. Digestive Endoscopy 18:2, 98-104
CrossRef574
Songhua Zhang, Akinori Yanaka, Masafumi Tauchi, Hideo Suzuki, Takeshi Shibahara, Hirofumi Matsui, Akira Nakahara, Naomi Tanaka. (2006) Hyperosmotic stress enhances interleukin-1beta expression in Helicobacter pylori-infected murine gastric epithelial cells in vitro. Journal of Gastroenterology and Hepatology 21:4, 759-766
CrossRef575
AYUMU TAGUCHI, NAOKI OHMIYA, AKIHIRO ITOH, YOSHIKI HIROOKA, YASUMASA NIWA, NAOYOSHI MORI, HIDEMI GOTO. (2006) Severity of atrophic gastritis related to antiparietal cell antibody and gastric carcinogenesis, including p53 mutations. Journal of Gastroenterology and Hepatology 21:3, 545-551
CrossRef576
Richard J. Saad, Philip Schoenfeld, Hyungjin Myra Kim, William D. Chey. (2006) Levofloxacin-Based Triple Therapy versus Bismuth-Based Quadruple Therapy for Persistent Helicobacter pylori Infection: A Meta-Analysis. CME. The American Journal of Gastroenterology 101:3, 488-496
CrossRef577
Katsuhiko Tsukada, Hiroyuki Katoh, Tatsuya Miyazaki, Minoru Fukuchi, Hiroyuki Kuwano, Hitoshi Kimura, Yasuyuki Fukai, Takanori Inose, Teiji Motojima, Naotaka Toda, Shuji Yamada. (2006) Factors Associated with the Development of Reflux Esophagitis After Helicobacter pylori Eradication. Digestive Diseases and Sciences 51:3, 539-542
CrossRef578
Tsutomu Chiba, Hiroshi Seno, Hiroyuki Marusawa, Yoshio Wakatsuki, Kazuichi Okazaki. (2006) Host factors are important in determining clinical outcomes of Helicobacter pylori infection. Journal of Gastroenterology 41:1, 1-9
CrossRef579
YOSHINORI WATANABE, NOBUO AOYAMA, TOSHIYUKI SAKAI, DAISUKE SHIRASAKA, SHUJI MAEKAWA, KOHEI KURODA, CASMIR WAMBURA, TAKAO TAMURA, YOSHISUKE NOSE, MASATO KASUGA. (2006) HLA-DQB1 locus and gastric cancer in Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 21:2, 420-424
CrossRef580
Teresa Starzynska, Katarzyna Ferenc, Thomas Wex, Thilo Kahne, Jan Lubinski, Malgorzata Lawniczak, Krzysztof Marlicz, Peter Malfertheiner. (2006) The Association Between the Interleukin-1 Polymorphisms and Gastric Cancer Risk Depends on the Family History of Gastric Carcinoma in the Study Population. The American Journal of Gastroenterology 101:2, 248-254
CrossRef581
Liviu A. Sicinschi, Lizbeth Lopez-Carrillo, M. Constanza Camargo, Pelayo Correa, Rosa A. Sierra, Robin R. Henry, Jia Chen, Jovanny Zabaleta, Maria B. Piazuelo, Barbara G. Schneider. (2006) Gastric cancer risk in a Mexican population: Role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin-1 and -10 genes. International Journal of Cancer 118:3, 649-657
CrossRef582
Chikara Kunisaki, Hirotoshi Akiyama, Masato Nomura, Goro Matsuda, Yuichi Otsuka, Hidetaka Andrew Ono, Hiroshi Shimada. (2006) Comparison of surgical outcomes of gastric cancer in elderly and middle-aged patients. The American Journal of Surgery 191:2, 216-224
CrossRef583
M Lindblad, L A García Rodríguez, E Chandanos, J Lagergren. (2006) Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. British Journal of Cancer 94:1, 136-141
CrossRef584
Takashi Majima, Takashi Ichikura, Kentaro Chochi, Toshinobu Kawabata, Hironori Tsujimoto, Hidekazu Sugasawa, Noritsugu Kuranaga, Eiji Takayama, Manabu Kinoshita, Hoshio Hiraide, Shuhji Seki, Hidetaka Mochizuki. (2006) Exploitation of interleukin-18 by gastric cancers for their growth and evasion of host immunity. International Journal of Cancer 118:2, 388-395
CrossRef585
Jun Tanabe, Naoki Kawai, Takashi Abe, Nariyuki Ueshima, Shin Mizutani, Masahiko Tsujimoto, Haruya Meren, Sunao Kawano, Tomoari Kamada, Ken Haruma. (2006) A CASE OF DIFFUSE-TYPE EARLY GASTRIC CANCER WITH NODULAR GASTRITIS. Digestive Endoscopy 18:1, 67-70
CrossRef586
Warren Strober, Peter J. Murray, Atsushi Kitani, Tomohiro Watanabe. (2006) Signalling pathways and molecular interactions of NOD1 and NOD2. Nature Reviews Immunology 6:1, 9-20
CrossRef587
Antonio Gasbarrini, Giovanni Gasbarrini, Iva Pelosini, Carmelo Scarpignato. (2006) Eradication of <i>Helicobacter pylori</i>: Are Rifaximin-Based Regimens Effective?. Digestion 73:1, 129-135
CrossRef588
Richard M Peek, Jean E Crabtree. (2006) Helicobacter infection and gastric neoplasia. The Journal of Pathology 208:2, 233-248
CrossRef589
Josine van Beek, Axel zur Hausen, Sander N Snel, Johannes Berkhof, Elma Klein Kranenbarg, Cornelis J. H van de Velde, Adriaan J. C van den Brule, Jaap M Middeldorp, Chris J. L. M Meijer, Elisabeth Bloemena. (2006) Morphological Evidence of an Activated Cytotoxic T-Cell Infiltrate in EBV-Positive Gastric Carcinoma Preventing Lymph Node Metastases. The American Journal of Surgical Pathology 30:1, 59-65
CrossRef590
Klaus Dirschmid, Claudia Platz-Baudin, Manfred Stolte. (2006) Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa?. Virchows Archiv 448:1, 80-84
CrossRef591
Yoshio Wakatsuki. (2006) Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 43:6, 687-689
CrossRef592
Mark Fowler, Rachael J. Thomas, John Atherton, Ian S. Roberts, Nicola J. High. (2006) Galectin-3 binds to Helicobacter pylori O-antigen: it is upregulated and rapidly secreted by gastric epithelial cells in response to H. pylori adhesion. Cellular Microbiology 8:1, 44-54
CrossRef593
S. F. Park. 2006. Helicobacter pylori. , 429-449.
CrossRef594
Seiichi Kato, Shigemi Nakajima, Yoshikazu Nishino, Kyoko Ozawa, Takanori Minoura, Mutsuko Konno, Shunichi Maisawa, Shigeru Toyoda, Norikazu Yoshimura, Ajula Vaid, Robert M. Genta. (2006) Association Between Gastric Atrophy and Helicobacter pylori Infection in Japanese Children: A Retrospective Multicenter Study. Digestive Diseases and Sciences 51:1, 99-104
CrossRef595
Kenneth E.L. McColl. (2006) Cancer of the gastric cardia. Best Practice & Research Clinical Gastroenterology 20:4, 687-696
CrossRef596
Mitsushige Sugimoto, Masayoshi Kajimura, Naohito Shirai, Takahisa Furuta, Shigeru Kanaoka, Mutsuhiro Ikuma, Yoshihiko Sato, Akira Hishida. (2006) Outcome of Radiotherapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Refractory to Helicobacter Pylori Eradication Therapy. Internal Medicine 45:6, 405-409
CrossRef597
Tomoari Kamada, Kuniaki Sugiu, Jiro Hata, Hiroaki Kusunoki, Hiroshige Hamada, Soichiro Kido, Yuichi Nagashima, Yuzuru Kawamura, Shinji Tanaka, Kazuaki Chayama, Ken Haruma. (2006) Evaluation of endoscopic and histological findings in Helicobacter pylori -positive Japanese young adults. Journal of Gastroenterology and Hepatology 21:1, 258-261
CrossRef598
Alex Cho, Amina Chaudhry, Lisa Minsky-Primus, Alan Tso, Guillermo Perez-Perez, David L Diehl, Stuart G Marcus, Francesca M Gany. (2006) Follow-Up Care After a Diagnosis of Helicobacter pylori Infection in an Asian Immigrant Cohort. Journal of Clinical Gastroenterology 40:1, 29-32
CrossRef599
Peter Malfertheiner, Lucia C. Fry, Klaus Mönkemüller. (2006) Can gastric cancer be prevented by Helicobacter pylori eradication?. Best Practice & Research Clinical Gastroenterology 20:4, 709-719
CrossRef600
Hiroharu Yamashita, Joji Kitayama, Dai Shida, Makoto Ishikawa, Kotaro Hama, Junken Aoki, Hiroyuki Arai, Hirokazu Nagawa. (2006) Differential expression of lysophosphatidic acid receptor-2 in intestinal and diffuse type gastric cancer. Journal of Surgical Oncology 93:1, 30-35
CrossRef601
NAOMI UEMURA. (2006) Nihon Naika Gakkai Zasshi 95:3, 464-467
CrossRef602
Anthony Axon. (2006) Helicobacter pylori. Journal of Clinical Gastroenterology 40:1, 15-19
CrossRef603
Wai K. Leung, Enders K. W. Ng, Candice C. H. Lam, Kui-Fat Chan, Wing Y. Chan, Alex C. M. Auyeung, Justin C. Y. Wu, Jessica Y. L. Ching, James Y. W. Lau, Joseph J. Y. Sung. (2006) Helicobacter pylori infection in 1st degree relatives of Chinese gastric cancer patients. Scandinavian Journal of Gastroenterology 41:3, 274-279
CrossRef604
Masashi Matsushima, Takayoshi Suzuki, Tomoyuki Kurumada, Sumio Watanabe, Kenichi Watanabe, Kenji Kobayashi, Ryuzo Deguchi, Aya Masui, Atsushi Takagi, Takayuki Shirai, Hiroe Muraoka, Intetsu Kobayashi, Tetsuya Mine. (2006) Tetracycline, metronidazole and amoxicillin-metronidazole combinations in proton pump inhibitor-based triple therapies are equally effective as alternative therapies against Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 21:1, 232-236
CrossRef605
Hiroyuki Ueda, Masanori Ito, Hidetaka Eguchi, Shinji Tanaka, Masaharu Yoshihara, Ken Haruma, Masanori Hatakeyama, Kazuaki Chayama. (2006) Development of a Novel Method to Detect <i>Helicobacter pylori</i><i>cagA</i> Genotype from Paraffin-Embedded Materials: Comparison between Patients with Duodenal Ulcer and Gastric Cancer in Young Japanese. Digestion 73:1, 47-53
CrossRef606
Xia Wang, Jing-Yuan Fang, Rong Lu, Dan-Feng Sun. (2006) A Meta-Analysis: Comparison of Esomeprazole and Other Proton Pump Inhibitors in Eradicating <i>Helicobacter pylori</i>. Digestion 73:2-3, 178-186
CrossRef607
Shigeaki Yoshida, Takahiro Kozu, Takuji Gotoda, Daizo Saito. (2006) Detection and treatment of early cancer in high-risk populations. Best Practice & Research Clinical Gastroenterology 20:4, 745-765
CrossRef608
Peng Yuan ZHENG, Fu Ai TANG, Yuan Ming QI, Jian LI. (2006) Association of peptic ulcer with increased expression of Lewis antigens, but not vacuolating cytotoxin activity or babA2 gene status, in Helicobacter pylori strains from China. Chinese Journal of Digestive Diseases 7:1, 61-65
CrossRef609
Robert T. Jensen. (2006) Consequences of Long-Term Proton Pump Blockade: Insights from Studies of Patients with Gastrinomas. Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology 98:1, 4-19
CrossRef610
Yasuyuki Goto, Takafumi Ando, Kazuhito Yamamoto, Akiko Tamakoshi, Emad El-Omar, Hidemi Goto, Nobuyuki Hamajima. (2006) Association between serum pepsinogens and polymorphismofPTPN11 encoding SHP-2 amongHelicobacter pylori seropositive Japanese. International Journal of Cancer 118:1, 203-208
CrossRef611
Hitoshi Katai, Takeshi Sano. (2005) Early gastric cancer: concepts, diagnosis, and management. International Journal of Clinical Oncology 10:6, 375-383
CrossRef612
Shigeto Mizuno, Yoshinori Morita, Toshio Inui, Akihiro Asakawa, Naohiko Ueno, Takashi Ando, Haruki Kato, Mutsumi Uchida, Toshikazu Yoshikawa, Akio Inui. (2005) Helicobacter pylori infection is associated with colon adenomatous polyps detected by high-resolution colonoscopy. International Journal of Cancer 117:6, 1058-1059
CrossRef613
Raquel Almeida, José Almeida, Michal Shoshkes, Nuno Mendes, Patrícia Mesquita, Elisabete Silva, Isabelle Van Seuningen, Celso A Reis, Filipe Santos-Silva, Leonor David. (2005) OCT-1 is over-expressed in intestinal metaplasia and intestinal gastric carcinomas and binds to, but does not transactivate, CDX2 in gastric cells. The Journal of Pathology 207:4, 396-401
CrossRef614
Yali Gao, Guoqing Hu, Frank Y. H. Lin, Philip M. Sherman, Dongqing Li. (2005) An Electrokinetically-Controlled Immunoassay for Simultaneous Detection of Multiple Microbial Antigens. Biomedical Microdevices 7:4, 301-312
CrossRef615
Masanori Hatakeyama, Hideaki Higashi. (2005) Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. Cancer Science 96:12, 835-843
CrossRef616
Bruce E. Stabile, Brian R. Smith, David L. Weeks. (2005) Helicobacter pylori Infection and Surgical Disease—Part II. Current Problems in Surgery 42:12, 804-862
CrossRef617
Shinkan Tokudome, Witjitra D. Samsuria, Soeripto, F. X. Ediati Triningsih, Sadao Suzuki, Akihiro Hosono, Teguh Triono, Indra Wijaya, Sarjadi, Ika P. Miranti, Reza Ghadimi, Malcolm A. Moore. (2005) Helicobacter pylori infection appears essential for stomach carcinogenesis: Observations in Semarang, Indonesia. Cancer Science 96:12, 873-875
CrossRef618
Mark S Pearce, Julian E Thomas, David I Campbell, Louise Parker. (2005) Does Increased Duration of Exclusive Breastfeeding Protect Against Helicobacter pylori Infection? The Newcastle Thousand Families Cohort Study at Age 49-51 Years. Journal of Pediatric Gastroenterology and Nutrition 41:5, 617-620
CrossRef619
Ruggiero Francavilla, Elena Lionetti, Stefania Paola Castellaneta, Anna Maria Magistà, Giuseppe Boscarelli, Domenico Piscitelli, Annacinzia Amoruso, Alfredo Di Leo, Vito Leonardo Miniello, Antonio Francavilla, Luciano Cavallo, Enzo Ierardi. (2005) Improved Efficacy of 10-Day Sequential Treatment for Helicobacter pylori Eradication in Children: A Randomized Trial. Gastroenterology 129:5, 1414-1419
CrossRef620
Nicholas J. Talley, Nimish B. Vakil, Paul Moayyedi. (2005) American Gastroenterological Association Technical Review on the Evaluation of Dyspepsia. Gastroenterology 129:5, 1756-1780
CrossRef621
Ping-I Hsu, Kwok-Hung Lai, Chiun-Ku Lin, Wen-Chi Chen, Hsien-Chung Yu, Jin-Shiung Cheng, Feng-Woei Tsay, Chung-Jen Wu, Ching-Chu Lo, Hui-Hwa Tseng, Yoshio Yamaoka, Jin-Liang Chen, Gin-Ho Lo. (2005) A Prospective Randomized Trial of Esomeprazole- versus Pantoprazole-Based Triple Therapy for Helicobacter pylori Eradication. The American Journal of Gastroenterology 100:11, 2387-2392
CrossRef622
Noriyoshi Kuzushita, Arlin B. Rogers, Nola A. Monti, Mark T. Whary, Min J. Park, Bassam I. Aswad, Haim Shirin, Andrew Koff, Hidetoshi Eguchi, Steven F. Moss. (2005) p27kip1 Deficiency Confers Susceptibility to Gastric Carcinogenesis in Helicobacter pylori–Infected Mice. Gastroenterology 129:5, 1544-1556
CrossRef623
FRANCESCO DI MARIO, ALI M MOUSSA, NADIA DAL BO, PIETRO CARUANA, ALBERTO PILOTTO, LUCAS G CAVALLARO, GIULIA M CAVESTRO, VERONICA IORI, ROBERTA MERLI, ANGELO FRANZE, MASSIMO RUGGE. (2005) Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: Prospective 4-year study. Journal of Gastroenterology and Hepatology 20:11, 1661-1666
CrossRef624
M. SUGIMOTO, T. FURUTA, N. SHIRAI, A. NAKAMURA, M. KAJIMURA, H. SUGIMURA, A. HISHIDA, T. ISHIZAKI. (2005) Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics 22:10, 1033-1040
CrossRef625
Concetta Tuccillo, Antonio Cuomo, Alba Rocco, Erika Martinelli, Stefania Staibano, Massimo Mascolo, Antonietta G Gravina, Gerardo Nardone, Vittorio Ricci, Fortunato Ciardiello, Camillo Del Vecchio Blanco, Marco Romano. (2005) Vascular endothelial growth factor and neo-angiogenesis inH. pylori gastritis in humans. The Journal of Pathology 207:3, 277-284
CrossRef626
Michael Stock, Florian Otto. (2005) Gene deregulation in gastric cancer. Gene 360:1, 1-19
CrossRef627
C. O'Morain. (2005) Helicobacter pylori infection and gastric cancer. British Journal of Surgery 92:10, 1187-1188
CrossRef628
Kazunari Murakami, Masaaki Kodama, Ryugo Sato, Tadayoshi Okimoto, Koichiro Watanabe, Toshio Fujioka. (2005) Helicobacter pylori eradication and associated changes in the gastric mucosa. Expert Review of Anti-infective Therapy 3:5, 757-764
CrossRef629
Koi Fan, Jianmei Ma, Zhaohui Wang, Min Liu, Mei Li, Shen Lü, Una Liu, Guowang Xu. (2005) The effect ofHelicobacter pylori infection on hMSH2 and P53 proteins in gastric carcinogenesis. Chinese Journal of Clinical Oncology 2:5, 791-795
CrossRef630
Yi-Qian Sun, Fredrik Petersson, Hans-Jürg Monstein, Johan Söderholm, Jens Rehfeld, Kurt Borch. (2005) Long-term morpho-functional development of Helicobacter pylori -induced gastritis in Mongolian gerbils. Scandinavian Journal of Gastroenterology 40:10, 1157-1167
CrossRef631
Katsuhiko Tsukada, Tatsuya Miyazaki, Hiroyuki Katoh, Minoru Fukuchi, Yasuyuki Fukai, Hitoshi Kimura, Makoto Sohda, Shuji Yamada, Naotaka Toda, Teiji Motojima, Hiroyuki Kuwano. (2005) The incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori. European Journal of Gastroenterology & Hepatology 17:10, 1025-1028
CrossRef632
L. Zhao, Z-X Shen, H-S Luo, J-P Yu. (2005) Clinical investigation on coexisting of duodenal ulcer and gastric cancer in China. International Journal of Clinical Practice 59:10, 1153-1156
CrossRef633
Nagisa Yoshino, Shunji Ishihara, M.A.K. Rumi, C.F. Ortega-Cava, Takafumi Yuki, Hideaki Kazumori, Shin Takazawa, Hiroshi Okamoto, Yasunori Kadowaki, Yoshikazu Kinoshita. (2005) Interleukin-8 Regulates Expression of Reg Protein in Helicobacter pylori-Infected Gastric Mucosa. The American Journal of Gastroenterology 100:10, 2157-2166
CrossRef634
Jiang Xuan, Ryuzo Deguchi, Sumio Watanabe, Hideki Ozawa, Tetsuya Urano, Yoshiaki Ogawa, Ryuki Fukuda, Hiroshi Kijima, Yasuhiro Koga, Atsushi Takagi. (2005) Relationship between IL-1β gene polymorphism and gastric mucosal IL-1β levels in patients with Helicobacter pylori infection. Journal of Gastroenterology 40:8, 796-801
CrossRef635
Scott B. Citino, Linda Munson. (2005) EFFICACY AND LONG-TERM OUTCOME OF GASTRITIS THERAPY IN CHEETAHS (ACINONYX JUBATUS). Journal of Zoo and Wildlife Medicine 36:3, 401-416
CrossRef636
E. LAHNER, C. BORDI, M. S. CATTARUZZA, C. IANNONI, M. MILIONE, G. DELLE FAVE, B. ANNIBALE. (2005) Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics 22:5, 471-481
CrossRef637
MASAYA KAWADE, TAKASHI JOH, TADAYUKI OSHIMA, NOBUO TAKAHASHI, KUMIKO OGAWA, HIROTAKA OHARA, TOMOYUKI NOMURA, MAKOTO ITOH. (2005) Prevalence of gastric cancer decreases with age in long-living elderly in Japan, possibly due to changes in Helicobacter pylori infection status. Journal of Gastroenterology and Hepatology 20:9, 1333-1337
CrossRef638
TOMOHIKO SHIMATANI, MASAKI INOUE, KEIKO IWAMOTO, HIDEYUKI HYOGO, MICHIYA YOKOZAKI, TOSHINARI SAEKI, SUSUMU TAZUMA, YOKO HORIKAWA. (2005) Prevalence of Helicobacter pylori infection, endoscopic gastric findings and dyspeptic symptoms among a young Japanese population born in the 1970s. Journal of Gastroenterology and Hepatology 20:9, 1352-1357
CrossRef639
Peter Malfertheiner, Pentti Sipponen, Michael Naumann, Paul Moayyedi, Francis Megraud, Shu-Dong Xiao, Kentaro Sugano, Olof Nyren, . (2005) Helicobacter pylori Eradication Has the Potential to Prevent Gastric Cancer: A State-of-the-Art Critique. The American Journal of Gastroenterology 100:9, 2100-2115
CrossRef640
Hiroshi Yasuda, Masaya Yamada, Yutaka Endo, Kazuaki Inoue, Makoto Yoshiba. (2005) Elevated cyclooxygenase-2 expression in patients with early gastric cancer in the gastric pylorus. Journal of Gastroenterology 40:7, 690-697
CrossRef641
A. S. RAGHUNATH, C. O'MORAIN, R. C. MCLOUGHLIN. (2005) Review article: the long-term use of proton-pump inhibitors. Alimentary Pharmacology and Therapeutics 22:s1, 55-63
CrossRef642
Björn Stenström, Kirsti Løseth, Lars Bevanger, Erik Sturegård, Torkel Wadström, Duan Chen. (2005) Gastric bypass surgery does not increase susceptibility to Helicobacter pylori infection in the stomach of rat or mouse. InflammoPharmacology 13:1-3, 229-234
CrossRef643
M STOLTE, M VIETH. (2005) Gastritis and gastric cancer: which morphological type of Helicobacter gastritis is a precancerous risk?. Chinese Journal of Digestive Diseases 6:3, 110-111
CrossRef644
Ramona M. McLoughlin, Colm A. O'Morain, Humphrey J. O'Connor. (2005) Eradication of Helicobacter pylori: recent advances in treatment. Fundamental and Clinical Pharmacology 19:4, 421-427
CrossRef645
B. DELANEY, K. McCOLL. (2005) Review article: Helicobacter pylori and gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics 22:s1, 32-40
CrossRef646
A. Yanaka, S. Zhang, M. Tauchi, H. Suzuki, T. Shibahara, H. Matsui, A. Nakahara, N. Tanaka, M. Yamamoto. (2005) Role of the nrf-2 gene in protection and repair of gastric mucosa against oxidative stress. InflammoPharmacology 13:1-3, 83-90
CrossRef647
H. Radosz-Komoniewska, T. Bek, J. Jozwiak, G. Martirosian. (2005) Pathogenicity of Helicobacter pylori infection. Clinical Microbiology and Infection 11:8, 602-610
CrossRef648
Michio Kaminishi. (2005) How is it possible to prevent gastric mucosal injury and remnant cancer after distal gastrectomy?. Journal of Gastroenterology 40:6, 661-663
CrossRef649
Hisanori Abe, Kazunari Murakami, Shunzo Satoh, Ryugo Sato, Masaaki Kodama, Tsuyoshi Arita, Toshio Fujioka. (2005) Influence of bile reflux and Helicobacter pylori infection on gastritis in the remnant gastric mucosa after distal gastrectomy. Journal of Gastroenterology 40:6, 563-569
CrossRef650
L. GATTA, A. ZULLO, F. PERNA, C. RICCI, V. DE FRANCESCO, A. TAMPIERI, V. BERNABUCCI, M. CAVINA, C. HASSAN, E. IERARDI, S. MORINI, D. VAIRA. (2005) A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses. Alimentary Pharmacology and Therapeutics 22:1, 45-49
CrossRef651
Emiko Rimbara, Norihisa Noguchi, Tai Yamaguchi, Koji Narui, Takashi Kawai, Masanori Sasatsu. (2005) Development of a Highly Sensitive Method for Detection of Clarithromycin-Resistant Helicobacter pylori from Human Feces. Current Microbiology 51:1, 1-5
CrossRef652
Soojin Park, Marie Yeo, Ju-hyun Jin, Ki-myung Lee, Jae-yeon Jung, Ryowon Choue, Sung Won Cho, Ki-baik Hahm. (2005) Rescue of Helicobacter pylori–Induced Cytotoxicity by Red Ginseng. Digestive Diseases and Sciences 50:7, 1218-1227
CrossRef653
Ja Young Lee, Hak Yang Kim, Kyung Ho Kim, Seong Man Kim, Myoung Kuk Jang, Joon Yong Park, Jin Heon Lee, Jin-Ho Kim, Jae Young Yoo. (2005) Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. Cancer Letters 225:2, 207-214
CrossRef654
B. Germaná, F. Di Mario, L.G. Cavallaro, A.M. Moussa, P. Lecis, S. Liatoupolou, G. Comparato, C. Carloni, G. Bertiato, M. Battiestel, N. Papa, G. Aragona, G.M. Cavestro, V. Iori, R. Merli, S. Bertolini, P. Caruana, A. Franzé. (2005) Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacter pylori antibodies in the management of dyspeptic patients in primary care. Digestive and Liver Disease 37:7, 501-508
CrossRef655
George Stamatis, Ana RanÄiÄ, Marina SokoviÄ, Jelena VukojeviÄ, Panayiotis Kyriazopoulos, Spyros Triantaphyllidis, Spyros Skaltsas, Helen Skaltsa. (2005) In vitro inhibition of Helicobacter pylori by micromycetes. FEMS Immunology & Medical Microbiology 45:1, 71-74
CrossRef656
Yali Gao, Frank Y.H. Lin, Guoqing Hu, Philip M. Sherman, Dongqing Li. (2005) Development of a novel electrokinetically driven microfluidic immunoassay for the detection of Helicobacter pylori. Analytica Chimica Acta 543:1-2, 109-116
CrossRef657
Akiko Shiotani, Hiroyasu Iishi, Noriya Uedo, Mitutaka Kumamoto, Yukinori Nakae, Shingo Ishiguro, Masaharu Tatsuta, David Y. Graham. (2005) Histologic and serum risk markers for noncardia early gastric cancer. International Journal of Cancer 115:3, 463-469
CrossRef658
Yongliang Zhu, Xian Zhong, Shu Zheng, Qin Du, Weizhen Xu. (2005) Transformed immortalized gastric epithelial cells by virulence factor CagA of Helicobacter pylori through Erk mitogen-activated protein kinase pathway. Oncogene 24:24, 3886-3895
CrossRef659
Ralf Kiesslich, Martin Goetz, Juergen Burg, Manfred Stolte, Ekkehard Siegel, Markus J. Maeurer, Steven Thomas, Dennis Strand, Peter R. Galle, Markus F. Neurath. (2005) Diagnosing Helicobacter pylori In Vivo by Confocal Laser Endoscopy. Gastroenterology 128:7, 2119-2123
CrossRef660
Shigeo Takaishi, Guanglin Cui, Dana M. Frederick, Jane E. Carlson, JeanMarie Houghton, Andrea Varro, Graham J. Dockray, Zhongming Ge, Mark T. Whary, Arlin B. Rogers, James G. Fox, Timothy C. Wang. (2005) Synergistic Inhibitory Effects of Gastrin and Histamine Receptor Antagonists on Helicobacter-Induced Gastric Cancer. Gastroenterology 128:7, 1965-1983
CrossRef661
Mina Booka, Masumi Okuda, Kouichirou Shin, Eikichi Miyashiro, Hiroko Hayashi, Koji Yamauchi, Yoshitaka Tamura, Norishige Yoshikawa. (2005) Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Analysis of Clarithromycin-Resistant Helicobacter pylori Infection in Children Using Stool Sample. Helicobacter 10:3, 205-213
CrossRef662
A. Zullo, L. Gatta, V. De Francesco, C. Hassan, C. Ricci, V. Bernabucci, M. Cavina, E. Ierardi, S. Morini, D. Vaira. (2005) High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study. Alimentary Pharmacology and Therapeutics 21:12, 1419-1424
CrossRef663
Tomohiko Shimatani, Masaki Inoue, Keiko Iwamoto, Hideyuki Hyogo, Michiya Yokozaki, Toshinari Saeki, Susumu Tazuma, Yoko Horikawa, Nobue Harada. (2005) Gastric Acidity in Patients with Follicular Gastritis is Significantly Reduced, but Can be Normalized After Eradication for Helicobacter pylori. Helicobacter 10:3, 256-265
CrossRef664
MASAAKI KODAMA, TOSHIO FUJIOKA, KAZUNARI MURAKAMI, TADAYOSHI OKIMOTO, RYUGO SATO, KOICHIRO WATANABE, MASARU NASU. (2005) Eradication of Helicobacter pylori reduced the immunohistochemical detection of p53 and MDM2 in gastric mucosa. Journal of Gastroenterology and Hepatology 20:6, 941-946
CrossRef665
Hidekazu Suzuki, Yuriko Minegishi, Yohei Nomoto, Takayuki Ota, Tatsuhiro Masaoka, Gijs R van den Brink, Toshifumi Hibi. (2005) Down-regulation of a morphogen (sonic hedgehog) gradient in the gastric epithelium ofHelicobacter pylori-infected Mongolian gerbils. The Journal of Pathology 206:2, 186-197
CrossRef666
Shiho Yamazaki, Shunji Kato, Norio Matsukura, Masahiro Ohtani, Yoshiyuki Ito, Hiroyuki Suto, Yukinao Yamazaki, Akiyo Yamakawa, Shinkan Tokudome, Hideaki Higashi, Masanori Hatakeyama, Takeshi Azuma. (2005) Identification of Helicobacter pylori and the cagA genotype in gastric biopsies using highly sensitive real-time PCR as a new diagnostic tool. FEMS Immunology & Medical Microbiology 44:3, 261-268
CrossRef667
E. A. Ott, L. E. Mazzoleni, M. I. Edelweiss, G. B. Sander, A. C. Wortmann, A. L. Theil, G. Somm, A. Cartell, L. F. Rivero, D. M. Uchoa, C. F. Francesconi, J. C. Prolla. (2005) Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial. Alimentary Pharmacology and Therapeutics 21:10, 1231-1239
CrossRef668
JeanMarie Houghton, Timothy C. Wang. (2005) Helicobacter pylori and Gastric Cancer: A New Paradigm For Inflammation-Associated Epithelial Cancers. Gastroenterology 128:6, 1567-1578
CrossRef669
Helen A. Papadaki, Charalambos Pontikoglou, Emily Stavroulaki, George Minadakis, Dimitrios A. Eliopoulos, Katerina Pyrovolaki, Panagiotis Skordilis, George D. Eliopoulos. (2005) High prevalence of Helicobacter pylori infection and monoclonal gammopathy of undetermined significance in patients with chronic idiopathic neutropenia. Annals of Hematology 84:5, 317-320
CrossRef670
T. Kamada, J. Hata, K. Sugiu, H. Kusunoki, M. Ito, S. Tanaka, K. Inoue, Y. Kawamura, K. Chayama, K. Haruma. (2005) Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan. Alimentary Pharmacology and Therapeutics 21:9, 1121-1126
CrossRef671
Susumu Take, Motowo Mizuno, Kuniharu Ishiki, Yasuhiro Nagahara, Tomowo Yoshida, Kenji Yokota, Keiji Oguma, Hiroyuki Okada, Yasushi Shiratori. (2005) The Effect of Eradicating Helicobacter Pylori on the Development of Gastric Cancer in Patients with Peptic Ulcer Disease. The American Journal of Gastroenterology 100:5, 1037-1042
CrossRef672
Keisuke Kubota, Nobuyuki Shimizu, Koji Nozaki, Yutarou Takeshita, Tetsuya Ueda, Kazuhiro Imamura, Naoki Hiki, Hirokazu Yamaguchi, Shouji Shimoyama, Ken-Ichi Mafune, Michio Kaminishi. (2005) Efficacy of Triple Therapy Plus Cetraxate for the Helicobacter pylori Eradication in Partial Gastrectomy Patients. Digestive Diseases and Sciences 50:5, 842-846
CrossRef673
John Lynch, George Davey Smith. (2005) A LIFE COURSE APPROACH TO CHRONIC DISEASE EPIDEMIOLOGY. Annual Review of Public Health 26:1, 1-35
CrossRef674
E. Rimbara, N. Noguchi, M. Tanabe, T. Kawai, Y. Matsumoto, M. Sasatsu. (2005) Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995-2001. Clinical Microbiology and Infection 11:4, 307-311
CrossRef675
N. Schmidt, U. Peitz, H. Lippert, P. Malfertheiner. (2005) Missing gastric cancer in dyspepsia. Alimentary Pharmacology and Therapeutics 21:7, 813-820
CrossRef676
Alistair J. Lax. (2005) Opinion: Bacterial toxins and cancer — a case to answer?. Nature Reviews Microbiology 3:4, 343-349
CrossRef677
Mae F. Go. (2005) Diagnosis and treatment of Helicobacter pylori. Current Treatment Options in Gastroenterology 8:2, 163-174
CrossRef678
D.A. Vattem, Y.-T. Lin, R. Ghaedian, K. Shetty. (2005) Cranberry synergies for dietary management of Helicobacter pylori infections. Process Biochemistry 40:5, 1583-1592
CrossRef679
Masae Tatematsu, Tetsuya Tsukamoto, Tsutomu Mizoshita. (2005) Role of Helicobacter pylori in Gastric Carcinogenesis: The Origin of Gastric Cancers and Heterotopic Proliferative Glands in Mongolian Gerbils. Helicobacter 10:2, 97-106
CrossRef680
Hong Lu, Ping-I. Hsu, David Y. Graham, Yoshio Yamaoka. (2005) Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 128:4, 833-848
CrossRef681
B. C. Y. WONG. (2005) Managing dyspepsia in regions with a high risk of gastric cancer. Alimentary Pharmacology and Therapeutics 21:s1, 19-20
CrossRef682
Barry J. Marshall, Helen M. Windsor. (2005) The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentation, treatment, and prevention. Medical Clinics of North America 89:2, 313-344
CrossRef683
NASRIN ZENDEHDEL, SIAVOSH NASSERI-MOGHADDAM, REZA MALEKZADEH, SADEGH MASSARRAT, MASOUD SOTOUDEH, FARIDEH SIAVOSHI. (2005) Helicobacter pylori reinfection rate 3 years after successful eradication. Journal of Gastroenterology and Hepatology 20:3, 401-404
CrossRef684
Koji Nozaki, Harunari Tanaka, Yuzuru Ikehara, Xueyuan Cao, Hayao Nakanishi, Takeshi Azuma, Shiho Yamazaki, Yoshio Yamaoka, Nobuyuki Shimizu, Ken-ichi Mafune, Michio Kaminishi, Masae Tatematsu. (2005) Helicobacter pylori-dependent NF-kappa B activation in newly established Mongolian gerbil gastric cancer cell lines. Cancer Science 96:3, 170-175
CrossRef685
G. Manes, O. Pieramico, F. Perri, D. Vaira, N. Giardullo, M. Romano, G. Nardone, A. Balzano. (2005) Twice-Daily Standard Dose of Omeprazole Achieves the Necessary Level of Acid Inhibition for Helicobacter pylori Eradication. A Randomized Controlled Trial Using Standard and Double Doses of Omeprazole in Triple Therapy. Digestive Diseases and Sciences 50:3, 443-448
CrossRef686
M. Ito, S. Tanaka, S. Takata, S. Oka, S. Imagawa, H. Ueda, Y. Egi, Y. Kitadai, W. Yasui, M. Yoshihara, K. Haruma, K. Chayama. (2005) Morphological changes in human gastric tumours after eradication therapy of Helicobacter pylori in a short-term follow-up. Alimentary Pharmacology and Therapeutics 21:5, 559-566
CrossRef687
Yi-Qian Sun, Ilze Girgensone, Per Leanderson, Fredrik Petersson, Kurt Borch. (2005) Effects of Antioxidant Vitamin Supplements on Helicobacter pylori-induced Gastritis in Mongolian Gerbils. Helicobacter 10:1, 33-42
CrossRef688
Steven F Moss, Martin J Blaser. (2005) Mechanisms of Disease: inflammation and the origins of cancer. Nature Clinical Practice Oncology 2:2, 90-97
CrossRef689
Sachiko Nomura, Hidekazu Suzuki, Tatsuhiro Masaoka, Kumiko Kurabayashi, Hiromasa Ishii, Masaki Kitajima, Kikuo Nomoto, Toshifumi Hibi. (2005) Effect of Dietary Anti-Urease Immunoglobulin Y on Helicobacter pylori Infection in Mongolian Gerbils. Helicobacter 10:1, 43-52
CrossRef690
Enrique Quintero, Ma. Angeles Pizarro, Luis Rodrigo, Josep M. Pique, Angel Lanas, Julio Ponce, Gonzalo Mino, Javier Gisbert, Aurora Jurado, Ma. Jose Herrero, Alejandro Jimenez, Julio Torrado, Ana Ponte, Francisco Diaz-de-Rojas, Eduardo Salido. (2005) Association of Helicobacter pylori-related Distal Gastric Cancer with the HLA Class II Gene DQB1*0602 and cagA+ Strains in a Southern European Population. Helicobacter 10:1, 12-21
CrossRef691
A. Seoane, X. Bessa, B. Balleste, E. O’callaghan, A. Panadès, F. Alameda, S. Navarro, M. Gallén, M. Andreu, F. Bory. (2005) Helicobacter pylori y cáncer gástrico: relación entre el subtipo histológico y la localización del tumor. Gastroenterología y Hepatología 28:2, 60-64
CrossRef692
Mark S. Pearce, James G. Steele, David I. Campbell, Julian E. Thomas. (2005) Tooth Loss and Helicobacter pylori Seropositivity: the Newcastle Thousand Families Cohort Study at Age 49-51 Years. Helicobacter 10:1, 90-94
CrossRef693
Luis A. Herrera, Luis Ben
CrossRef694
Gerhard Faller, Thomas Kirchner. (2005) Immunological and morphogenic basis of gastric mucosa atrophy and metaplasia. Virchows Archiv 446:1, 1-9
CrossRef695
Nagamitsu Iso, Takeshi Matsuhisa, Kazuo Shimizu. (2005) Helicobacter pylori Infection among Patients Visiting a Clinic in Kasama City, Ibaraki Prefecture. Journal of Nippon Medical School 72:6, 341-354
CrossRef696
Carmelo Scarpignato, Iva Pelosini. (2005) Rifaximin, a Poorly Absorbed Antibiotic: Pharmacology and Clinical Potential. Chemotherapy 51:1, 36-66
CrossRef697
Mikio Karita, Satoshi Teramukai, Satoru Matsumoto, Hidemi Shibuta. (2005) Intracellular VacA Is a Valuable Marker to Predict Whether Helicobacter pylori Induces Progressive Atrophic Gastritis That Is Associated with the Development of Gastric Cancer. Digestive Diseases and Sciences 50:1, 56-64
CrossRef698
X. Calvet. (2005) Tratamiento erradicador de Helicobacter pylori en la enfermedad no ulcerosa. Gastroenterología y Hepatología 28:1, 40-46
CrossRef699
Zhannat Z. Nurgalieva, David Y. Graham, Kristina R. Dahlstrom, Qingyi Wei, Erich M. Sturgis. (2005) A pilot study ofHelicobacter pylori infection and risk of laryngopharyngeal cancer. Head & Neck 27:1, 22-27
CrossRef700
Yuji Naito, Toshikazu Yoshikawa. (2005) Carcinogenesis and Chemoprevention in Gastric Cancer Associated with Helicobacter pylori Infection: Role of Oxidants and Antioxidants. Journal of Clinical Biochemistry and Nutrition 36:2, 37-49
CrossRef701
D. A. Vattem, Y.-T. Lin, K. Shetty. (2005) Enrichment of Phenolic Antioxidants and Anti- Helicobacter pylori Properties of Cranberry Pomace by Solid-State Bioprocessing. Food Biotechnology 19:1, 51-68
CrossRef702
Hironori Mutoh, Nobuyuki Hamajima, Kazuo Tajima, Takeshi Kobayashi, Hiroyuki Honda. (2005) Exhaustive exploring using Artificial Neural Network for identification of SNPs combination related to Helicobacter pylori infection susceptibility. Chem-Bio Informatics Journal 5:2, 15-26
CrossRef703
Patrick McCue, Yuan-Tong Lin, Ronald G. Labbe, Kalidas Shetty. (2005) Sprouting and Solid-State Bioprocessing by Rhizopus oligosporus Increase the In Vitro Antibacterial Activity of Aqueous Soybean Extracts Against Helicobacter pylori. Food Biotechnology 18:2, 229-249
CrossRef704
Mathijs P. Bergman, Christina M. J. E. Vandenbroucke-Grauls, Ben J. Appelmelk, Mario M. D'Elios, Amedeo Amedei, Annalisa Azzurri, Marisa Benagiano, Gianfranco Del Prete. (2005) The Story So Far: Helicobacter Pylori and Gastric Autoimmunity. International Reviews of Immunology 24:1-2, 63-91
CrossRef705
Yuji Naito, Masanori Ito, Toshio Watanabe, Hidekazu Suzuki. (2005) Biomarkers in Patients with Gastric Inflammation: A Systematic Review. Digestion 72:2-3, 164-180
CrossRef706
Mario Milco D’Elios, Mathijs P. Bergman, Amedeo Amedei, Ben J. Appelmelk, Gianfranco Del Prete. (2004) Helicobacter pylori and gastric autoimmunity. Microbes and Infection 6:15, 1395-1401
CrossRef707
Eduardo L. Franco, Pelayo Correa, Regina M. Santella, Xifeng Wu, Steven N. Goodman, Gloria M. Petersen. (2004) Role and limitations of epidemiology in establishing a causal association. Seminars in Cancer Biology 14:6, 413-426
CrossRef708
Ping-I Hsu, Chin-Ni Li, Hui-Hwa Tseng, Kwok-Hung Lai, Ping-Ning Hsu, Gin-Ho Lo, Ching-Chu Lo, Jeng-Jung Yeh, Luo-Ping Ger, Michael Hsiao, Yoshio Yamaoka, Il-Ran Hwang, Angela Chen. (2004) The Interleukin-1 RN Polymorphism and Helicobacter pylori Infection in the Development of Duodenal Ulcer. Helicobacter 9:6, 605-613
CrossRef709
Thais Lopez, Mariela Quesada, Jaume Almirall, Isabel Sanfeliu, Ferran Segura, Xavier Calvet. (2004) Usefulness of Non-invasive Tests for Diagnosing Helicobacter pylori Infection in Patients Undergoing Dialysis for Chronic Renal Failure. Helicobacter 9:6, 674-680
CrossRef710
Anthony P. Moran, Bethlehem Shiberu, John A. Ferris, Yuriy A. Knirel, Sof'ya N. Senchenkova, Andreij V. Perepelov, Per-Erik Jansson, Joanna B. Goldberg. (2004) Role of Helicobacter pylori rfaJ genes (HP0159 and HP1416) in lipopolysaccharide synthesis. FEMS Microbiology Letters 241:1, 57-65
CrossRef711
Kee-Myung Lee, Marie Yeo, Jung-Sun Choue, Joo-Hyun Jin, Soo Jin Park, Jae-Youn Cheong, Kwang Jae Lee, Jin-Hong Kim, Ki-Baik Hahm. (2004) Protective Mechanism of Epigallocatechin-3-Gallate against Helicobacter pylori-Induced Gastric Epithelial Cytotoxicity via the Blockage of TLR-4 Signaling. Helicobacter 9:6, 632-642
CrossRef712
J. Pisegna, G. Holtmann, C. W. Howden, P. H. Katelaris, P. Sharma, S Spechler, G. Triadafilopoulos, G. Tytgat. (2004) Review article: oesophageal complications and consequences of persistent gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics 20:s9, 47-56
CrossRef713
Philip A. Beachy, Sunil S. Karhadkar, David M. Berman. (2004) Tissue repair and stem cell renewal in carcinogenesis. Nature 432:7015, 324-331
CrossRef714
Atsushi Tatsuguchi, Kazumasa Miyake, Katya Gudis, Seiji Futagami, Taku Tsukui, Ken Wada, Teruyuki Kishida, Yuh Fukuda, Yuichi Sugisaki, Choitsu Sakamoto. (2004) Effect of Helicobacter pylori Infection on Ghrelin Expression in Human Gastric Mucosa. The American Journal of Gastroenterology 99:11, 2121-2127
CrossRef715
Nóra Gyémánt, Annamária Molnár, Gabriella Spengler, Yvette Mándi, Margit Szabó, J. Molnár. (2004) Bacterial Models for Tumor Development. Acta Microbiologica et Immunologica Hungarica 51:3, 321-332
CrossRef716
Suzana Fichman, Yaron Niv. (2004) Histological changes in the gastric mucosa after Helicobacter pylori eradication. European Journal of Gastroenterology & Hepatology 16:11, 1183-1188
CrossRef717
Xueyuan Cao, Tetsuya Tsukamoto, Koji Nozaki, Nobuyuki Shimizu, Tsutomu Mizoshita, Toshiko Kumagai, Michio Kaminishi, Masae Tatematsu. (2004) Eradication of Helicobacter pylori induces apoptosis and inhibits proliferation of heterotopic proliferative glands in infected Mongolian gerbils. Cancer Science 95:11, 872-877
CrossRef718
B. Hino, R. Eliakim, A. Levine, H. Sprecher, D. Berkowitz, C. Hartman, O. Eshach-Adiv, Raanan Shamir. (2004) Comparison of Invasive and Non-Invasive Tests Diagnosis and Monitoring of Helicobacter Pylori Infection in Children. Journal of Pediatric Gastroenterology and Nutrition 39:5, 519-523
CrossRef719
Jie Yang, Zhibin Hu, Yaochu Xu, Jin Shen, Juyin Niu, Xu Hu, Jiantao Guo, Qingyi Wei, Xinru Wang, Hongbing Shen. (2004) Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population. Cancer Letters 215:2, 191-198
CrossRef720
Ian L.P. Beales. (2004) Gastrin and interleukin-1β stimulate growth factor secretion from cultured rabbit gastric parietal cells. Life Sciences 75:25, 2983-2995
CrossRef721
Shinya Toyokuni. 2004. Helicobacter pylori and Gastric Cancer. .
CrossRef722
Fuminao Takeshima, Masaki Kunisaki, Tomoyuki Aritomi, Masayuki Osabe, Fumitaka Akama, Tomonori Nakasone, Daisuke Niino, Sayaka Katayama, Hajime Isomoto, Katsuhisa Omagari, Yohei Mizuta, Ikuo Murata, Shigeru Kohno. (2004) Hepatic Mucosa-Associated Lymphoid Tissue Lymphoma and Hepatocellular Carcinoma in a Patient With Hepatitis B Virus Infection. Journal of Clinical Gastroenterology 38:9, 823-826
CrossRef723
Seong-Gene Lee, Byungsik Kim, Jung-Hwan Yook, Sung-Tae Oh, Inchul Lee, Kyuyoung Song. (2004) TNF/LTA polymorphisms and risk for gastric cancer/duodenal ulcer in the Korean population. Cytokine 28:2, 75-82
CrossRef724
Calin Stoicov, Reza Saffari, Xun Cai, Chhaya Hasyagar, JeanMarie Houghton. (2004) Molecular biology of gastric cancer: Helicobacter infection and gastric adenocarcinoma: bacterial and host factors responsible for altered growth signaling. Gene 341, 1-17
CrossRef725
Shigeru Hiramoto, Kazuro Itoh, Satomi Shizuuchi, Yasuji Kawachi, Yoshirou Morishita, Masao Nagase, Yoshio Suzuki, Yukio Nobuta, Yuhshi Sudou, Osamu Nakamura, Imae Kagaya, Hideo Goshima, Yoshikatsu Kodama, Faustino C. Icatro, Wasaburo Koizumi, Katsunori Saigenji, Soichiro Miura, Toshiro Sugiyama, Nobutake Kimura. (2004) Melanoidin, a Food Protein-Derived Advanced Maillard Reaction Product, Suppresses Helicobacter pylori in vitro and in vivo. Helicobacter 9:5, 429-435
CrossRef726
Angelo Zullo, Cesare Hassan, Salvatore MA Campo, Sergio Morini. (2004) Evolving therapy for Helicobacter pylori infection. Expert Opinion on Therapeutic Patents 14:10, 1453-1464
CrossRef727
Takafumi Ando, Tomoyuki Tsuzuki, Tomokazu Mizuno, Masaaki Minami, Kenji Ina, Kazuo Kusugami, Junki Takamatsu, Kouichi Adachi, Emad El-Omar, Michio Ohta, Hidemi Goto. (2004) Characteristics of Helicobacter pylori -Induced Gastritis and the Effect of H. pylori Eradication in Patients with Chronic Idiopathic Thrombocytopenic Purpura. Helicobacter 9:5, 443-452
CrossRef728
Satoshi Matsubara, Hideyuki Shibata, Mami Takahashi, Fumiyasu Ishikawa, Teruo Yokokura, Takashi Sugimura, Keiji Wakabayashi. (2004) Cloning of Mongolian gerbil cDNAs encoding inflammatory proteins, and their expression in glandular stomach during H. pylori infection. Cancer Science 95:10, 798-802
CrossRef729
Yao-Jong Yang, Jiunn-Jong Wu, Bor-Shyang Sheu, Ai-Wen Kao, Ay-Huey Huang. (2004) The rdxA Gene Plays A More Major Role Than frxA Gene Mutation in High-level Metronidazole Resistance of Helicobacter pylori in Taiwan. Helicobacter 9:5, 400-407
CrossRef730
N. J. Talley. (2004) Review article: gastro-oesophageal reflux disease - how wide is its span?. Alimentary Pharmacology and Therapeutics 20:s5, 27-37
CrossRef731
Chiara Ricci, Nimish Vakil, Massimo Rugge, Luigi Gatta, Federico Perna, John F. Osborn, Valentina M. Russo, Andrea Tampieri, Veronica Bernabucci, Mario Miglioli, Dino Vaira. (2004) Serological Markers for Gastric Atrophy in Asymptomatic Patients Infected with Helicobacter pylori. The American Journal of Gastroenterology 99:10, 1910-1915
CrossRef732
Peter C. Konturek, Stanislaw J. Konturek, Wladyslaw Ochmański. (2004) Neuroendocrinology of gastric H+ and duodenal HCO3− secretion: the role of brain–gut axis. European Journal of Pharmacology 499:1-2, 15-27
CrossRef733
Masanori Hatakeyama. (2004) Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nature Reviews Cancer 4:9, 688-694
CrossRef734
R. A. Wallace, P. J. Schluter, M. Duff, H. Ouellette-Kuntz, P. M. Webb, M. Scheepers. (2004) A Review of the Risk Factors for, Consequences, Diagnosis, and Management of Helicobacter pylori in Adults with Intellectual Disabilities. Journal of Policy and Practice in Intellectual Disabilities 1:3-4, 147-163
CrossRef735
HIROYA NAKATA, HIDEKAZU ITOH, TADASHI ISHIGUCHI, TAKUYA IWATA, HIROAKI SATO, YUJI HIGASHIMOTO, HISASHI FUJIMOTO, MASAO ICHINOSE. (2004) Immunological rapid urease test using monoclonal antibody for Helicobacter pylori. Journal of Gastroenterology and Hepatology 19:9, 970-974
CrossRef736
Song-Ze Ding, Ann M. O’Hara, Tim L. Denning, Bernadette Dirden-Kramer, Randy C. Mifflin, Victor E. Reyes, Kieran A. Ryan, Susan N. Elliott, Tadahide Izumi, Istvan Boldogh, Sankar Mitra, Peter B. Ernst, Sheila E. Crowe. (2004) Helicobacter pylori and H2O2 increase AP endonuclease-1/redox factor-1 expression in human gastric epithelial cells. Gastroenterology 127:3, 845-858
CrossRef737
Yoshiko Nakayama, David Y Graham. (2004) Helicobacter pylori infection: diagnosis and treatment. Expert Review of Anti-infective Therapy 2:4, 599-610
CrossRef738
E.J Kuipers, P.D Siersema. (2004) The aetiology and clinical relevance of gastric intestinal metaplasia. Digestive and Liver Disease 36:8, 501-504
CrossRef739
Satoshi Tanida, Takashi Joh, Keisuke Itoh, Hiromi Kataoka, Makoto Sasaki, Hirotaka Ohara, Takahiro Nakazawa, Tomoyuki Nomura, Yumi Kinugasa, Hiroshi Ohmoto, Hiroshi Ishiguro, Kohichiro Yoshino, Shigeki Higashiyama, Makoto Itoh. (2004) The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cells. Gastroenterology 127:2, 559-569
CrossRef740
Y. Tindberg, T. H. Casswall, M. Blennow, C. Bengtsson, M. Granstrom, M. Sorberg. (2004) Helicobacter pylori eradication in children and adolescents by a once daily 6-day treatment with or without a proton pump inhibitor in a double-blind randomized trial. Alimentary Pharmacology and Therapeutics 20:3, 295-302
CrossRef741
G. Nardone, A. Rocco, P. Malfertheiner. (2004) Helicobacter pylori and molecular events in precancerous gastric lesions. Alimentary Pharmacology and Therapeutics 20:3, 261-270
CrossRef742
H. Suzuki, S. Nomura, T. Masaoka, H. Goshima, N. Kamata, Y. Kodama, H. Ishii, M. Kitajima, K. Nomoto, T. Hibi. (2004) Effect of dietary anti-Helicobacter pylori-urease immunoglobulin Y on Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics 20:s1, 185-192
CrossRef743
X. Calvet, M. Quesada, I. Sanfeliu, F. Salceda, M. Roselló, A. Montserrat, E. Brullet, F. Segura. (2004) Diagnosis of Helicobacter pylori infection in dyspeptic patients by stool antigen detection. Digestive and Liver Disease 36:7, 450-454
CrossRef744
R. M. Genta. (2004) Screening for gastric cancer: does it make sense?. Alimentary Pharmacology and Therapeutics 20:s2, 42-47
CrossRef745
Mei-Ju Chen, Deng-Chyang Wu, Ying-Chin Ko, Yuan-Yow Chiou. (2004) Personal History and Family History as a Predictor of Gastric Cardiac Adenocarcinoma Risk: A Case-Control Study in Taiwan. The American Journal of Gastroenterology 99:7, 1250-1257
CrossRef746
H. Murata, S. Tsuji, M. Tsujii, H. Y. Fu, H. Tanimura, M. Tsujimoto, N. Matsuura, S. Kawano, M. Hori. (2004) Helicobacter bilis infection in biliary tract cancer. Alimentary Pharmacology and Therapeutics 20:s1, 90-94
CrossRef747
S. Kato, N. Matsukura, A. Togashi, G. Masuda, N. Matsuda, N. Yamada, Z. Naito, T. Matsuhisa, T. Tajiri. (2004) Sex differences in mucosal response to Helicobacter pylori infection in the stomach and variations in interleukin-8, COX-2 and trefoil factor family 1 gene expression. Alimentary Pharmacology and Therapeutics 20:s1, 17-24
CrossRef748
M. Suzuki, H. Suzuki, T. Masaoka, S. Tanaka, K. Suzuki, H. Ishii. (2004) Helicobacter pylori eradication treatment modulates epithelial cell proliferation and tissue content of hepatocyte growth factor in the gastric mucosa. Alimentary Pharmacology and Therapeutics 20:s1, 158-164
CrossRef749
F. Kaneko, H. Suzuki, N. Hasegawa, K. Kurabayshi, H. Saito, S. Otani, H. Nakamizo, K. Kawata, M. Miyairi, K. Ishii, H. Ishii. (2004) High prevalence rate of Helicobacter pylori resistance to clarithromycin during long-term multiple antibiotic therapy for chronic respiratory disease caused by non-tuberculous mycobacteria. Alimentary Pharmacology and Therapeutics 20:s1, 62-67
CrossRef750
N. Matsukura, T. Tajiri, S. Kato, A. Togashi, G. Masuda, A. Tokunaga, N. Yamada. (2004) Diagnostic value of culture, histology and PCR for Helicobacter pylori in the remnant stomach after surgery. Alimentary Pharmacology and Therapeutics 20:s1, 33-38
CrossRef751
T. Masaoka, H. Suzuki, A. G. Kamiya, H. Ishii. (2004) Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis. Alimentary Pharmacology and Therapeutics 20:s1, 68-73
CrossRef752
A. Chen, C.-N. Li, P.-I. Hsu, K.-H. Lai, H.-H. Tseng, P.-N. Hsu, G.-H. Lo, C.-C. Lo, C.-K. Lin, I.-R. Hwang, Y. Yamaoka, H.-C. Chen. (2004) Risks of interleukin-1 genetic polymorphisms and Helicobacter pylori infection in the development of gastric cancer. Alimentary Pharmacology and Therapeutics 20:2, 203-211
CrossRef753
S. Nakajima, T. Hattori. (2004) Oesophageal adenocarcinoma or gastric cancer with or without eradication of Helicobacter pylori infection in chronic atrophic gastritis patients: a hypothetical opinion from a systematic review. Alimentary Pharmacology and Therapeutics 20:s1, 54-61
CrossRef754
Itaru Ohyama, Naoki Ohmiya, Yasumasa Niwa, Kennosuke Shirai, Ayumu Taguchi, Akihiro Itoh, Yoshiki Hirooka, Kenji Wakai, Nobuyuki Hamajima, Naoyoshi Mori, Hidemi Goto. (2004) The association between tumour necrosis factor-α gene polymorphism and the susceptibility to rugal hyperplastic gastritis and gastric carcinoma. European Journal of Gastroenterology & Hepatology 16:7, 693-700
CrossRef755
Mario M. D'Elios, Ben J. Appelmelk, Amedeo Amedei, Mathijs P. Bergman, Gianfranco Del Prete. (2004) Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry. Trends in Molecular Medicine 10:7, 316-323
CrossRef756
M. Kato, M. Asaka, Y. Shimizu, A. Nobuta, H. Takeda, T. Sugiyama, . (2004) Relationship between Helicobacter pylori infection and the prevalence, site and histological type of gastric cancer. Alimentary Pharmacology and Therapeutics 20:s1, 85-89
CrossRef757
Ahmad Aly, Arthur Shulkes, Graham S Baldwin. (2004) Gastrins, cholecystokinins and gastrointestinal cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1704:1, 1-10
CrossRef758
Soojin Park, Won Seok Kim, Un Jung Choi, Sang Uk Han, Yong Seok Kim, Young Bae Kim, Myung Hee Chung, Ki-Tak Nam, Dae Yong Kim, Sung Won Cho, Ki-Baik Hahm. (2004) Amelioration of Oxidative Stress with Ensuing Inflammation Contributes to Chemoprevention of H. pylori -Associated Gastric Carcinogenesis. Antioxidants & Redox Signaling 6:3, 549-560
CrossRef759
H. Kai, M. Ito, Y. Kitadai, S. Tanaka, K. Haruma, K. Chayama. (2004) Chronic gastritis with expression of inducible nitric oxide synthase is associated with high expression of interleukin-6 and hypergastrinaemia. Alimentary Pharmacology and Therapeutics 19:12, 1309-1314
CrossRef760
Brendan Drumm, Andrew S. Day, Ben Gold, Frederic Gottrand, Seiichi Kato, Elisabete Kawakami, Armando Madrazo, John Snyder, Julian Thomas. (2004) Helicobacter pylori and Peptic Ulcer: Working Group Report of the Second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. Journal of Pediatric Gastroenterology and Nutrition 39, S626-S631
CrossRef761
T.-U. Wheeldon, M. Granstrom, T. T. H. Hoang, D. C. Phuncarg, L. E. Nilsson, M. Sorberg. (2004) The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication. Alimentary Pharmacology and Therapeutics 19:12, 1315-1321
CrossRef762
Maria Held, Lars Engstrand, Lars-Erik Hansson, Reinhold Bergstrom, Torkel Wadstrom, Olof Nyren. (2004) Is the Association Between Helicobacter pylori and Gastric Cancer Confined to CagA-Positive Strains?. Helicobacter 9:3, 271-277
CrossRef763
Yi-Qian Sun, Johan D. Soderholm, Fredrik Petersson, Kurt Borch. (2004) Long-Standing Gastric Mucosal Barrier Dysfunction in Helicobacter pylori-Induced Gastritis in Mongolian Gerbils. Helicobacter 9:3, 217-227
CrossRef764
V. De Francesco, N. Della Valle, V. Stoppino, A. Amoruso, N. Muscatiello, C. Panella, E. Ierardi. (2004) Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia. Alimentary Pharmacology and Therapeutics 19:9, 993-998
CrossRef765
V. De Francesco, A. Zullo, C. Hassan, N.Della Valle, L. Pietrini, M.F. Minenna, S. Winn, R. Monno, V. Stoppino, S. Morini, C. Panella, E. Ierardi. (2004) The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study. Digestive and Liver Disease 36:5, 322-326
CrossRef766
A. Shiotani, H. Iishi, M. Kumamoto, Y. Nakae. (2004) Helicobacter pylori infection and increased nitrite synthesis in the stomach. Digestive and Liver Disease 36:5, 327-332
CrossRef767
Elisabet Carlsohn, Jonas Ångström, Mark R Emmett, Alan G Marshall, Carol L Nilsson. (2004) Chemical cross-linking of the urease complex from Helicobacter pylori and analysis by Fourier transform ion cyclotron resonance mass spectrometry and molecular modeling. International Journal of Mass Spectrometry 234:1-3, 137-144
CrossRef768
Ian M. Joseph, Denise Kirschner. (2004) A model for the study of Helicobacter pylori interaction with human gastric acid secretion. Journal of Theoretical Biology 228:1, 55-80
CrossRef769
Masashi Yamori, Masaru Yoshida, Tomohiro Watanabe, Yasuhiko Shirai, Tadahiko Iizuka, Toru Kita, Yoshio Wakatsuki. (2004) Antigenic activation of Th1 cells in the gastric mucosa enhances dysregulated apoptosis and turnover of the epithelial cells. Biochemical and Biophysical Research Communications 316:4, 1015-1021
CrossRef770
Takashi Kawai, Kohei Kawakami, Taku Kudo, Kazuo Takei, Fuminori Moriyasu, Yuu Takagi, Tatsuya Aoki, Yasuhisa Koyanagi, Hiromi Serizawa, Emiko Rinbara, Masahisa Noguchi, Masanori Sasatsu. (2004) Correlation between serum pepsinogen levels and gastric mucosal histological findings before and after Helicobacter pylori eradication therapy. Digestive Endoscopy 16:2, 122-128
CrossRef771
Kazumasa Miyake, Taku Tsukui, Yoko Shinji, Kei Shinoki, Tetsuro Hiratsuka, Hitoshi Nishigaki, Seiji Futagami, Ken Wada, Katya Gudis, Katsuhiko Iwakiri, Nobutaka Yamada, Choitsu Sakamoto. (2004) Teprenone, but not H2-Receptor Blocker or Sucralfate, Suppresses Corpus Helicobacter pylori Colonization and Gastritis in Humans: Teprenone Inhibition of H. pylori-Induced Interleukin-8 in MKN28 Gastric Epithelial Cell Lines. Helicobacter 9:2, 130-137
CrossRef772
S Kim, K Haruma, M Ito, S Tanaka, M Yoshihara, K Chayama. (2004) Magnifying gastroendoscopy for diagnosis of histologic gastritis in the gastric antrum. Digestive and Liver Disease 36:4, 286-291
CrossRef773
Md. Badruzzaman, Hidetaka Matsui, Sk. Md. Fazle Akbar, Bunzo Matsuura, Morikazu Onji. (2004) Mechanism of Action of Low Recurrence of Gastritis Caused by Helicobacter pylori with the Type II Urease B Gene. Helicobacter 9:2, 173-180
CrossRef774
D. M. Pritchard, S. M. C. Przemeck. (2004) How useful are the rodent animal models of gastric adenocarcinoma?. Alimentary Pharmacology and Therapeutics 19:8, 841-859
CrossRef775
Hiroshi Ohata, Shintaro Kitauchi, Noriko Yoshimura, Kouichi Mugitani, Masataka Iwane, Hideya Nakamura, Akiyoshi Yoshikawa, Kimihiko Yanaoka, Kenji Arii, Hideyuki Tamai, Yasuhito Shimizu, Tatsuya Takeshita, Osamu Mohara, Masao Ichinose. (2004) Progression of chronic atrophic gastritis associated withHelicobacter pylori infection increases risk of gastric cancer. International Journal of Cancer 109:1, 138-143
CrossRef776
Cigdem Arikan, Funda ??zgen??, G??khan T??mg??r, Basak Doganavsargil, Sema Aydo??du, Ra??it Vural Ya??ci. (2004) Favorable Long-term Outcome After Isolated Liver Transplantation in a Child With Short Bowel Syndrome. Journal of Pediatric Gastroenterology and Nutrition 38:3, 361-362
CrossRef777
Takahisa Furuta, Naohito Shirai, Mitsushige Sugimoto, Kyoichi Ohashi, Takashi Ishizaki. (2004) Pharmacogenomics of proton pump inhibitors. Pharmacogenomics 5:2, 181-202
CrossRef778
J.M. Piqué Badía. (2004) Relación entre Helicobacter pylori, gastritis crónica y cáncer gástrico. Medicine - Programa de Formación Médica Continuada Acreditado 9:2, 93-99
CrossRef779
TOSHIFUMI OHKUSA, HIROTO Miwa, SHU ENDO, ISAO OKAYASU, NOBUHIRO SATO. (2004) Helicobacter pylori is a fragile bacteria when stored at low and ultra-low temperatures. Journal of Gastroenterology and Hepatology 19:2, 200-204
CrossRef780
D. Forman, D. Y. Graham. (2004) Impact of Helicobacter pylori on society-role for a strategy of 'search and eradicate'. Alimentary Pharmacology and Therapeutics 19:s1, 17-21
CrossRef781
Toshikazu Ushijima, Mitsuru Sasako. (2004) Focus on gastric cancer. Cancer Cell 5:2, 121-125
CrossRef782
Dominique Lamarque. (2004) Certaines associations du polymorphisme génétique des interleukines humaines constituent des facteurs prédisposant à l’adénocarcinome gastrique. Gastroentérologie Clinique et Biologique 28:2, 202-204
CrossRef783
W. M. Wong, K. C. Lai, W. M. Hui, K. F. Lam, J. Q. Huang, W. H. C. Hu, N. Y. H. Wong, C. L. K. Lam, H. H. X. Xia, A. O. O. Chan, S. K. Lam, B. C. Y. Wong. (2004) Double-blind, randomized controlled study to assess the effects of lansoprazole 30 mg and lansoprazole 15 mg on 24-h oesophageal and intragastric pH in Chinese subjects with gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics 19:4, 455-462
CrossRef784
W. D. Chey, P. Moayyedi. (2004) Uninvestigated dyspepsia and non-ulcer dyspepsia-the use of endoscopy and the roles of Helicobacter pylori eradication and antisecretory therapy. Alimentary Pharmacology and Therapeutics 19:s1, 1-8
CrossRef785
A. T. R. Axon. (2004) Personal view: to treat or not to treat? Helicobacter pylori and gastro-oesophageal reflux disease - an alternative hypothesis. Alimentary Pharmacology and Therapeutics 19:3, 253-261
CrossRef786
Samir K. Sinha, Bruce Martin, Benjamin D. Gold, Qunsheng Song, Michael Sargent, Charles N. Bernstein. (2004) The Incidence of Helicobacter pylori Acquisition in Children of a Canadian First Nations Community and the Potential for Parent-to-Child Transmission. Helicobacter 9:1, 59-68
CrossRef787
Alexander Krah, Stephan Miehlke, Klaus-Peter Pleissner, Ursula Zimny-Arndt, Christian Kirsch, Norbert Lehn, Thomas F. Meyer, Peter R. Jungblut, Toni Aebischer. (2004) Identification of candidate antigens for serologic detection ofHelicobacter pylori-infected patients with gastric carcinoma. International Journal of Cancer 108:3, 456-463
CrossRef788
Wai K. Leung, Joseph J.Y. Sung. (2004) Pathogenesis of Pre-Neoplastic Lesions of the Stomach: Targets for Prevention. Digestive Diseases 22:4, 306-312
CrossRef789
Tomoari Kamada, Ken Haruma, Kuniaki Sugiu, Yuichi Nagashima, Dong Mei Qian, Hideki Koga, Masaharu Takeda, Hiroaki Kusunoki, Keisuke Honda, Yoshinori Fujimura, Tsukasa Tsunoda, Yoshito Sadahira. (2004) Case of early gastric cancer with nodular gastritis. Digestive Endoscopy 16:1, 39-43
CrossRef790
Akira Babazono, Motonobu Miyazaki, Hiroshi Une, Eiji Yamamoto, Toshihide Tsuda, Yoshio Mino, Alan L Hillman. (2004) Does Seropositivity for Helicobacter pylori Antibodies Increase Outpatient Costs for Gastric and Duodenal Ulcer or Inflammation?. PharmacoEconomics 22:15, 975-983
CrossRef791
A. Leodolter, M. Naumann, P. Malfertheiner. (2004) Prevention of Gastric Cancer by <i>Helicobacter pylori </i>Eradication. Digestive Diseases 22:4, 313-319
CrossRef792
Gerardo Nardone, Alba Rocco. (2004) Chemoprevention of Gastric Cancer: Role of COX-2 Inhibitors and Other Agents. Digestive Diseases 22:4, 320-326
CrossRef793
Kentaro Sugano, Kiichi Sato, Kenshi Yao. (2004) New Diagnostic Approaches for Early Detection of Gastric Cancer. Digestive Diseases 22:4, 327-333
CrossRef794
Rocco Maurizio Zagari, Franco Bazzoli. (2004) Gastric Cancer: Who Is at Risk?. Digestive Diseases 22:4, 302-305
CrossRef795
J.-D de Korwin. (2004) Infection à Helicobacter pylori et résistance aux antibiotiques. La Revue de Médecine Interne 25:1, 54-64
CrossRef796
Vuka Katic, Desanka Tasic-Dimov, Jovan Dimitrijevic, Vesna Zivkovic, Dragojlo Gmijovic, Miodrag Stojanovic, Dragoljub Popovic. (2004) Uloga infekcije Helicobacterom pylori u razvoju želudačnih neoplazmi. Vojnosanitetski pregled 61:4, 405-411
CrossRef797
Jia Qing Huang, Ge Fan Zheng, Katica Sumanac, E.Jan Irvine, Richard H Hunt. (2003) Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 125:6, 1636-1644
CrossRef798
HIROYUKI NISHIBAYASHI, SHUJI KANAYAMA, TATSUYA KIYOHARA, KATSUMI YAMAMOTO, YOSHIJI MIYAZAKI, YUICHI YASUNAGA, YASUHISA SHINOMURA, TATSUYA TAKESHITA, TORU TAKEUCHI, KANEHISA MORIMOTO, YUJI MATSUZAWA. (2003) Helicobacter pylori-induced enlarged-fold gastritis is associated with increased mutagenicity of gastric juice, increased oxidative DNA damage, and an increased risk of gastric carcinoma. Journal of Gastroenterology and Hepatology 18:12, 1384-1391
CrossRef799
Andrew G. Harris, Stuart L. Hazell. (2003) Localisation of Helicobacter pylori catalase in both the periplasm and cytoplasm, and its dependence on the twin-arginine target protein, KapA, for activity. FEMS Microbiology Letters 229:2, 283-289
CrossRef800
Hanchen Li, Calin Stoicov, Xun Cai, Timothy C. Wang, JeanMarie Houghton. (2003) Helicobacter and gastric cancer disease mechanisms: Host response and disease susceptibility. Current Gastroenterology Reports 5:6, 459-467
CrossRef801
Michael Camilleri. (2003) GI clinical research 2002–2003: the year in review. Clinical Gastroenterology and Hepatology 1:6, 415-420
CrossRef802
Yasuhiko Kitadai, Atsunori Sasaki, Masanori Ito, Shinji Tanaka, Naohide Oue, Wataru Yasui, Miki Aihara, Kenichi Imagawa, Ken Haruma, Kazuaki Chayama. (2003) Helicobacter pylori infection influences expression of genes related to angiogenesis and invasion in human gastric carcinoma cells. Biochemical and Biophysical Research Communications 311:4, 809-814
CrossRef803
Manfred Stolte, Michael Vieth, Matthias PA Ebert. (2003) High-grade dysplasia in sporadic fundic gland polyps. European Journal of Gastroenterology & Hepatology 15:11, 1153-1156
CrossRef804
Nuno Lunet, Henrique Barros. (2003) Helicobacter pylori infection and gastric cancer: Facing the enigmas. International Journal of Cancer 106:6, 953-960
CrossRef805
Howard C Crawford, Uma S Krishna, Dawn A Israel, Lynn M Matrisian, M.Kay Washington, Richard M Peek. (2003) Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa. Gastroenterology 125:4, 1125-1136
CrossRef806
Annie On On CHAN, Wai Man WONG, Shiu Kum LAM, Benjamin Chun-Yu WONG. (2003) Prevention of gastric cancer. Chinese Journal of Digestive Diseases 4:3, 100-104
CrossRef807
Chun-Mei Zhao, Xin Wang, Lennart Friis-Hansen, Helge L Waldum, Jostein Halgunset, Torkel Wadström, Duan Chen. (2003) Chronic Helicobacter pylori infection results in gastric hypoacidity and hypergastrinemia in wild-type mice but vagally induced hypersecretion in gastrin-deficient mice. Regulatory Peptides 115:3, 161-170
CrossRef808
Satoshi Matsubara, Hideyuki Shibata, Fumiyasu Ishikawa, Teruo Yokokura, Mami Takahashi, Takashi Sugimura, Keiji Wakabayashi. (2003) Suppression of Helicobacter pylori-induced gastritis by green tea extract in Mongolian gerbils. Biochemical and Biophysical Research Communications 310:3, 715-719
CrossRef809
J. D. Korwin. (2003) Conduite à tenir en cas d’infection àH. pylori et de reflux gastro-œsophagien. Acta Endoscopica 33:5, 697-706
CrossRef810
Michael Höcker, Peter Hohenberger. (2003) Helicobacter pylori virulence factors—one part of a big picture. The Lancet 362:9391, 1231-1233
CrossRef811
Nicholas J Talley. (2003) Dyspepsia1 1Loren Laine, M.D.Clinical Management EditorUniversity of Southern CaliforniaLos Angeles, California. Gastroenterology 125:4, 1219-1226
CrossRef812
M. Vergara, M. Vallve, J. P. Gisbert, X. Calvet. (2003) Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication. Alimentary Pharmacology and Therapeutics 18:6, 647-654
CrossRef813
Uday Chand Ghoshal, Rakesh Aggarwal, Chalamalasetty Sreenivasa Baba. (2003) Recurrent duodenal ulcer haemorrhage: a pharmacoeconomic comparison of various management strategies. Expert Opinion on Pharmacotherapy 4:9, 1593-1603
CrossRef814
M.Brian Fennerty. (2003) Gastric intestinal metaplasia on routine endoscopic biopsy. Gastroenterology 125:2, 586-590
CrossRef815
Toshiyuki Itoh, Masaru Yoshida, Tsutomu Chiba, Toru Kita, Yoshio Wakatsuki. (2003) A Coordinated Cytotoxic Effect of IFN-gamma and Cross-Reactive Antibodies in the Pathogenesis of Helicobacter pylori Gastritis. Helicobacter 8:4, 268-278
CrossRef816
S Toracchio, L Marzio. (2003) Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998–2002. Digestive and Liver Disease 35:8, 541-545
CrossRef817
Takanobu Kato, Michiko Miyamoto, Tomoko Date, Kotaro Yasui, Choji Taya, Hiromichi Yonekawa, Chiharu Ohue, Shintaro Yagi, Ekihiro Seki, Tadamichi Hirano, Jiro Fujimoto, Tomoyuki Shirai, Takaji Wakita. (2003) Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice. Cancer Science 94:8, 679-685
CrossRef818
Shigemi Nakajima, Takanori Hattori. (2003) Active and Inactive Gastroesophageal Reflux Diseases Related to Helicobacter pylori Therapy. Helicobacter 8:4, 279-293
CrossRef819
José Carlos Machado, Céu Figueiredo, Paulo Canedo, Paul Pharoah, Ralph Carvalho, Sérgio Nabais, Catarina Castro Alves, Maria Luisa Campos, Leen-jan Van Doorn, Carlos Caldas, Raquel Seruca, Fátima Carneiro, Manuel Sobrinho-Simões. (2003) A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 125:2, 364-371
CrossRef820
Gabriele Capurso, Riccardo Ricci, Francesco Panzuto, Flavia Baccini, Siro Passi, Emilio Di Giulio, Gianfranco Delle Fave, Bruno Annibale. (2003) Intragastric Ascorbic But Not Uric Acid is Depleted in Relation with the Increased pH in Patients with Atrophic Body Gastritis and H. Pylori Gastritis. Helicobacter 8:4, 300-306
CrossRef821
F. Parente, C. Cucino, A. Anderloni, G. Grandinetti, G. Bianchi Porro. (2003) Treatment of Helicobacter Pylori Infection Using a Novel Antiadhesion Compound (3'sialyllactose sodium salt). A Double blind, Placebo-Controlled Clinical Study. Helicobacter 8:4, 252-256
CrossRef822
Mette Wildner—Christensen, Jane MØller Hansen, Ove B Schaffalitzky De Muckadell. (2003) Rates of dyspepsia one year after Helicobacter pylori screening and eradication in a Danish population. Gastroenterology 125:2, 372-379
CrossRef823
F. Cremonini, S. Di Caro, S. Delgado-Aros, A. Sepulveda, G. Gasbarrini, A. Gasbarrini, M. Camilleri. (2003) Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics 18:3, 279-289
CrossRef824
K. B. Hahm, D. H. Kim, K. M. Lee, J. S. Lee, Y. J. Surh, Y. B. Kim, B. M. Yoo, J. H. Kim, H. J. Joo, Y. K. Cho, K. T. Nam, S. W. Cho. (2003) Effect of long-term administration of rebamipide on Helicobacter pylori infection in mice. Alimentary Pharmacology and Therapeutics 18:s1, 24-38
CrossRef825
Peter Hohenberger, Stephan Gretschel. (2003) Gastic cancer. The Lancet 362:9380, 305-315
CrossRef826
M Ohtani, T Azuma, S Yamazaki, A Yamakawa, Y Ito, A Muramatsu, M Dojo, Y Yamazaki, M Kuriyama. (2003) Association of the HLA-DRB1 gene locus with gastric adenocarcinoma in Japan. Digestive and Liver Disease 35:7, 468-472
CrossRef827
Peiguo G. Chu, Zhong Jiang, Lawrence M. Weiss. (2003) Hepatocyte Antigen as a Marker of Intestinal Metaplasia. The American Journal of Surgical Pathology 27:7, 952-959
CrossRef828
T-U. Wheeldon, T. T. H. Hoang, D. C. Phung, A. Bjorkman, M. Granstrom, M. Sorberg. (2003) Helicobacter pylori eradication and peptic ulcer healing: the impact of deleting the proton pump inhibitor and using a once-daily treatment. Alimentary Pharmacology and Therapeutics 18:1, 93-100
CrossRef829
Dietrich Rothenbacher, Hermann Brenner. (2003) Burden of Helicobacter pylori and H. pylori-related diseases in developed countries: recent developments and future implications. Microbes and Infection 5:8, 693-703
CrossRef830
(2003) Celecoxib versus Diclofenac and Omeprazole to Prevent Recurrent Ulcer Bleeding. New England Journal of Medicine 348:24, 2464-2466
Full Text831
R. M. Mc Loughlin, S. S. Sebastian, H. J. O'Connor, M. Buckley, C. A. O'Morain. (2003) Test and treat or test and scope for Helicobacter pylori infection. Any change in gastric cancer prevention?. Alimentary Pharmacology and Therapeutics 17:s2, 82-88
CrossRef832
A. Sasaki, K. Haruma, N. Manabe, S. Tanaka, M. Yoshihara, K. Chayama. (2003) Long-term observation of reflux oesophagitis developing after Helicobacter pylori eradication therapy. Alimentary Pharmacology and Therapeutics 17:12, 1529-1534
CrossRef833
S. Kabir. (2003) Review article: clinic-based testing for Helicobacter pylori infection by enzyme immunoassay of faeces, urine and saliva. Alimentary Pharmacology and Therapeutics 17:11, 1345-1354
CrossRef834
(2003) Helicobacter pylori treatment may not ‘eradicate’ gastric cancer risk. Digestive and Liver Disease 35:6, 450-451
CrossRef835
Masaharu Miyazawa, Hidekazu Suzuki, Tatsuhiro Masaoka, Akemi Kai, Makoto Suematsu, Hiroshi Nagata, Soichiro Miura, Hiromasa Ishii. (2003) Suppressed apoptosis in the inflamed gastric mucosa of Helicobacter pylori-colonized iNOS-knockout mice. Free Radical Biology and Medicine 34:12, 1621-1630
CrossRef836
A Zullo, A Romiti, S Tomao, C Hassan, V Rinaldi, M Giustini, S Morini, F Taggi. (2003) Gastric cancer prevalence in patients with liver cirrhosis. European Journal of Cancer Prevention 12:3, 179-182
CrossRef837
YOUNG-WOON CHANG, SUN-KEE MIN, KYUNG-JIN KIM, YO-SEOB HAN, JOO-HEE LEE, SEOK-HO DONG, HYO-JONG KIM, BYUNG-HO KIM, JOUNG-IL LEE, RIN CHANG. (2003) Delta 13 C-urea breath test value is a useful indicator for Helicobacter pylori eradication in patients with functional dyspepsia. Journal of Gastroenterology and Hepatology 18:6, 726-731
CrossRef838
G. Nardone. (2003) Molecular basis of gastric carcinogenesis. Alimentary Pharmacology and Therapeutics 17:s2, 75-81
CrossRef839
Eliette Touati, Valérie Michel, Jean-Michel Thiberge, Nicole Wuscher, Michel Huerre, Agnès Labigne. (2003) Chronic Helicobacter pylori infections induce gastric mutations in mice1 1This report is dedicated to the memory of Prof. Maurice Hofnung.. Gastroenterology 124:5, 1408-1419
CrossRef840
Jaroslav Zivny, Timothy C. Wang, Rhonda Yantiss, Kyung H. Kim, JeanMarie Houghton. (2003) Role of Therapy or Monitoring in Preventing Progression to Gastric Cancer. Journal of Clinical Gastroenterology 36, S50-60S
CrossRef841
Robert M. Genta. (2003) The Gastritis Connection. Journal of Clinical Gastroenterology 36, 44-49
CrossRef842
Cyrus R. Kapadia. (2003) Gastric Atrophy, Metaplasia, and Dysplasia. Journal of Clinical Gastroenterology 36, S29-S36
CrossRef843
Toshio Yamada, Hiroto Miwa, Takuya Fujino, Shu Hirai, Tetsuji Yokoyama, Nobuhiro Sato. (2003) Improvement of Gastric Atrophy After Helicobacter pylori Eradication Therapy. Journal of Clinical Gastroenterology 36:5, 405-410
CrossRef844
P. Correa. (2003) Bacterial Infections as a Cause of Cancer. JNCI Journal of the National Cancer Institute 95:7, 3E-3E
CrossRef845
E.Isaac Faraji, Barbara B Frank. (2003) Multifocal atrophic gastritis and gastric carcinoma. Hematology/Oncology Clinics of North America 17:2, 487-504
CrossRef846
Kunio Takeuchi, Yoshihiro Ohno, Yasushi Tsuzuki, Tetsu Ando, Masao Sekihara, Takashi Hara, Hiroyuki Kuwano. (2003) Helicobacter pylori Infection and Early Gastric Cancer. Journal of Clinical Gastroenterology 36:4, 321-324
CrossRef847
Takeshi Aihara, Eiji Nakamura, Kikuko Amagase, Kazuyoshi Tomita, Teruaki Fujishita, Kazuharu Furutani, Susumu Okabe. (2003) Pharmacological control of gastric acid secretion for the treatment of acid-related peptic disease: past, present, and future. Pharmacology & Therapeutics 98:1, 109-127
CrossRef848
A Zullo, C Hassan, V De Francesco, R Lorenzetti, M Marignani, S Angeletti, E Ierardi, S Morini. (2003) A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication. Digestive and Liver Disease 35:4, 232-236
CrossRef849
Ai Montani, Shizuka Sasazuki, Manami Inoue, Kazuhide Higuchi, Tetsuo Arakawa, Shoichiro Tsugane. (2003) Food/nutrient intake and risk of atrophic gastritis among the Helicobacter pylori-infected population of northeastern Japan. Cancer Science 94:4, 372-377
CrossRef850
Christian Prinz, Nadia Hafsi, Petra Voland. (2003) Helicobacter pylori virulence factors and the host immune response: implications for therapeutic vaccination. Trends in Microbiology 11:3, 134-138
CrossRef851
Anna H. Wu, Jean E. Crabtree, Leslie Bernstein, Peter Hawtin, Myles Cockburn, Chiu-chen Tseng, David Forman. (2003) Role ofHelicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. International Journal of Cancer 103:6, 815-821
CrossRef852
James Versalovic. (2003) Helicobacter pylori: Pathology and Diagnostic Strategies. American Journal of Clinical Pathology 119:3, 403-412
CrossRef853
Yaron Niv. (2003) Family History of Gastric Cancer. Journal of Clinical Gastroenterology 36:3, 204-208
CrossRef854
Liviu A Sicinschi, Pelayo Correa, Luis E Bravo, Barbara G Schneider. (2003) Detection and typing of Helicobacter pylori cagA/vacA genes by radioactive, one-step polymerase chain reaction in stool samples from children. Journal of Microbiological Methods 52:2, 197-207
CrossRef855
(2003) Discussion 2. Alimentary Pharmacology and Therapeutics 17:s1, 25-27
CrossRef856
Takeshi M. Matsuhisa, Nobutaka Y. Yamada, Shunji K. Kato, Norio M. Matsukura. (2003) Helicobacter pylori Infection, Mucosal Atrophy and Intestinal Metaplasia in Asian Populations: A Comparative Study in Age-, Gender- and Endoscopic Diagnosis-Matched Subjects. Helicobacter 8:1, 29-35
CrossRef857
B. Bjorkholm, P. Falk, L. Engstrand, O. Nyren. (2003) Helicobacter pylori: resurrection of the cancer link. Journal of Internal Medicine 253:2, 102-119
CrossRef858
C. A. Fallone, S. Tran, M. Semret, F. Discepola, M. Behr, A. N. Barkun. (2003) Helicobacter DNA in bile: correlation with hepato-biliary diseases. Alimentary Pharmacology and Therapeutics 17:3, 453-458
CrossRef859
Martin Welin, Noel M. A. Holmgren, Patric Nilsson, Helena Enroth. (2003) Statistical Model of the Interactions Between Helicobacter pylori Infection and Gastric Cancer Development. Helicobacter 8:1, 72-78
CrossRef860
Ki-Baik Hahm, Young-Joon Song, Tae-Young Oh, Jeong-Sang Lee, Young-Joon Surh, Young-Bae Kim, Byung-Moo Yoo, Jin-Hong Kim, Sang-Uk Ha, Ki-Taik Nahm, Myung-Wook Kim, Dae-Yong Kim, Sung-Won Cho. (2003) Chemoprevention of Helicobacter pylori-associated Gastric Carcinogenesis in a Mouse Model; Is It Possible?. Journal of Biochemistry and molecular biology 36:1, 82-94
CrossRef861
Masayuki Tatemichi, Gerson Shigeaki Hamada, Ines Nobuko Nishimoto, Luiz Paulo Kowalski, Kiyoshi Iriya, Joaquim Jose Gama Rodrigues, Shoichiro Tsugane. (2003) Ethnic difference in serology of Helicobacter pylori CagA between Japanese and non-Japanese Brazilians for non-cardia gastric cancer. Cancer Science 94:1, 64-69
CrossRef862
REZA MALEKZADEH, SHAHIN MERAT, MOHAMMAD-HASSAN DERAKHSHAN, FARIDEH SIAVOSHI, ABBAS YAZDANBOD, JAVAD MIKAELI, RASOUL SOTOUDEMANESH, MASOUD SOTOUDEH, MOHAMMAD-JAFAR FARAHVASH, SIAVOSH NASSERI-MOGHADDAM, AKRAM POURSHAMS, SHAHAB DOLATSHAHI, BEHNOOSH ABEDI, MASOUD BABAEI, SHAHNAM ARSHI, ALI MAJIDPOUR. (2003) Low Helicobacter pylori eradication rates with 4- and 7-day regimens in an Iranian population. Journal of Gastroenterology and Hepatology 18:1, 13-17
CrossRef863
H. Kawabata, Y. Habu, H. Tomioka, H. Kutsumi, M. Kobayashi, K. Oyasu, T. Hayakumo, S. Mizuno, K. Kiyota, M. Nakajima, K. Kimoto, H. Inokuchi, K. Kawai. (2003) Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin. Alimentary Pharmacology and Therapeutics 17:2, 259-264
CrossRef864
Jon R. Kelley, John M. Duggan. (2003) Gastric cancer epidemiology and risk factors. Journal of Clinical Epidemiology 56:1, 1-9
CrossRef865
Raquel Almeida, Elisabete Silva, Filipe Santos-Silva, Debra G Silberg, Jiangfu Wang, Carmen De Bol
CrossRef866
D. Y. Graham, A. R. Opekun, Y. Yamaoka, M. S. Osato, H. M. T. El-Zimaity. (2003) Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. Alimentary Pharmacology and Therapeutics 17:2, 193-200
CrossRef867
Ka-Fai To, Wai K. Leung, Tin-Lap Lee, Jun Yu, Joanna H.M. Tong, Michael W.Y. Chan, Enders K.W. Ng, S.C. Sydney Chung, Joseph J.Y. Sung. (2002) Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. International Journal of Cancer 102:6, 623-628
CrossRef868
M Weisse, R Moore. 2002. Antimicrobial effects of wine. , 299-313.
CrossRef869
Marina Mollenhauer-Rektorschek, Guido Hanauer, George Sachs, Klaus Melchers. (2002) Expression of UreI is required for intragastric transit and colonization of gerbil gastric mucosa by Helicobacter pylori. Research in Microbiology 153:10, 659-666
CrossRef870
Barbara L Bass. (2002) What’s new in general surgery: gastrointestinal conditions. Journal of the American College of Surgeons 195:6, 835-854
CrossRef871
George Sachs, Jai Moo Shin, Olga Vagin, Keith Munson, David Weeks, David R Scott, Petra Voland. (2002) Current trends in the treatment of upper gastrointestinal disease. Best Practice & Research Clinical Gastroenterology 16:6, 835-849
CrossRef872
S. Vincent Rajkumar, Robert A. Kyle, Matthew F. Plevak, Joseph A. Murray, Terry M. Therneau. (2002) Helicobacter pylori infection and monoclonal gammopathy of undetermined significance. British Journal of Haematology 119:3, 706-708
CrossRef873
Xueyuan Cao, Tetsuya Tsukamoto, Koji Nozaki, Harunari Tanaka, Nobuyuki Shimizu, Michio Kaminishi, Toshiko Kumagai, Masae Tatematsu. (2002) Earlier Helicobacter pylori Infection Increases the Risk for the N-Methyl-N-nitrosourea-induced Stomach Carcinogenesis in Mongolian Gerbils. Cancer Science 93:12, 1293-1298
CrossRef874
Li Li, Robert M. Genta, Mae F. Go, Oscar Gutierrez, Jong G. Kim, David Y. Graham. (2002) Helicobacter pylori Strain and the Pattern of Gastritis Among First-Degree Relatives of Patients with Gastric Carcinoma. Helicobacter 7:6, 349-355
CrossRef875
Mae F. Go. (2002) Treatment and management of Helicobacter pylori infection. Current Gastroenterology Reports 4:6, 471-477
CrossRef876
Michael K. Sanders, David A. Peura. (2002) Helicobacter pylori-associated diseases. Current Gastroenterology Reports 4:6, 448-454
CrossRef877
Milutin Bulajic, Patrick Maisonneuve, Wulf Schneider-Brachert, Petra M
CrossRef878
M. Hojo, H. Miwa, T. Ohkusa, R. Ohkura, A. Kurosawa, N. Sato. (2002) Alteration of histological gastritis after cure of Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics 16:11, 1923-1932
CrossRef879
M. Miyamoto, K. Haruma, M. Yoshihara, M. Sumioka, T. Nishisaka, S. Tanaka, K. Inoue, K. Chayama. (2002) Five cases of nodular gastritis and gastric cancer: a possible association between nodular gastritis and gastric cancer. Digestive and Liver Disease 34:11, 819-820
CrossRef880
Pelayo Correa. (2002) Gastric neoplasia. Current Gastroenterology Reports 4:6, 463-470
CrossRef881
Minatsu Kobayashi, Yoshitaka Tsubono, Shizuka Sasazuki, Satoshi Sasaki, Shoichiro Tsugane, . (2002) Vegetables, fruit and risk of gastric cancer in Japan: A 10-year follow-up of the JPHC study Cohort I. International Journal of Cancer 102:1, 39-44
CrossRef882
Suerbaum, Sebastian, Michetti, Pierre, . (2002) Helicobacter pylori Infection. New England Journal of Medicine 347:15, 1175-1186
Full Text883
Vincenzo Francesco, Domenico Faleo, Carmen Panella, Enzo Ierardi, Marcella Margiotta. (2002) Sequential eradicating therapy: a treatment that does not discriminate Helicobacter pylori strains in patients with nonulcer dyspepsia?. The American Journal of Gastroenterology 97:10, 2686-2687
CrossRef884
Alberto Pilotto, Nathalie Salles. (2002) Helicobacter pylori infection in geriatrics. Helicobacter 7:s1, 56-62
CrossRef885
B. Annibale, E. Di Giulio, P. Caruana, E. Lahner, G. Capurso, C. Bordi, G. Delle Fave. (2002) The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis. Alimentary Pharmacology and Therapeutics 16:10, 1723-1731
CrossRef886
Antonia R. Sepulveda, Luiz Gonzaga V. Coelho. (2002) Helicobacter pylori and gastric malignancies. Helicobacter 7:s1, 37-42
CrossRef887
L. Perez Aldana, M. Kato, S. Nakagawa, M. Kawarasaki, T. Nagasako, T. Mizushima, H. Oda, J. Kodaira, Y. Shimizu, Y. Komatsu, R. Zheng, H. Takeda, T. Sugiyama, M. Asaka. (2002) The Relationship Between Consumption of Antimicrobial Agents and the Prevalence of Primary Helicobacter pylori Resistance. Helicobacter 7:5, 306-309
CrossRef888
Brian Sullivan, Walter Coyle, Richard Nemec, Thomas Dunteman. (2002) Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori. The American Journal of Gastroenterology 97:10, 2536-2539
CrossRef889
MICHIKO YAMASHITA, MITSUYOSHI HIROKAWA, MASAHIKO NAKASONO, HIROSHI KIYOKU, NOBUYA SANO, MASAHIKO FUJII, TAKASHI KOYAMA, SADAHIRO YOSHIDA, TOSHIAKI SANO. (2002) Gastric inverted hyperplastic polyp. Report of four cases and relation to gastritis cystica profunda. APMIS 110:10, 717-723
CrossRef890
Michio Kaminishi, Hirokazu Yamaguchi, Sachiyo Nomura, Takeshi Oohara, Shigeru Sakai, Hisayuki Fukutomi, Akira Nakahara, Hiromasa Kashimura, Masaya Oda, Tetsuji Kitahora, Hideyuki Ichikawa, Tsuyosi Yabana, Yuichi Yagawa, Toshiro Sugiyama, Masayuki Itabashi, Masamitsu Unakami, Yanao Oguro, Takao Sakita. (2002) Endoscopic classification of chronic gastritis based on a pilot study by the research society for gastritis. Digestive Endoscopy 14:4, 138-151
CrossRef891
Markus Gerhard, Roland Rad, Christian Prinz, Michael Naumann. (2002) Pathogenesis of Helicobacter pylori infection. Helicobacter 7:s1, 17-23
CrossRef892
F. Francesch, R.M. Genta, A. Gasbarrini, N.Gentiloni Silveri, G. Gasbarrini, A.R. Sepulveda. (2002) Helicobacter pylori infection and expression of the angiogenic factor platelet-derived endothelial cell growth factor by pre-neoplastic gastric mucosal lesions and gastric carcinoma. Digestive and Liver Disease 34:9, 621-625
CrossRef893
Francis KL Chan, WK Leung. (2002) Peptic-ulcer disease. The Lancet 360:9337, 933-941
CrossRef894
Douglas J. Passaro, E. Julia Chosy, Julie Parsonnet. (2002) Helicobacter pylori: Consensus and Controversy. Clinical Infectious Diseases 35:3, 298-304
CrossRef895
Toshio Fukai, Ai Marumo, Kiyoshi Kaitou, Toshihisa Kanda, Sumio Terada, Taro Nomura. (2002) Anti-Helicobacter pylori flavonoids from licorice extract. Life Sciences 71:12, 1449-1463
CrossRef896
Rino Rappuoli, Duccio Berti, Samuele Peppoloni, Giuseppe Del Giudice, Paolo Ruggiero. (2002) New strategies for the prevention and treatment of Helicobacter pylori infection. Expert Opinion on Investigational Drugs 11:8, 1127-1138
CrossRef897
Tsutomu Chiba. (2002) Factors contributing to the development of gastric cancer due to Helicobacter pylori infection. Current Gastroenterology Reports 4:4, 267-268
CrossRef898
M. Ito, K. Haruma, T. Kamada, M. Mihara, S. Kim, Y. Kitadai, M. Sumii, S. Tanaka, M. Yoshihara, K. Chayama. (2002) Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Alimentary Pharmacology and Therapeutics 16:8, 1449-1456
CrossRef899
Toru Hiyama, Shinji Tanaka, Yasuhiko Kitadai, Masanori Ito, Masaharu Sumii, Masaharu Yoshihara, Fumio Shimamoto, Ken Haruma, Kazuaki Chayama. (2002) p53 Codon 72 polymorphism in gastric cancer susceptibility in patients withHelicobacter pylori-associated chronic gastritis. International Journal of Cancer 100:3, 304-308
CrossRef900
R. M. Genta. (2002) After gastritis - an imaginary journey into a Helicobacter-free world. Alimentary Pharmacology and Therapeutics 16:s4, 89-94
CrossRef901
C Wallasch, J.E Crabtree, D Bevec, P.A Robinson, H Wagner, A Ullrich. (2002) Helicobacter pylori-stimulated EGF receptor transactivation requires metalloprotease cleavage of HB-EGF. Biochemical and Biophysical Research Communications 295:3, 695-701
CrossRef902
W. K. Leung, J. J. Y. Sung. (2002) Intestinal metaplasia and gastric carcinogenesis. Alimentary Pharmacology and Therapeutics 16:7, 1209-1216
CrossRef903
A. Axon. (2002) Gastric cancer and Helicobacter pylori. Alimentary Pharmacology and Therapeutics 16:s4, 83-88
CrossRef904
E.Isaac Faraji, Barbara B Frank. (2002) Multifocal atrophic gastritis and gastric carcinoma. Gastroenterology Clinics of North America 31:2, 499-516
CrossRef905
Howard C. Crawford, Charles R. Scoggins, M. Kay Washington, Lynn M. Matrisian, Steven D. Leach. (2002) Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas. Journal of Clinical Investigation 109:11, 1437-1444
CrossRef906
Jeanmarie Houghton, James G Fox, Timothy C Wang. (2002) Gastric cancer: Laboratory bench to clinic. Journal of Gastroenterology and Hepatology 17:4, 495-502
CrossRef907
Judy B. Splawski. (2002) Helicobacter pylori and Nonulcer Dyspepsia: Is There a Relation?. Journal of Pediatric Gastroenterology and Nutrition 34:3, 274
CrossRef908
Uri Ladabaum, William D. Chey. (2002) Uninvestigated dyspepsia. Current Treatment Options in Gastroenterology 5:2, 125-131
CrossRef909
Yuzo Mitsuno, Shin Maeda, Haruhiko Yoshida, Yoshihiro Hirata, Keiji Ogura, Masao Akanuma, Takao Kawabe, Yasushi Shiratori, Masao Omata. (2002) Helicobacter pylori Activates the Proto-oncogene c-fos through SRE Transactivation. Biochemical and Biophysical Research Communications 291:4, 868-874
CrossRef910
Kenji Noguchi, Katsuaki Kato, Takuya Moriya, Takashi Suzuki, Michiya Saito, Tohru Kikuchi, Jing Yang, Akira Imatani, Hitoshi Sekine, Syuichi Ohara, Takayoshi Toyota, Tooru Shimosegawa, Hironobu Sasano. (2002) Analysis of cell damage in Helicobacter pylori-associated gastritis. Pathology International 52:2, 110-118
CrossRef911
C. E. M. De Block, I. H. De Leeuw, J. J. P. M. Bogers, P. A. Pelckmans, M. M. Ieven, E. A. E. Van Marck, V. Van Hoof, E. Maday, K. L. Van Acker, L. F. Van Gaal. (2002) Helicobacter pylori, parietal cell antibodies and autoimmune gastropathy in type 1 diabetes mellitus. Alimentary Pharmacology and Therapeutics 16:2, 281-289
CrossRef912
(2002) Helicobacter pylori Infection and the Development of Gastric Cancer. New England Journal of Medicine 346:1, 65-67
Full Text913
Norio Matsukura. (2002) Relation Between Helicobacter Pylori and Diseases: Knowledge for Clinician. Journal of Nippon Medical School 69:2, 200-204
CrossRef914
Naoki MANTANI, Nobuyasu SEKIYA, Shinya SAKAI, Toshiaki KOGURE, Yutaka SHIMADA, Katsutoshi TERASAWA. (2002) Rhubarb Use in Patients Treated with Kampo Medicines. A Risk for Gastric Cancer?. YAKUGAKU ZASSHI 122:6, 403-405
CrossRef915
Antonio Crespo, Byungse Suh. (2001) Helicobacter pylori infection: Epidemiology, pathophysiology, and therapy. Archives of Pharmacal Research 24:6, 485-498
CrossRef916
Fox, James G., , Wang, Timothy C., . (2001) Helicobacter pylori — Not a Good Bug after All. New England Journal of Medicine 345:11, 829-832
Full Text
